Publications de l’équipe 2

Genomics & Biomarkers of lymphoma & Solid Tumors team 2021-2026
in chronological order

Original articles as first/last/corresponding

1. Krzisch D, Zduniak A, Veresezan EL, Daliphard S, Contentin N, Penther D, Etancelin P, Jardin F, Camus V. Successful treatment of T/myeloid mixed-phenotype acute leukemia with the translocation (10;11)(p13;q14) PICALM/AF10 with 3 + 7 myeloid standard treatment: A case report. Clin Case Rep. 2021 Jan 29;9(3):1507-1513. doi: 10.1002/ccr3.3815. PMID: 33768878; PMCID: PMC7981630. https://onlinelibrary.wiley.com/doi/10.1002/ccr3.3815
2. Thureau S, Lebret L, Lequesne J, Cabourg M, Dandoy S, Gouley C, Lefebvre L, Mallet R, Mihailescu SD, Moldovan C, Rigal O, Veresezan O, Modzewelski R, Clatot F. Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy. Cancers (Basel). 2021 Feb 11;13(4):753. doi: 10.3390/cancers13040753. PMID: 33670339; PMCID: PMC7917983. https://www.mdpi.com/2072-6694/13/4/753
3. Zduniak A, Mihailescu SD, Lequesne J, Lenain P, Contentin N, Pepin LF, Ménard AL, Leprêtre S, Lemasle E, Lanic H, Stamatoullas-Bastard A, Tilly H, Tamion F,Jardin F, Camus V. Outcomes after intensive care unit admission in newly diagnosed diffuse large B-cell lymphoma patients: A real-life study. Eur J Haematol. 2021 Jun;106(6):788-799. doi: 10.1111/ejh.13606. Epub 2021 Mar 5. PMID: 33624346. https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13606
4. Texte E, Lequesne J, Tilly H, Jardin F, Vera P, Stamatoullas A, Becker S. SUVmax-based assessment of PET response shows a superior specificity to Deauville criteria for predicting recurrence in Hodgkin’s lymphoma. Leuk Lymphoma. 2021 May;62(5):1088-1097. doi: 10.1080/10428194.2020.1855341. Epub 2020 Dec 8. PMID: 33289431.
5. Camus V, Jardin F. Cell-Free DNA for the Management of Classical Hodgkin Lymphoma. Pharmaceuticals (Basel). 2021 Mar 2;14(3):207. doi: 10.3390/ph14030207. PMID: 33801462; PMCID: PMC7998645. https://www.mdpi.com/1424-8247/14/3/207
6. Camus V, Bigenwald C, Ribrag V, Lazarovici J, Jardin F, Sarkozy C. Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacy. Expert Rev Anticancer Ther. 2021 Sep;21(9):941-956. doi: 10.1080/14737140.2021.1953986. Epub 2021 Aug 18. PMID: 34233557. https://www.tandfonline.com/doi/10.1080/14737140.2021.1953986?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
7. Camus V, Tilly H. Polatuzumab vedotin, an anti-CD79b antibody-drug conjugate for the treatment of relapsed/refractory diffuse large B-cell lymphoma. Future Oncol. 2021 Jan;17(2):127-135. doi: 10.2217/fon-2020-0675. Epub 2020 Sep 21. PMID: 32954807. https://www.tandfonline.com/doi/10.2217/fon-2020-0675?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
8. Jaouadi O, Limam I, Abdelkarim M, Berred E, Chahbi A, Caillot M, Sola B, Ben Aissa-Fennira F. 5,6-Epoxycholesterol Isomers Induce Oxiapoptophagy in Myeloma Cells. Cancers (Basel). 2021 Jul 26;13(15):3747. doi: 10.3390/cancers13153747. PMID: 34359648; PMCID: PMC8345143. https://www.mdpi.com/2072-6694/13/15/3747
9. Saidak Z, Soudet S, Lottin M, Salle V, Sevestre MA, Clatot F, Galmiche A. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment. Cancer Immunol Immunother. 2021 Apr;70(4):923-933. doi: 10.1007/s00262-020-02739-w. Epub 2020 Oct 15. PMID: 33057845; PMCID: PMC10991611. https://link.springer.com/article/10.1007/s00262-020-02739-w
10. Dubois S, Ruminy P, Bohers E, Viailly PJ, Veresezan L, Picquenot JM, Bobée V, Viennot M, Penther D, Camus V, Thieblemont C, Pouaty C, Tilly H, Jardin F. Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma. Clin Case Rep. 2021 Aug 16;9(8):e04504. doi: 10.1002/ccr3.4504. PMID: 34429980; PMCID: PMC8365538. https://onlinelibrary.wiley.com/doi/10.1002/ccr3.4504
11. Pénichoux J, Dubois S, Krzisch D, Menard AL, Lanic H, Camus V, Lemasle E, Leprêtre S, Lenain P, Contentin N, Daliphard S, Buchonnet G, Penther D, Bastard C, Tilly H, Jardin F, Stamatoullas A. Prognostic relevance of lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience. Leuk Lymphoma. 2021 Sep;62(9):2272-2275. doi: 10.1080/10428194.2021.1907381. Epub 2021 Apr 2. PMID: 33797310. https://www.tandfonline.com/doi/10.1080/10428194.2021.1907381?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
12. Piton N, Lanic MD, Marguet F, Lamy A, Blanchard F, Guisier F, Viennot M, Salaün M, Thiberville L, Jardin F,Sabourin JC, Ruminy P. An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology. Lab Invest. 2021 May;101(5):648-660. doi: 10.1038/s41374-021-00536-2. Epub 2021 Jan 25. PMID: 33495574. https://www.sciencedirect.com/science/article/pii/S0023683722006432?via%3Dihub
13. Caillot M, Dakik H, Mazurier F, Sola B. Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death. Cancers (Basel). 2021 May 17;13(10):2411. doi: 10.3390/cancers13102411. PMID: 34067602; PMCID: PMC8156203. https://www.mdpi.com/2072-6694/13/10/2411
14. Drieux F, Ruminy P, Sater V, Marchand V, Fataccioli V, Lanic MD, Viennot M, Viailly PJ, Sako N, Robe C, Dupuy A, Vallois D, Veresezan L, Poullot E, Picquenot JM, Bossard C, Parrens M, Lemonnier F, Jardin F, de Leval L, Gaulard P. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay. J Mol Diagn. 2021 Aug;23(8):929-940. doi: 10.1016/j.jmoldx.2021.04.013. Epub 2021 Jun 18. PMID: 34147695. https://www.sciencedirect.com/science/article/pii/S1525157821001240?via%3Dihub
15. Zalmaï L, Viailly PJ, Biichle S, Cheok M, Soret L, Angelot-Delettre F, Petrella T, Collonge-Rame MA, Seilles E, Geffroy S, Deconinck E, Daguindau E, Bouyer S, Dindinaud E, Baunin V, Le Garff-Tavernier M, Roos-Weil D, Wagner-Ballon O, Salaun V, Feuillard J, Brun S, Drenou B, Mayeur-Rousse C, Okamba P, Dorvaux V, Tichionni M, Rose J, Rubio MT, Jacob MC, Raggueneau V, Preudhomme C, Saas P, Ferrand C, Adotevi O, Roumier C, Jardin F, Garnache-Ottou F, Renosi F. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape. Haematologica. 2021 Dec 1;106(12):3056-3066. doi: 10.3324/haematol.2020.253740. PMID: 33054115; PMCID: PMC8634182. https://haematologica.org/article/view/haematol.2020.253740
16. Camus V, Viennot M, Lequesne J, Viailly PJ, Bohers E, Bessi L, Marcq B, Etancelin P, Dubois S, Picquenot JM, Veresezan EL, Cornic M, Burel L, Loret J, Becker S, Decazes P, Lenain P, Lepretre S, Lemasle E, Lanic H, Ménard AL, Contentin N, Tilly H, Stamatoullas A, Jardin F. Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. Haematologica. 2021 Jan 1;106(1):154-162. doi: 10.3324/haematol.2019.237719. PMID: 32079702; PMCID: PMC7776248. https://haematologica.org/article/view/9656
17. Oberic L, Peyrade F, Puyade M, Bonnet C, Dartigues-Cuillères P, Fabiani B, Ruminy P, Maisonneuve H, Abraham J, Thieblemont C, Feugier P, Salles G, Bijou F, Pica GM, Damaj G, Haioun C, Casasnovas RO, Farhat H, Le Calloch R, Waultier-Rascalou A, Malak S, Paget J, Gat E, Tilly H, Jardin F. Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older. J Clin Oncol. 2021 Apr 10;39(11):1203-1213. doi: 10.1200/JCO.20.02666. Epub 2021 Jan 14. PMID: 33444079. https://orbi.uliege.be/handle/2268/256117
18. Csanyi-Bastien M, Lanic MD, Beaussire L, Ferric S, François A, Meseure D, Jardin F, Wassef M, Ruminy P, Laé M. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors. Am J Surg Pathol. 2021 Nov 1;45(11):1487-1498. doi: 10.1097/PAS.0000000000001718. PMID: 33899788. https://journals.lww.com/ajsp/fulltext/2021/11000/pan_trk_immunohistochemistry_is_highly_correlated.5.aspx
19. Saidak Z, Lailler C, Testelin S, Chauffert B, Clatot F, Galmiche A. Contribution of Genomics to the Surgical Management and Study of Oral Cancer. Ann Surg Oncol. 2021 Oct;28(11):5842-5854. doi: 10.1245/s10434-021-09904-0. Epub 2021 Apr 12. PMID: 33846893; PMCID: PMC8460589. https://link.springer.com/article/10.1245/s10434-021-09904-0
20. Sefrioui D, Beaussire L, Gillibert A, Blanchard F, Toure E, Bazille C, Perdrix A, Ziegler F, Gangloff A, Hassine M, Elie C, Bignon AL, Parzy A, Gomez P, Thill C, Clatot F, Sabourin JC, Frebourg T, Benichou J, Bouhier-Leporrier K, Gallais MP, Sarafan-Vasseur N, Michel P, Di Fiore F. CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC). Br J Cancer. 2021 Aug;125(5):725-733. doi: 10.1038/s41416-021-01431-9. Epub 2021 Jun 10. PMID: 34112948; PMCID: PMC8405627. https://pmc.ncbi.nlm.nih.gov/articles/PMC8405627/
21. Vion R, Fontanilles M, Di Fiore F, Clatot F. Place des biopsies liquides dans le diagnostic et la caractérisation moléculaire des cancers du sein: Role of liquid biopsies in the diagnosis and molecular characterization of breast cancer. Bull Cancer. 2021 Dec;108(11S):11S46-11S54. French. doi: 10.1016/S0007-4551(21)00636-6. PMID: 34969515. https://www.sciencedirect.com/science/article/pii/S0007455121006366?via%3Dihub
22. Viailly PJ, Sater V, Viennot M, Bohers E, Vergne N, Berard C, Dauchel H, Lecroq T, Celebi A, Ruminy P, Marchand V, Lanic MD, Dubois S, Penther D, Tilly H, Mareschal S, Jardin F. Improving high-resolution copy number variation analysis from next generation sequencing using unique molecular identifiers. BMC Bioinformatics. 2021 Mar 12;22(1):120. doi: 10.1186/s12859-021-04060-4. PMID: 33711922; PMCID: PMC7971104. https://link.springer.com/article/10.1186/s12859-021-04060-4
23. Piton N, Marguet F, Guisier F, Lamy A, Sabourin JC. Le RNAseq en oncologie de routine [RNAseq in routine oncology]. Ann Pathol. 2021 Sep;41(5):463-469. French. doi: 10.1016/j.annpat.2021.06.003. Epub 2021 Aug 8. PMID: 34376297. https://www.sciencedirect.com/science/article/pii/S024264982100136X?via%3Dihub
24. Cazelles C, Belhadj K, Vellemans H, Camus V, Poullot E, Gaulard P, Veresezan L, Itti E, Becker S, Carvalho M, Dupuis J, Le Bras F, Lemonnier F, Roulin L, El Gnaoui T, Jardin F, Mounier N, Tilly H, Haioun C. Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation. Leuk Lymphoma. 2021 Sep;62(9):2161-2168. doi: 10.1080/10428194.2021.1901090. Epub 2021 Mar 25. PMID: 33764240. https://www.tandfonline.com/doi/10.1080/10428194.2021.1901090?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
25. Bohers E, Viailly PJ, Jardin F. cfDNA Sequencing: Technological Approaches and Bioinformatic Issues. Pharmaceuticals (Basel). 2021 Jun 21;14(6):596. doi: 10.3390/ph14060596. PMID: 34205827; PMCID: PMC8234829. https://www.mdpi.com/1424-8247/14/6/596 /
26. Camus V, Rossi C, Sesques P, Lequesne J, Tonnelet D, Haioun C, Durot E, Willaume A, Gauthier M, Moles-Moreau MP, Antier C, Lazarovici J, Monjanel H, Bernard S, Tardy M, Besson C, Lebras L, Choquet S, Le Du K, Bonnet C, Bailly S, Damaj G, Laribi K, Maisonneuve H, Houot R, Chauchet A, Jardin F, Traverse-Glehen A, Decazes P, Becker S, Berriolo-Riedinger A, Tilly H. Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Blood Adv. 2021 Oct 12;5(19):3862-3872. doi: 10.1182/bloodadvances.2021004778. PMID: 34461634; PMCID: PMC8679665. https://pmc.ncbi.nlm.nih.gov/articles/PMC8679665/
27. Olympios N, Gilard V, Marguet F, Clatot F, Di Fiore F, Fontanilles M. TERT Promoter Alterations in Glioblastoma: A Systematic Review. Cancers (Basel). 2021 Mar 8;13(5):1147. doi: 10.3390/cancers13051147. PMID: 33800183; PMCID: PMC7962450. https://www.mdpi.com/2072-6694/13/5/1147
28. Fontanilles M, Sanson M, Touat M. Liquid biopsy in neuro-oncology: are we finally there? Ann Oncol. 2021 Dec;32(12):1472-1474. doi: 10.1016/j.annonc.2021.10.215. PMID: 34815016. https://www.sciencedirect.com/science/article/pii/S0923753421047517?via%3Dihub
29. Tonnelet D, Bohn MDP, Becker S, Decazes P, Camus V, Thureau S, Tilly H, Jardin F, Vera P. Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence. EJNMMI Res. 2021 Apr 12;11(1):37. doi: 10.1186/s13550-021-00776-9. PMID: 33846870; PMCID: PMC8041962. https://link.springer.com/article/10.1186/s13550-021-00776-9
30. Allouchery V, Perdrix A, Calbrix C, Berghian A, Lequesne J, Fontanilles M, Leheurteur M, Etancelin P, Sarafan-Vasseur N, Di Fiore F, Clatot F. Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients. Sci Rep. 2021 Dec 15;11(1):24041. doi: 10.1038/s41598-021-02643-y. PMID: 34911971; PMCID: PMC8674263. https://pmc.ncbi.nlm.nih.gov/articles/PMC8674263/
31. Le Gouill S, Ghesquières H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Lamy T, Thieblemont C, Maisonneuve H, Gressin R, Bouhabdallah K, Haioun C, Damaj G, Fornecker L, Bouhabdallah R, Feugier P, Sibon D, Cartron G, Bonnet C, André M, Chartier L, Ruminy P, Kraeber-Bodéré F, Bodet-Milin C, Berriolo-Riedinger A, Brière J, Jais JP, Molina TJ, Itti E, Casasnovas RO. Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA. Blood. 2021 Apr 29;137(17):2307-2320. doi: 10.1182/blood.2020008750. PMID: 33211799. https://www.sciencedirect.com/science/article/pii/S0006497121009125?via%3Dihub
32. Troussard X, Maitre E, Paillassa J. Leucémie à tricholeucocytes : quelles sont les meilleures options thérapeutiques pour les patients en rechute ou réfractaires ? [Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]. Bull Cancer. 2021 Jul-Aug;108(7-8):771-778. French. doi: 10.1016/j.bulcan.2021.03.011. Epub 2021 May 20. PMID: 34023063. https://www.sciencedirect.com/science/article/pii/S0007455121001661?via%3Dihub
33. Troussard X, Grever MR. The revised guidelines for the diagnosis and management of hairy cell leukaemia and the hairy cell leukaemia variant. Br J Haematol. 2021 Apr;193(1):11-14. doi: 10.1111/bjh.17201. Epub 2020 Dec 23. PMID: 33368172. https://onlinelibrary.wiley.com/doi/10.1111/bjh.17201
34. Jardin F. NFkB Pathway and Hodgkin Lymphoma. Biomedicines. 2022 Sep 1;10(9):2153. doi: 10.3390/biomedicines10092153. PMID: 36140254; PMCID: PMC9495867. https://www.mdpi.com/2227-9059/10/9/2153
35. Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trněný M, Sharman JP, Herbaux C, Burke JM, Matasar M, Rai S, Izutsu K, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Greil R, Mykhalska L, Bergua-Burgués JM, Cheung MC, Pinto A, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Hirata J, Jiang Y, Yan M, Lee C, Flowers CR, Salles G. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma. N Engl J Med. 2022 Jan 27;386(4):351-363. doi: 10.1056/NEJMoa2115304. Epub 2021 Dec 14. PMID: 34904799; PMCID: PMC11702892. https://pmc.ncbi.nlm.nih.gov/articles/PMC11702892/
36. Jardin F, Tilly H. Chemotherapy-free treatment in unfit patients aged 75 years and older with DLBCL: toward a new paradigm? Lancet Healthy Longev. 2022 Jul;3(7):e453-e454. doi: 10.1016/S2666-7568(22)00150-7. PMID: 36102755. https://www.sciencedirect.com/science/article/pii/S2666756822001507?via%3Dihub
37. Paunescu AC, Copie Bergman C, Malak S, Le Gouill S, Ribrag V, Bouabdallah K, Sibon D, Rumpold G, Preau M, Mounier N, Haioun C, Jardin F, Besson C. Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study. Ann Hematol. 2022 Feb;101(2):333. doi: 10.1007/s00277-021-04705-7. Erratum for: Ann Hematol. 2022 Feb;101(2):317-332. doi: 10.1007/s00277-021-04689-4. PMID: 34694443; PMCID: PMC9119275. https://link.springer.com/article/10.1007/s00277-021-04705-7
38. Paunescu AC, Copie CB, Malak S, Gouill SL, Ribrag V, Bouabdallah K, Sibon D, Rumpold G, Preau M, Mounier N, Haioun C, Jardin F, Besson C. Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study. Ann Hematol. 2022 Feb;101(2):317-332. doi: 10.1007/s00277-021-04689-4. Epub 2021 Oct 6. Erratum in: Ann Hematol. 2022 Feb;101(2):333. doi: 10.1007/s00277-021-04705-7. PMID: 34617134; PMCID: PMC8494456. https://pmc.ncbi.nlm.nih.gov/articles/PMC8494456/
39. Maitre E, Paillassa J, Troussard X. Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders. Front Oncol. 2022 Dec 22;12:1068981. doi: 10.3389/fonc.2022.1068981. PMID: 36620555; PMCID: PMC9815161. https://pmc.ncbi.nlm.nih.gov/articles/PMC9815161/
40. Maitre E, Cornet E, Debliquis A, Drenou B, Gravey F, Chollet D, Cheze S, Docquier M, Troussard X, Matthes T. Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy. J Cancer Res Clin Oncol. 2022 Aug;148(8):2013-2022. doi: 10.1007/s00432-022-04010-4. Epub 2022 Apr 27. PMID: 35476232; PMCID: PMC9293816. https://pmc.ncbi.nlm.nih.gov/articles/PMC9293816/
41. Paillassa J, Maitre E, Troussard X. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances. Curr Oncol Rep. 2022 Sep;24(9):1133-1143. doi: 10.1007/s11912-022-01285-1. Epub 2022 Apr 11. PMID: 35403971.
42. Maitre E, Cornet E, Salaün V, Kerneves P, Chèze S, Repesse Y, Damaj G, Troussard X. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders. Cancers (Basel). 2022 Feb 18;14(4):1050. doi: 10.3390/cancers14041050. PMID: 35205796; PMCID: PMC8870214. https://pmc.ncbi.nlm.nih.gov/articles/PMC8870214/
43. Anderson RA, Kelsey TW, Perdrix A, Olympios N, Duhamel O, Lambertini M, Clatot F. Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer. Breast Cancer Res Treat. 2022 Apr;192(2):273-282. doi: 10.1007/s10549-021-06508-w. Epub 2022 Jan 8. PMID: 34997365; PMCID: PMC8927041. https://link.springer.com/article/10.1007/s10549-021-06508-w
44. Camus V, Belot A, Oberic L, Sibon D, Ghesquières H, Thieblemont C, Fruchart C, Casasnovas O, Michot JM, Molina TJ, Bosly A, Joubert C, Haioun C, Nicolas-Virelizier E, Feugier P, Fitoussi O, Delarue R, Tilly H. Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial. Blood Adv. 2022 Dec 27;6(24):6169-6179. doi: 10.1182/bloodadvances.2022007609. PMID: 35737565; PMCID: PMC9772793. https://pmc.ncbi.nlm.nih.gov/articles/PMC9772793/
45. Grancher A, Beaussire L, Manfredi S, Le Malicot K, Dutherage M, Verdier V, Mulot C, Bouché O, Phelip JM, Levaché CB, Deguiral P, Coutant S, Sefrioui D, Emile JF, Laurent-Puig P, Bibeau F, Michel P, Sarafan-Vasseur N, Lepage C, Di Fiore F. Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer. Front Oncol. 2022 Nov 10;12:973167. doi: 10.3389/fonc.2022.973167. PMID: 36439476; PMCID: PMC9685416. https://pmc.ncbi.nlm.nih.gov/articles/PMC9685416/
46. Sater V, Viailly PJ, Lecroq T, Prieur-Gaston É, Bohers É, Viennot M, Ruminy P, Dauchel H, Vera P, Jardin F. UMI-Varcal: A Low-Frequency Variant Caller for UMI-Tagged Paired-End Sequencing Data. Methods Mol Biol. 2022;2493:235-245. doi: 10.1007/978-1-0716-2293-3_14. PMID: 35751818.
47. Pirlog R, Piton N, Lamy A, Guisier F, Berindan-Neagoe I, Sabourin JC, Marguet F. Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas. Cancers (Basel). 2022 Feb 17;14(4):1030. doi: 10.3390/cancers14041030. PMID: 35205778; PMCID: PMC8870399. https://pmc.ncbi.nlm.nih.gov/articles/PMC8870399/
48. Mihailescu SD, Jaselme P, Fontoura ML, Feddag-Hannachi L, Veresezan EL, Drieux F, Camus V, Bouclet F, Tilly H, Cardinaël N, Jardin F. Comparison of bone marrow trephine sample quality between a drill-powered system and a manual needle system. Ann Diagn Pathol. 2022 Aug;59:151952. doi: 10.1016/j.anndiagpath.2022.151952. Epub 2022 Apr 20. PMID: 35468352.https://www.sciencedirect.com/science/article/pii/S1092913422000545?via%3Dihub
49. Pénichoux J, Rio J, Kammoun L, Vermeulin T, Pepin LF, Camus V, Dubois S, Bouclet F, Alani M, Contentin N, Leprêtre S, Stamatoullas A, Lanic H, Lemasle E, Ménard AL, Lenain P, Gilles-Baray M, Georgescu D, Clatot F, Tilly H, Jardin F. Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first-line treatment for patients with diffuse large B-cell lymphoma. Eur J Haematol. 2022 Jul;109(1):41-49. doi: 10.1111/ejh.13767. Epub 2022 Mar 21. PMID: 35285085; PMCID: PMC9313835. https://pmc.ncbi.nlm.nih.gov/articles/PMC9313835/
50. Sefrioui D, Verdier V, Savoye-Collet C, Beaussire L, Ghomadi S, Gangloff A, Goria O, Riachi G, Montialoux H, Schwarz L, Tuech JJ, Frebourg T, Michel P, Sarafan-Vasseur N, Di Fiore F. Circulating DNA changes are predictive of disease progression after transarterial chemoembolization. Int J Cancer. 2022 Feb 1;150(3):532-541. doi: 10.1002/ijc.33829. Epub 2021 Nov 1. PMID: 34622951. https://onlinelibrary.wiley.com/doi/10.1002/ijc.33829
51. Sola B, Caillot M. L’embryon de poule – Un modèle préclinique alternatif en cancérologie [The hen embryo: An alternative preclinical model in cancer]. Med Sci (Paris). 2022 Oct;38(10):795-799. French. doi: 10.1051/medsci/2022123. Epub 2022 Oct 11. PMID: 36219079. https://www.medecinesciences.org/fr/articles/medsci/full_html/2022/08/msc220151/msc220151.html
52. Lan X, Ruminy P, Bohers E, Rainville V, Viennot M, Viailly PJ, Etancelin P, Tilly H, Mihailescu S, Bouclet F, Leprêtre S, Jardin F. 5′ Rapid amplification of cDNA ends (5’RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia. Leuk Res. 2022 Dec;123:106952. doi: 10.1016/j.leukres.2022.106952. Epub 2022 Sep 16. PMID: 36272389. https://www.sciencedirect.com/science/article/pii/S0145212622001783?via%3Dihub
53. Zduniak A, Lévêque E, Perdrix A, Etancelin P, Ménard AL, Lenain P, Contentin N, Pépin LF, Leprêtre S, Lemasle E, Lanic H, Stamatoullas-Bastard A, Kammoun-Quique L, Tilly H, Bauer F, Jardin F, Camus V. Cardiovascular outcomes of patients treated for non-Hodgkin lymphoma with first-line doxorubicin-based chemotherapy. Leuk Lymphoma. 2022 Dec;63(14):3340-3350. doi: 10.1080/10428194.2022.2123222. Epub 2022 Sep 18. PMID: 36120853.
54. Grancher A, Michel P, Di Fiore F, Sefrioui D. Colorectal cancer chemoprevention: is aspirin still in the game? Cancer Biol Ther. 2022 Dec 31;23(1):446-461. doi: 10.1080/15384047.2022.2104561. PMID: 35905195; PMCID: PMC9341367. https://pmc.ncbi.nlm.nih.gov/articles/PMC9341367/
55. Lanic MD, Le Loarer F, Rainville V, Sater V, Viennot M, Beaussire L, Viailly PJ, Angot E, Hostein I, Jardin F, Ruminy P, Laé M. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay. Mod Pathol. 2022 May;35(5):649-663. doi: 10.1038/s41379-021-00980-x. Epub 2022 Jan 24. PMID: 35075283. https://www.sciencedirect.com/science/article/pii/S089339522200117X?via%3Dihub
56. Candon S, Lemee V, Leveque E, Etancelin P, Paquin C, Carette M, Contentin N, Bobee V, Alani M, Cardinael N, Lepretre S, Camus V, Bouclet F, Boulet E, Menard AL, Lanic H, Stamatoullas A, Lemasle E, Pepin LF, Richard D, Dubois S, Tilly H, Dalleac A, Plantier JC, Etienne M, Jardin F. Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas. Haematologica. 2022 Mar 1;107(3):755-758. doi: 10.3324/haematol.2021.280139. PMID: 34854280; PMCID: PMC8883534. https://pmc.ncbi.nlm.nih.gov/articles/PMC8883534/
57. Camus V, Viennot M, Lévêque E, Viailly PJ, Tonnelet D, Veresezan EL, Drieux F, Etancelin P, Dubois S, Stamatoullas A, Tilly H, Bohers E, Jardin F. Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study. Leuk Lymphoma. 2022 Apr;63(4):834-844. doi: 10.1080/10428194.2021.2010060. Epub 2022 Jan 25. PMID: 35075971.
58. Fontanilles M, Deniel A, Marguet F, Beaussire L, Magne N, Derrey S, Blanchard F, Alexandru C, Coutant S, Laquerrière A, Clatot F, Di Fiore F, Sarafan-Vasseur N. Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma. Rev Neurol (Paris). 2022 Nov;178(9):975-980. doi: 10.1016/j.neurol.2022.02.462. Epub 2022 Jul 21. PMID: 35871016.
59. https://www.sciencedirect.com/science/article/pii/S0035378722006403?via%3Dihub
60. Maitre E, Tomowiak C, Lebecque B, Bijou F, Benabed K, Naguib D, Kerneves P, Cornet E, Viailly PJ, Arsham J, Sola B, Jardin F, Troussard X. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. Cancers (Basel). 2022 Apr 10;14(8):1904. doi: 10.3390/cancers14081904. PMID: 35454811; PMCID: PMC9028144. https://pmc.ncbi.nlm.nih.gov/articles/PMC9028144/
61. Troussard X, Maître E, Cornet E. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. Am J Hematol. 2022 Feb 1;97(2):226-236. doi: 10.1002/ajh.26390. Epub 2021 Nov 8. PMID: 34710243. https://onlinelibrary.wiley.com/doi/10.1002/ajh.26390
62. Gros A, Menguy S, Bobée V, Ducharme O, Cassaigne IC, Vergier B, Parrens M, Beylot-Barry M, Pham-Ledard A, Ruminy P, Jardin F, Merlio JP. Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling. PLoS One. 2022 Apr 22;17(4):e0266978. doi: 10.1371/journal.pone.0266978. PMID: 35452489; PMCID: PMC9032422. https://pmc.ncbi.nlm.nih.gov/articles/PMC9032422/
63. Delapierre B, Troussard X, Damaj G, Dejardin O, Tron L. Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study. Cancer Epidemiol. 2023 Feb;82:102292. doi: 10.1016/j.canep.2022.102292. Epub 2022 Nov 18. PMID: 36410088. https://www.sciencedirect.com/science/article/pii/S1877782122001977?via%3Dihub
64. Simonin M, Jardin F, Leblanc T, Latour S, Landman Parker J. An update on molecular features and therapeutic perspectives of pediatric classical Hodgkin Lymphoma. What the clinician needs to know? Eur J Med Genet. 2023 Jan;66(1):104672. doi: 10.1016/j.ejmg.2022.104672. Epub 2022 Nov 22. PMID: 36423786. https://www.sciencedirect.com/science/article/pii/S1769721222002531?via%3Dihub
65. Codjia T, Roussel E, Papet E, Pinson J, Monge M, Tortajada P, Tuech JJ, Schwarz L. Can the Realization of an External Wirsungostomy be an Option for High-Risk Pancreatic Anastomosis After Pancreaticoduodenectomy? World J Surg. 2023 Jun;47(6):1533-1539. doi: 10.1007/s00268-023-06927-4. Epub 2023 Mar 8. PMID: 36884081. https://onlinelibrary.wiley.com/doi/10.1007/s00268-023-06927-4
66. Roussel E, Papet E, Chati R, Schwarz L, Tuech JJ, Huet E. When Gastroplasty Is Not Feasible in Ivor Lewis Esophagectomy: A Single-Center Study of Intrathoracic Esophagojejunostomy. J Laparoendosc Adv Surg Tech A. 2023 Nov;33(11):1102-1108. doi: 10.1089/lap.2023.0197. Epub 2023 Oct 4. PMID: 37792402.
67. Herault A, Lévêque E, Draye-Carbonnier S, Decazes P, Zduniak A, Modzelewski R, Libraire J, Achamrah N, Ménard AL, Lenain P, Contentin N, Grall M, Leprêtre S, Lemasle E, Lanic H, Alani M, Stamatoullas-Bastard A, Tilly H, Jardin F, Tamion F, Camus V. High prevalence of pre-existing sarcopenia in critically ill patients with hematologic malignancies admitted to the intensive care unit for sepsis or septic shock. Clin Nutr ESPEN. 2023 Jun;55:373-383. doi: 10.1016/j.clnesp.2023.04.007. Epub 2023 Apr 22. PMID: 37202070. https://www.sciencedirect.com/science/article/pii/S2405457723001006?via%3Dihub
68. Camus V, Etancelin P, Drieux F, Veresezan EL, Picquenot JM, Penther D, Viennot M, Ruminy P, Contentin N, Lemasle E, Leprêtre S, Dubois S, Penichoux J, Stamatoullas A, Zduniak A, Lanic H, Jardin F. Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T-cell lymphoma: A case report. Clin Case Rep. 2023 Jun 23;11(6):e7623. doi: 10.1002/ccr3.7623. PMID: 37361652; PMCID: PMC10290197. https://pmc.ncbi.nlm.nih.gov/articles/PMC10290197/
69. Maitre E, Macro M, Troussard X. Hairy cell leukaemia with unusual BRAF mutations. J Cell Mol Med. 2023 Sep;27(17):2626-2630. doi: 10.1111/jcmm.17890. Epub 2023 Aug 2. PMID: 37530550; PMCID: PMC10468650. https://onlinelibrary.wiley.com/doi/10.1111/jcmm.17890
70. Lanic MD, Guérin R, Sater V, Durdilly P, Ruminy P, Skálová A, Laé M. A novel SMARCA2-CREM fusion expending the molecular spectrum of salivary gland hyalinazing clear cell carcinoma beyond the FET genes. Genes Chromosomes Cancer. 2023 Apr;62(4):231-236. doi: 10.1002/gcc.23114. Epub 2022 Dec 25. PMID: 36504225. https://onlinelibrary.wiley.com/doi/10.1002/gcc.23114
71. Caillot M, Miloudi H, Taly A, Profitós-Pelejà N, Santos JC, Ribeiro ML, Maitre E, Saule S, Roué G, Jardin F, Sola B. Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin’s lymphoma. Mol Oncol. 2023 Dec;17(12):2546-2564. doi: 10.1002/1878-0261.13386. Epub 2023 Apr 21. PMID: 36727672; PMCID: PMC10701774. https://pmc.ncbi.nlm.nih.gov/articles/PMC10701774/
72. Pénichoux J, Lanic H, Thill C, Ménard AL, Camus V, Stamatoullas A, Lemasle E, Leprêtre S, Lenain P, Contentin N, Kraut-Tauzia J, Fruchart C, Kammoun L, Damaj G, Farge A, Delette C, Modzelewski R, Vaudaux S, Pépin LF, Tilly H, Jardin F. Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study. Ann Hematol. 2023 Jul;102(7):1811-1823. doi: 10.1007/s00277-023-05200-x. Epub 2023 Apr 14. Erratum in: Ann Hematol. 2024 Jan;103(1):369. doi: 10.1007/s00277-023-05497-8. PMID: 37058153; PMCID: PMC10260702. https://pmc.ncbi.nlm.nih.gov/articles/PMC10260702/
73. Lanic MD, Guérin R, Wassef M, Durdilly P, Rainville V, Sater V, Jardin F, Ruminy P, Costes-Martineau V, Laé M. Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay. Histopathology. 2023 Nov;83(5):685-699. doi: 10.1111/his.14971. Epub 2023 Jun 22. PMID: 37350081. https://onlinelibrary.wiley.com/doi/10.1111/his.14971
74. Vion R, Fleury P, Blazejewski V, Rigal O, Fontanilles M, Lequesne J, Di Fiore F, Clatot F. Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer. Breast Care (Basel). 2023 May;18(2):113-121. doi: 10.1159/000529104. Epub 2023 Jan 17. PMID: 37261130; PMCID: PMC10228251. https://pmc.ncbi.nlm.nih.gov/articles/PMC10228251/
75. Arhant G, Lachkar S, Thiebaut PA, Marguet F, Lamy A, Thiberville L, Salaün M, Guisier F, Sabourin JC, Piton N. Detection of Tumor DNA in Bronchoscopic Fluids in Peripheral NSCLC: A Proof-of-Concept Study. JTO Clin Res Rep. 2023 Oct 19;5(2):100596. doi: 10.1016/j.jtocrr.2023.100596. PMID: 38328474; PMCID: PMC10847031. https://pmc.ncbi.nlm.nih.gov/articles/PMC10847031/
76. Noeuveglise A, Sarafan-Vasseur N, Beaussire L, Marguet F, Modzelewski R, Hanzen C, Alexandru C, Magne N, Langlois O, Di Fiore F, Clatot F, Thureau S, Fontanilles M. Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma. ESMO Open. 2023 Feb;8(1):100740. doi: 10.1016/j.esmoop.2022.100740. Epub 2022 Dec 23. PMID: 36566697; PMCID: PMC10024094. https://pmc.ncbi.nlm.nih.gov/articles/PMC10024094/
77. Drouyer A, Beaussire L, Jorda P, Leheurteur M, Guillemet C, Berghian A, Georgescu D, Di Fiore F, Perdrix A, Clatot F. Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma. BMC Cancer. 2023 Nov 3;23(1):1061. doi: 10.1186/s12885-023-11559-x. PMID: 37924026; PMCID: PMC10625264. https://pmc.ncbi.nlm.nih.gov/articles/PMC10625264/
78. Levacher C, Viennot M, Drouet A, Beaussire L, Coutant S, Théry JC, Baert-Desurmont S, Laé M, Ruminy P, Houdayer C. Disequilibrium between BRCA1 and BRCA2 Circular and Messenger RNAs Plays a Role in Breast Cancer. Cancers (Basel). 2023 Apr 6;15(7):2176. doi: 10.3390/cancers15072176. PMID: 37046838; PMCID: PMC10093293. https://pmc.ncbi.nlm.nih.gov/articles/PMC10093293/
79. Camus V, Viailly PJ, Drieux F, Veresezan EL, Sesques P, Haioun C, Durot E, Patey M, Rossi C, Martin L, Rainville V, Bohers E, Ruminy P, Penther D, Kaltenbach S, Bruneau J, Paillassa J, Tournilhac O, Willaume A, Antier C, Lazarovici J, Lévêque E, Decazes P, Becker S, Tonnelet D, Berriolo-Riedinger A, Gaulard P, Tilly H, Molina TJ, Traverse-Glehen A, Jardin F. High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma. Blood Adv. 2023 Dec 12;7(23):7331-7345. doi: 10.1182/bloodadvances.2023011169. PMID: 37862676; PMCID: PMC10701594. https://pmc.ncbi.nlm.nih.gov/articles/PMC10701594/
80. Gagnat G, Hobeika C, Modzelewski R, Collet CS, Di Fiore F, Druesne L, Tuech JJ, Schwarz L. Evaluation of sarcopenia biomarkers in older patients undergoing major surgery for digestive cancer. SAXO prospective cohort study. Eur J Surg Oncol. 2023 Jan;49(1):285-292. doi: 10.1016/j.ejso.2022.08.038. Epub 2022 Sep 6. PMID: 36167704. https://www.sciencedirect.com/science/article/pii/S0748798322006497?via%3Dihub
81. Belot A, Camus V, Portugues C, Paget J, Chartier L, Cony-Makhoul P, Tilly H, Joubert C. Long-term excess mortality and net survival among elderly diffuse large B-cell lymphoma patients after front-line R-CHOP treatment. Br J Haematol. 2023 Jun;201(5):857-864. doi: 10.1111/bjh.18705. Epub 2023 Feb 22. PMID: 36813551. https://onlinelibrary.wiley.com/doi/10.1111/bjh.18705
82. Haddad E, Bottet B, Thiebaut PA, Morin S, Dreyfus H, Vannier É, Vincent C, Marguet F, Lamy A, Sobol H, Baste JM, Guisier F, Sabourin JC, Piton N. Squamous Cell Carcinoma of the Lung With Microsatellite Instability in a Patient With Lynch Syndrome: A Case Report. JTO Clin Res Rep. 2023 Oct 19;5(1):100595. doi: 10.1016/j.jtocrr.2023.100595. PMID: 38229768; PMCID: PMC10788277. https://pmc.ncbi.nlm.nih.gov/articles/PMC10788277/
83. Messéant O, Drieux F, Sako N, Fataccioli V, Camus V, Robe C, Houot R, Tas P, Llamas-Gutierrez F, Lamaison C, Abraham J, Delage-Corre M, Benguerfi S, Bossard JB, Gaulard P, Lemonnier F. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution. Eur J Cancer. 2024 Jan;197:113479. doi: 10.1016/j.ejca.2023.113479. Epub 2023 Dec 12. PMID: 38128263. https://www.sciencedirect.com/science/article/pii/S0959804923007815?via%3Dihub
84. Delaye M, Neuzillet C, Sabourin JC. Portrait moléculaire dans les cancers des voies biliaires : enquête nationale de pratique auprès des plateformes françaises [Molecular profiling in biliary tract cancers: A national practice survey of French platforms]. Bull Cancer. 2024 Nov;111(11):1030-1037. French. doi: 10.1016/j.bulcan.2024.08.013. Epub 2024 Sep 23. PMID: 39317593. https://www.sciencedirect.com/science/article/pii/S0007455124003102?via%3Dihub
85. Gross Z, Veyrat-Masson R, Grange B, Huet S, Verney A, Traverse-Glehen A, Ruminy P, Baseggio L. Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data. Hematol Oncol. 2024 Jan;42(1):e3245. doi: 10.1002/hon.3245. PMID: 38287532. https://onlinelibrary.wiley.com/doi/10.1002/hon.3245
86. Ghesquières H, Cherblanc F, Belot A, Micon S, Bouabdallah KK, Esnault C, Fornecker LM, Thokagevistk K, Bonjour M, Bijou F, Haioun C, Morineau N, Ysebaert L, Damaj G, Tessoulin B, Guidez S, Morschhauser F, Thiéblemont C, Chauchet A, Gressin R, Jardin F, Fruchart C, Labouré G, Fouillet L, Lionne-Huyghe P, Bonnet A, Lebras L, Amorim S, Leyronnas C, Olivier G, Guieze R, Houot R, Launay V, Drénou B, Fitoussi O, Detourmignies L, Abraham J, Soussain C, Lachenal F, Pica GM, Fogarty P, Cony-Makhoul P, Bernier A, Le Guyader-Peyrou S, Monnereau A, Boissard F, Rossi C, Camus V. Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort. Blood Adv. 2024 Jan 23;8(2):296-308. doi: 10.1182/bloodadvances.2023010798. PMID: 37874913; PMCID: PMC10824688. https://pmc.ncbi.nlm.nih.gov/articles/PMC10824688/
87. Camus V, Thieblemont C, Gaulard P, Cheminant M, Casasnovas RO, Ysebaert L, Damaj GL, Guidez S, Pica GM, Kim WS, Lim ST, Andre M, Gutiérrez N, Penarrubia MJ, Staber PB, Trotman J, Hüttmann A, Stefoni V, Tucci A, Fogarty P, Farhat H, Abraham J, Abarah W, Belmecheri F, Ribrag V, Delfau-Larue MH, Cottereau AS, Itti E, Li J, Delarue R, de Leval L, Morschhauser F, Bachy E. Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial. J Clin Oncol. 2024 May 10;42(14):1612-1618. doi: 10.1200/JCO.23.01687. Epub 2024 Feb 16. PMID: 38364196. https://ascopubs.org/doi/10.1200/JCO.23.01687?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
88. Bobée V, Viennot M, Rainville V, Veresezan L, Drieux F, Viailly PJ, Michel V, Sater V, Lanic MD, Bohers E, Camus V, Tilly H, Jardin F, Ruminy P. Analysis of immunoglobulin/T-cell receptor repertoires by high-throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma. Hemasphere. 2024 Feb 26;8(2):e50. doi: 10.1002/hem3.50. PMID: 38435425; PMCID: PMC10896008. https://pmc.ncbi.nlm.nih.gov/articles/PMC10896008/
89. Pénichoux J, Lanic H, Thill C, Ménard AL, Camus V, Stamatoullas A, Lemasle E, Leprêtre S, Lenain P, Contentin N, Kraut-Tauzia J, Fruchart C, Kammoun L, Damaj G, Farge A, Delette C, Modzelewski R, Vaudaux S, Pépin LF, Tilly H, Jardin F. Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑
90. cell lymphoma: results of a multicentric prospective cohort study. Ann Hematol. 2024 Jan;103(1):369. doi: 10.1007/s00277-023-05497-8. Erratum for: Ann Hematol. 2023 Jul;102(7):1811-1823. doi: 10.1007/s00277-023-05200-x. PMID: 37880485; PMCID: PMC10761374. https://pmc.ncbi.nlm.nih.gov/articles/PMC10761374/
91. Draye-Carbonnier S, Camus V, Becker S, Tonnelet D, Lévêque E, Zduniak A, Jardin F, Tilly H, Vera P, Decazes P. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma. Sci Rep. 2024 Apr 5;14(1):8033. doi: 10.1038/s41598-024-58412-0. PMID: 38580734; PMCID: PMC10997640. https://pmc.ncbi.nlm.nih.gov/articles/PMC10997640/
92. Guérin R, Menard AL, Angot E, Piton N, Vera P, Schwarz L, Sabourin JC, Laé M, Thiébaut PA. An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms. Diagn Pathol. 2024 Apr 20;19(1):62. doi: 10.1186/s13000-024-01483-4. PMID: 38643139; PMCID: PMC11031972.https://pmc.ncbi.nlm.nih.gov/articles/PMC11031972/
93. Beaussire-Trouvay L, Duhamel O, Perdrix A, Lévêque E, Vion R, Rovelet-Lecrux A, Sarafan-Vasseur N, Di Fiore F, Crouzet A, Leheurteur M, Clatot F. Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer. Front Oncol. 2024 Jul 8;14:1382008. doi: 10.3389/fonc.2024.1382008. PMID: 39040450; PMCID: PMC11260666. https://pmc.ncbi.nlm.nih.gov/articles/PMC11260666/
94. Camus V, Houot R, Brisou G, Tessoulin B, Bailly S, Sesques P, Decroocq J, Krzisch D, Oberic L, Lemonnier F, Bouabdallah K, Campidelli A, Tounes L, Abraham J, Herbaux C, Morschhauser F, Damaj GL, Guidez S, Carras S, Fornecker LM, Choquet S, Hermine O, Paillassa J, Chauchet A, Casasnovas O, Drieu La Rochelle L, Castilla-Llorente C, Joris M, Dupont V, Marquet A, Le Gouill S, Jardin F. Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy. Blood Adv. 2024 Oct 22;8(20):5371-5381. doi: 10.1182/bloodadvances.2024013726. PMID: 39163620; PMCID: PMC11568786. https://pmc.ncbi.nlm.nih.gov/articles/PMC11568786/
95. Pinson J, Henriques J, Beaussire L, Sarafan-Vasseur N, Sa Cunha A, Bachet JB, Vernerey D, Di Fiore F, Schwarz L; PANACHE01-PRODIGE48 group. New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 Trial. Ann Surg. 2024 Nov 1;280(5):734-744. doi: 10.1097/SLA.0000000000006468. Epub 2024 Aug 5. PMID: 39101207. https://journals.lww.com/annalsofsurgery/fulltext/2024/11000/new_biomarkers_to_define_a_biological_borderline.7.aspx
96. Daban A, Beaussire-Trouvay L, Lévêque É, Alexandru C, Tennevet I, Langlois O, Veresezan O, Marguet F, Clatot F, Di Fiore F, Sarafan-Vasseur N, Fontanilles M. Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients. Transl Oncol. 2024 Apr;42:101897. doi: 10.1016/j.tranon.2024.101897. Epub 2024 Feb 9. PMID: 38340682; PMCID: PMC10867437. https://pmc.ncbi.nlm.nih.gov/articles/PMC10867437/
97. Fontanilles M, Heisbourg JD, Daban A, Di Fiore F, Pépin LF, Marguet F, Langlois O, Alexandru C, Tennevet I, Ducatez F, Pilon C, Plichet T, Mokbel D, Lesueur C, Bekri S, Tebani A. Metabolic remodeling in glioblastoma: a longitudinal multi-omics study. Acta Neuropathol Commun. 2024 Oct 12;12(1):162. doi: 10.1186/s40478-024-01861-5. PMID: 39394177; PMCID: PMC11470540. https://pmc.ncbi.nlm.nih.gov/articles/PMC11470540/
98. Thiebaut PA, Isnard P, Couronné L, Kaltenbach S, Lepine C, Sibon D, Balducci E, Ruminy P, Badoual C, Brière J, Hermine O, Asnafi V, Gaulard P, Bruneau J, Molina TJ. Multimodal integration of clinic, pathology, and genomics for a rare diagnosis of EBV-positive primary mediastinal large B-cell lymphoma. Virchows Arch. 2024 Nov;485(5):931-936. doi: 10.1007/s00428-024-03836-2. Epub 2024 Jun 4. PMID: 38834916.
99. Maerevoet M, Casasnovas O, Cartron G, Morschhauser F, Thieblemont C, Bouabdallah K, Feugier P, Szablewski V, Becker S, Tilly H. Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma-Final Analysis. Cancers (Basel). 2024 Jul 26;16(15):2672. doi: 10.3390/cancers16152672. PMID: 39123400; PMCID: PMC11311764. https://pmc.ncbi.nlm.nih.gov/articles/PMC11311764/
100. Troussard X. Hairy cell leukemia (HCL) and HCL-like disorders: present, emergent treatment options and future directions. Expert Rev Hematol. 2024 Dec;17(12):907-915. doi: 10.1080/17474086.2024.2427660. Epub 2024 Nov 14. PMID: 39535173.
101. Troussard X, Maître E, Paillassa J. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies. Am J Hematol. 2024 Apr;99(4):679-696. doi: 10.1002/ajh.27240. Epub 2024 Mar 5. PMID: 38440808. https://onlinelibrary.wiley.com/doi/10.1002/ajh.27240
102. Troussard X, Maitre E. Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment. J Cell Mol Med. 2024 Feb;28(3):e18060. doi: 10.1111/jcmm.18060. Epub 2023 Dec 14. PMID: 38095234; PMCID: PMC10844692. https://pmc.ncbi.nlm.nih.gov/articles/PMC10844692/
103. Trněný M, Fogliatto L, Gardner F, Flinn I, Larouche JF, Haioun C, Canales M, Goto H, Hajek R, Salles G, Singh A, Yan M, Kothari R, Man G, Sahin D, Hirata J, Lee C, Tilly H, Flowers CR. Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes. Blood Adv. 2025 Jul 8;9(13):3263-3267. doi: 10.1182/bloodadvances.2024014695. PMID: 40088467; PMCID: PMC12246594. https://pmc.ncbi.nlm.nih.gov/articles/PMC12246594/
104. Hu B, Reagan PM, Sehn LH, Sharman JP, Hertzberg M, Zhang H, Kim A, Herbaux C, Molina L, Maruyama D, Stenner F, Chohan S, Kothari R, Lee Batlevi C, Hirata J, Sahin D, Lee C, Sugidono M, Tilly H. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. Blood Adv. 2025 May 27;9(10):2489-2499. doi: 10.1182/bloodadvances.2024014707. PMID: 40085955; PMCID: PMC12143816. https://pmc.ncbi.nlm.nih.gov/articles/PMC12143816/
105. Letailleur V, Chaillol I, Cherblanc F, Ghesquières H, Peyrade F, Guidez S, Bijou F, Sesques P, Rossi C, Fornecker LM, Fouillet L, Carras S, Chartier L, Belot A, Oberic L, Jardin F, Tessoulin B. Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials. Blood Cancer J. 2025 Nov 3;15(1):190. doi: 10.1038/s41408-025-01374-x. PMID: 41184256; PMCID: PMC12583804. https://www.nature.com/articles/s41408-025-01374-x
106. Laguerre K, Caillot M, Casas-Solvas JM, Vargas-Berenguel A, Urbinati G, Gref R. Gemcitabine-monophosphate encapsulation in « stealth » MOFs effectively inhibits tumor growth in vivo. Int J Pharm. 2025 Apr 30;675:125537. doi: 10.1016/j.ijpharm.2025.125537. Epub 2025 Mar 31. PMID: 40174810. https://www.sciencedirect.com/science/article/pii/S0378517325003746?via%3Dihub
107. Camus V, Viennot M, Viailly PJ, Drieux F, Veresezan EL, Bobée V, Rainville V, Bohers E, Sesques P, Haioun C, Durot E, Bayaram M, Rossi C, Martin L, Penther D, Kaltenbach S, Bruneau J, Paillassa J, Tournilhac O, Gower N, Willaume A, Antier C, Renaud L, Lévêque E, Decazes P, Becker S, Tonnelet D, Gaulard P, Tilly H, Molina TJ, Traverse-Glehen A, Donzel M, Ruminy P, Jardin F. Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5’RACE. Blood Adv. 2025 Jan 14;9(1):101-115. doi: 10.1182/bloodadvances.2024013723. PMID: 39293080; PMCID: PMC11742575. https://pmc.ncbi.nlm.nih.gov/articles/PMC11742575/
108. Grancher A, Tagemouati L, Gillibert A, Schwarz L, Vernon V, Sefrioui D, Michel P, Dutherage M, Di Fiore F. Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma. Clin Res Hepatol Gastroenterol. 2025 May;49(5):102583. doi: 10.1016/j.clinre.2025.102583. Epub 2025 Mar 28. PMID: 40158796. https://www.sciencedirect.com/science/article/pii/S2210740125000634?via%3Dihub
109. Pulcini S, Beaussire-Trouvay L, Marguet F, Viailly PJ, Langlois O, Alexandru C, Tennevet I, Di Fiore F, Sarafan-Vasseur N, Fontanilles M. The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort. J Neurooncol. 2025 Feb;171(3):619-628. doi: 10.1007/s11060-024-04879-w. Epub 2024 Nov 16. PMID: 39549128; PMCID: PMC11729081. https://pmc.ncbi.nlm.nih.gov/articles/PMC11729081/
110. Renaud L, Donzel M, Decroocq J, Decazes P, Galtier J, Burroni B, Veresezan EL, Sesboüé C, Dartigues P, Chassagne-Clément C, Martin L, Mauduit C, Kaltenbach S, Penther D, Etancelin P, Sibon D, Bailly S, Martin V, Durot E, Kirova Y, Grenier A, Maerevoet M, Bernard W, Naveau L, Cabannes-Hamy A, Cottereau AS, Jacquet-Francillon N, Noel R, Reichert T, Sarkozy C, Bussot L, Bailly S, Amorim S, Krzisch D, Cornillon J, Legendre H, Chevillon F, Cavalieri D, Sesques P, Minard-Colin V, Haioun C, Morschhauser F, Houot R, Jardin F, Tilly H, Traverse-Glehen A, Camus V. Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines. Eur J Cancer. 2025 May 2;220:115369. doi: 10.1016/j.ejca.2025.115369. Epub 2025 Mar 22. PMID: 40157284. https://www.sciencedirect.com/science/article/pii/S0959804925001509?via%3Dihub
111. Camus V, Molina T, Desmots F, Blanc-Durand P, Kanoun S, Moslemi A, Ruminy P, Le Gouill S, Ghesquières H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Houot R, Thieblemont C, Maisonneuve H, Claves F, Bouabdallah K, Haioun C, Damaj GL, Fornecker LM, Noel R, Feugier P, Sibon D, Cartron G, Bonnet C, Bernard W, Kraeber-Bodéré F, Bodet-Milin C, Jais JP, Brière J, Rossi C, Elsensohn MH, Chartier L, Itti E, Jardin F, Fest T. Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma. Blood Adv. 2025 May 13;9(9):2232-2246. doi: 10.1182/bloodadvances.2024015577. PMID: 40030008; PMCID: PMC12088757.
112. Lépine C, Trinquet A, Laé M, Costes-Martineau V. Tumeurs nasosinusiennes à translocation [Translocated sinonasal tumors]. Ann Pathol. 2025 Jan;45(1):43-52. French. doi: 10.1016/j.annpat.2023.12.013. Epub 2024 Feb 13. PMID: 38355380. https://www.sciencedirect.com/science/article/pii/S0242649824000075?via%3Dihub
113. Laé M, Lanic MD, Lépine C, Hourseau M, Benzerdjeb N, Uro-Coste E, Costes-Martineau V. Les tumeurs des glandes salivaires associées à des transcrits de fusion [Fusion genes in salivary gland tumors]. Ann Pathol. 2025 Jan;45(1):29-42. French. doi: 10.1016/j.annpat.2023.12.012. Epub 2024 Feb 13. PMID: 38355379. https://www.sciencedirect.com/science/article/pii/S0242649824000051?via%3Dihub
114. Grancher A, Beaussire-Trouvay L, Vernon V, Dutherage M, Blondin V, Elie C, Bouhier-Leporrier K, Galais MP, Clabaut T, Bignon AL, Parzy A, Gangloff A, Schwarz L, Lévêque E, Sabourin JC, Michel P, Vasseur N, Sefrioui D, Gilibert A, Di Fiore F. ctDNA variations according to treatment intensity in first-line metastatic colorectal cancer. Br J Cancer. 2025 May;132(9):814-821. doi: 10.1038/s41416-025-02971-0. Epub 2025 Mar 15. PMID: 40089635; PMCID: PMC12041588. https://www.nature.com/articles/s41416-025-02971-0
115. Penichoux J, Decazes P, Rossi C, Sesques P, Haioun C, Durot E, Gower N, Willaume A, Oberic L, Paillassa J, Antier C, Renaud L, Tournilhac O, Thieblemont C, Besson C, Lebras L, Choquet S, Le Du K, Bonnet C, Bailly S, Damaj G, Laribi K, Houot R, Chauchet A, Becker S, Tonnelet D, Tilly H, Jardin F, Lévêque E, Camus V. Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell Lymphoma. Hematol Oncol. 2025 Jul;43(4):e70117. doi: 10.1002/hon.70117. PMID: 40646709; PMCID: PMC12254528. https://pmc.ncbi.nlm.nih.gov/articles/PMC12254528/
116. Schwarz L, Bachet JB, Meurisse A, Bouché O, Assenat E, Piessen G, Hammel P, Regenet N, Taieb J, Turrini O, Paye F, Turpin A, Souche FR, Laurent C, Kianmanesh R, Michel P, Vernerey D, Mabrut JY, Turco C, Truant S, Sa Cunha A; PANACHE01-FRENCH08-PRODIGE48 Investigators. Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study). J Clin Oncol. 2025 Jun 10;43(17):1984-1996. doi: 10.1200/JCO-24-01378. Epub 2025 Apr 4. PMID: 40184561. https://ascopubs.org/doi/10.1200/JCO-24-01378?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
117. Zduniak A, Martinet J, Lévêque E, Becker S, Tonnelet D, Santos ED, Leroy C, Alani M, Rouvet J, Brousseau M, Giverne C, Cuffel A, Jacquot S, Roucheux A, Veuiller A, Lecornu N, Norbert ME, Boyer O,Tilly H, Jardin F, Latouche JB, Camus V. Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center Experience. Hematol Oncol. 2025 Nov;43(6):e70139. doi: 10.1002/hon.70139. PMID: 41057236; PMCID: PMC12504011. https://pmc.ncbi.nlm.nih.gov/articles/PMC12504011/
118. Clatot F, Even C, Daste A, Borel C, Fayette J, Chebbah M, Le Clanche S, Saada E. Defining a need for rapid response and practical guidance for recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) management in France: A Delphi consensus. PLoS One. 2025 Sep 19;20(9):e0332413. doi: 10.1371/journal.pone.0332413. Erratum in: PLoS One. 2025 Dec 22;20(12):e0339448. doi: 10.1371/journal.pone.0339448. PMID: 40971372; PMCID: PMC12448362. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448362/
119. Galtier J, Sesques P, Dupont V, Bachy E, Di Blasi R, Thieblemont C, Brisou G, Gastinne T, Cartron G, Gros FX, Morschhauser F, André A, Bay JO, Joris M, Tanguy-Schmidt A, Demailly A, Le Gouill S, Houot R, Bouabdallah K, Camus V. Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis. Hemasphere. 2025 Dec 8;9(12):e70263. doi: 10.1002/hem3.70263. PMID: 41368077; PMCID: PMC12683939. https://pmc.ncbi.nlm.nih.gov/articles/PMC12683939/
120. Rainville V, Lanic MD, Drieux F, Piton N, Rizzo D, Jardin F, Ruminy P. Detection of Cancer-Associated Gene Fusion by Ligation-Dependent RT-PCR. Methods Mol Biol. 2025;2962:25-37. doi: 10.1007/978-1-0716-4726-4_3. PMID: 40699420.
121. Hoba J, Grancher A, Hautefeuille V, Turpin A, Bouhier-Leporrier K, Galais MP, Bignon AL, Di Fiore A, Desgrippes R, Miglianico L, Avisse B, Baconnier M, Lam YH, Dutherage M, Sefrioui D, Malicot KL, Phelip JM, Michel P, Gillibert A, i Fiore F. Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer. Dig Liver Dis. 2025 Jan;57(1):30-37. doi: 10.1016/j.dld.2024.05.014. Epub 2024 Jun 8. PMID: 38851974. https://www.sciencedirect.com/science/article/pii/S1590865824007722?via%3Dihub
122. Zduniak A, Lévêque E, Draye-Carbonnier S, Becker S, Tonnelet D, Dubois S, Vera P, Tilly H, Jardin F, Decazes P, Camus V. Combining Total Metabolic Tumor Volume With Beta-2-Microglobulin Levels Predicts Outcomes in High-Burden Follicular Lymphoma Patients. Hematol Oncol. 2025 Jan;43(1):e70010. doi: 10.1002/hon.70010. PMID: 39676608; PMCID: PMC11647558. https://pmc.ncbi.nlm.nih.gov/articles/PMC11647558/
123. Vion R, Calbrix C, Berghian A, Lévêque E, Fontanilles M, Paquin C, Ruminy P, Rouvet J, Leheurteur M, Olympios N, Rainville V, Di Fiore F, Clatot F. Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine). Clin Transl Oncol. 2026 Feb;28(2):711-718. doi: 10.1007/s12094-025-04011-y. Epub 2025 Aug 3. PMID: 40754555. https://link.springer.com/article/10.1007/s12094-025-04011-y
124. Decazes P, Rossi C, Sesques P, Becker S, Viennot M, Mihailescu SD, Lemonnier F, Durot E, Gower N, Willaume A, Obéric L, Paillassa J, Antier C, Renaud L, Tournilhac O, Thieblemont C, Besson C, Lebras L, Choquet S, Le Dû K, Bonnet C, Bailly S, Damaj GL, Laribi K, Morineau N, Houot R, Chauchet A, Jardin F, Tilly H, Veresezan EL, Drieux F, Donzel M, Traverse-Glehen A, Tonnelet D, Camus V. Prognostic Value of Combined Baseline FDG PET/CT Radiomic Parameters in Primary Mediastinal B-Cell Lymphoma. Blood Adv. 2026 May 12:bloodadvances.2026020168. doi: 10.1182/bloodadvances.2026020168. Epub ahead of print. PMID: 42118857. https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2026020168/568356/Prognostic-Value-of-Combined-Baseline-FDG-PET-CT?guestAccessKey
125. Najar W, Barette L, Penther D, Maarek O, Stamatoullas A, Penichoux J, Veresezan EL, Daliphard S, Buchonnet G, Bobee V, Jardin F, De Botton S, Fenaux P, Camus V. Myelodysplastic syndrome with cryptic 5q deletions in young male patients showing sustained response to lenalidomide. Haematologica. 2026 Jan 29. doi: 10.3324/haematol.2025.288855. Epub ahead of print. PMID: 41609063. https://haematologica.org/article/view/13124
126. Beaussire-Trouvay L, Obongo-Anga FR, Lévêque E, Berghian A, François A, Bon-Mardion N, Meret E, Deneuve S, Bohers E, Viennot M, Burel L, Libraire J, Libert L, Sarafan-Vasseur N, Di Fiore F, Clatot F. Peri-Operative Detection of Circulating Tumor DNA Using a Customized NGS Tumor-Informed Assay in Patients With HPV-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma. Int J Cancer. 2026 Apr 10. doi: 10.1002/ijc.70478. Epub ahead of print. PMID: 41964148. https://onlinelibrary.wiley.com/doi/10.1002/ijc.70478
127. Levacher C, Delfosse J, Charbonnier C, Charbonnier F, Viennot M, Kasper E, Mauillon J, Parodi N, Baert-Desurmont S, Ruminy P, Houdayer C. Simultaneous Study of Circular RNAs and Messenger RNAs in Colorectal Cancer: The Unbalanced Fate of a Couple? Cancers (Basel). 2026 Feb 3;18(3):496. doi: 10.3390/cancers18030496. PMID: 41681969; PMCID: PMC12897111. https://pmc.ncbi.nlm.nih.gov/articles/PMC12897111/
128. Bouclet F, Pénichoux J, Mihailescu SD, Seris S, Burel L, Richard D, Collard S, Jennet E, Bertrand E, Alani M, Dubois S, Ménard AL, Camus V, Stamatoullas A, Lenain P, Contentin N, Leprêtre S, Tilly H, Lemasle E, Lanic H, Daouphars M, Pépin LF, Moussay S, Jardin F. Concordance between Tympanic and Enteral Temperature for Early Fever Detection in Hematologic Intensive Care Unit Patients: A Prospective Study. Acta Haematol. 2026;149(2):113-124. doi: 10.1159/000544693. Epub 2025 Apr 22. PMID: 40262543.
129. Camus V, Krzisch D, Bruscaggin A, Lévêque E, Viennot M, Fornecker LM, Cheminant M, Bailly S, Morschhauser F, Feugier P, Choquet S, Durot E, Carras S, Delette C, Damaj G, Waultier Rascalou A, Lebreton P, Le Dû K, Galtier J, Houot R, Morineau N, Laribi K, Lebras L, Obéric L, Amorim S, Bocchetta S, Viailly PJ, Rainville V, Ruminy P, Caillot M, Terzi di Bergamo L, Piffaretti D, Pirosa MC, Salehi M, Forestieri G, Drieux F, Veresezan EL, Traverse-Glehen A, Donzel M, Burel L, Bohers E, Lanic MD, Penther D, Becker S, Decazes P, Tonnelet D, Draye-Carbonnier S, Tilly H, Jardin F, Rossi D, Sesques P. Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study. Blood Adv. 2026 Apr 14:bloodadvances.2025019108. doi: 10.1182/bloodadvances.2025019108. Epub ahead of print. PMID: 41979332. https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2025019108/567746/Interim-assessment-by-circulating-tumor-DNA-in?guestAccessKey
130. Simonin M, Viennot M, Haouy S, Ducassou S, Curtillet C, Garnier N, Phulpin A, Paillard C, Rigaud C, Couec ML, Carausu L, Bonneau J, Pellier I, Barbati M, Millot F, Dourthe MÉ, Kanold J, Schneider P, Stephan JL, Leglise C, Pluchart C, Viailly PJ, Michel V, Boudjemaa S, Jonca B, Leblanc T, Landman-Parker J, Jardin F. Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults. Hemasphere. 2026 Apr 20;10(4):e70357. doi: 10.1002/hem3.70357. PMID: 42016573; PMCID: PMC13093264. https://pmc.ncbi.nlm.nih.gov/articles/PMC13093264/
131. Tauveron-Jalenques U, Inchiappa L, Paillassa J, Maitre E, Willems L, Stocker N, Merabet F, Lok A, Lara D, Bijou F, Herbaux C, Ramos I, Guièze R, Tomowiak C, Troussard X. BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study. Br J Haematol. 2026 Apr 9. doi: 10.1111/bjh.70476. Epub ahead of print. PMID: 41958072. https://onlinelibrary.wiley.com/doi/10.1111/bjh.70476
132. Sesques P, Manson G, Cartron G, Gros FX, Morschhauser F, Castilla-Llorente C, Brisou G, Bories P, Thieblemont C, Drieu La Rochelle L, Tessoulin B, André A, Rossi C, Paillassa J, Guidez S, Capes A, Herbreteau L, Choquet S, Bay JO, Chauchet A, Lebras L, Claves F, Abraham J, Malfuson JV, Rubio MT, Decroocq J, Fornecker LM, Damaj G, Fouillet L, Joris M, Loschi M, Hermine O, Hafirassou H, Zele EV, Dupont V, Gouill SL, Houot R, Camus V. Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group. Hemasphere. 2026 May 6;10(5):e70356. doi: 10.1002/hem3.70356. PMID: 42099680; PMCID: PMC13148476. https://pmc.ncbi.nlm.nih.gov/articles/PMC13148476/

Original articles in collaboration

1. Manson G, Brice P, Herbaux C, Silva MG, Bouabdallah K, Deau B, Bouteloup J, Schiano JM, Nicolas-Virelizier E, Maerevoet M, Ghesquieres H, Stamatoullas A, Antier C, Carlo-Stella C, de Charette M, Poizeau F, Dercle L, Houot R. Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1699-1700. doi: 10.1007/s00259-021-05321-3. Erratum for: Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1144-1153. doi: 10.1007/s00259-020-05015-2. PMID: 33745014.
2. Eude F, Toledano MN, Vera P, Tilly H, Mihailescu SD, Becker S. Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell LymphomA: Is There a Superior Method? Metabolites. 2021 Jan 26;11(2):72. doi: 10.3390/metabo11020072. PMID: 33530590; PMCID: PMC7911393. https://www.mdpi.com/2218-1989/11/2/72
3. Hirschbühl K, Labopin M, Houhou M, Gabellier L, Labussière-Wallet H, Lioure B, Beelen D, Cornelissen J, Wulf G, Jindra P, Tilly H, Passweg J, Niittyvuopio R, Bug G, Schmid C, Nagler A, Giebel S, Mohty M. Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplant. 2021 May;56(5):1190-1199. doi: 10.1038/s41409-020-01173-x. Epub 2020 Dec 9. PMID: 33293597.
4. Hain E, Challine A, Tzedakis S, Mare A, Martinino A, Fuks D, Adham M, Piessen G, Regimbeau JM, Buc E, Barbier L, Vaillant JC, Jeune F, Sulpice L, Muscari F, Schwarz L, Deguelte S, Sa Cunha A, Truant S, Dousset B, Sauvanet A, Gaujoux S. Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial. Front Med (Lausanne). 2021 Jan 15;7:488. doi: 10.3389/fmed.2020.00488. PMID: 33521003; PMCID: PMC7844059. https://pmc.ncbi.nlm.nih.gov/articles/PMC7844059/
5. Maurer MJ, Jakobsen LH, Mwangi R, Schmitz N, Farooq U, Flowers CR, de Nully Brown P, Thompson CA, Frederiksen H, Cunningham D, Jørgensen J, Poeschel V, Nowakowski G, Seymour JF, Merli F, Haioun C, Ghesquieres H, Ziepert M, Tilly H, Salles G, Shi Q, El-Galaly TC, Habermann TM. Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma. Am J Hematol. 2021 May 1;96(5):599-605. doi: 10.1002/ajh.26149. Epub 2021 Mar 18. PMID: 33661547; PMCID: PMC8763015. https://pmc.ncbi.nlm.nih.gov/articles/PMC8763015/
6. Tessoulin B, Chiron D, Thieblemont C, Oberic L, Bouadballah K, Gyan E, Damaj G, Ribrag V, Gressin R, Feugier P, Casasnovas O, Zerazhi H, Lemonnier F, Maisonneuve H, Joubert C, Van Den Neste E, Lamy T, Tilly H, Moreau A, Hermine O, Le Gouill S. Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial. Bone Marrow Transplant. 2021 Jul;56(7):1700-1709. doi: 10.1038/s41409-020-01198-2. Epub 2021 Mar 3. PMID: 33658645.
7. Lambertini M, Ceppi M, Hamy AS, Caron O, Poorvu PD, Carrasco E, Grinshpun A, Punie K, Rousset-Jablonski C, Ferrari A, Paluch-Shimon S, Toss A, Senechal C, Puglisi F, Pogoda K, Pérez-Fidalgo JA, De Marchis L, Ponzone R, Livraghi L, Estevez-Diz MDP, Villarreal-Garza C, Dieci MV, Clatot F, Duhoux FP, Graffeo R, Teixeira L, Córdoba O, Sonnenblick A, Ferreira AR, Partridge AH, Di Meglio A, Saule C, Peccatori FA, Bruzzone M, t’Kint de Roodenbeke MD, Ameye L, Balmaña J, Del Mastro L, Azim HA Jr. Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants. NPJ Breast Cancer. 2021 Feb 12;7(1):16. doi: 10.1038/s41523-021-00224-w. PMID: 33579978; PMCID: PMC7880991. https://pmc.ncbi.nlm.nih.gov/articles/PMC7880991/
8. Hofman P, Ilié M, Chamorey E, Brest P, Schiappa R, Nakache V, Antoine M, Barberis M, Begueret H, Bibeau F, Bonnetaud C, Boström P, Brousset P, Bubendorf L, Carvalho L, Cathomas G, Cazes A, Chalabreysse L, Chenard MP, Copin MC, Côté JF, Damotte D, de Leval L, Delongova P, Thomas de Montpreville V, de Muret A, Dema A, Dietmaier W, Evert M, Fabre A, Forest F, Foulet A, Garcia S, Garcia-Martos M, Gibault L, Gorkiewicz G, Jonigk D, Gosney J, Hofman A, Kern I, Kerr K, Kossai M, Kriegsmann M, Lassalle S, Long-Mira E, Lupo A, Mamilos A, Matěj R, Meilleroux J, Ortiz-Villalón C, Panico L, Panizo A, Papotti M, Pauwels P, Pelosi G, Penault-Llorca F, Pop O, Poté N, Cajal SRY, Sabourin JC, Salmon I, Sajin M, Savic-Prince S, Schildhaus HU, Schirmacher P, Serre I, Shaw E, Sizaret D, Stenzinger A, Stojsic J, Thunnissen E, Timens W, Troncone G, Werlein C, Wolff H, Berthet JP, Benzaquen J, Marquette CH, Hofman V, Calabrese F. Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future. ESMO Open. 2021 Feb;6(1):100024. doi: 10.1016/j.esmoop.2020.100024. Epub 2020 Dec 2. PMID: 33399086; PMCID: PMC7780004. https://pmc.ncbi.nlm.nih.gov/articles/PMC7780004/
9. Canet J, Cony-Makhoul P, Orazio S, Cornet E, Troussard X, Maynadié M, Étienne G, Monnereau A. Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit? Cancer Med. 2021 Oct;10(20):6959-6970. doi: 10.1002/cam4.4186. Epub 2021 Sep 22. PMID: 34551198; PMCID: PMC8525157. https://pmc.ncbi.nlm.nih.gov/articles/PMC8525157/
10. Zaanan A, Henriques J, Cohen R, Sefrioui D, Evrard C, de la Fouchardiere C, Lecomte T, Aparicio T, Svrcek M, Taieb J, André T, Vernerey D, Tougeron D; Association des Gastro-entérologues Oncologues (AGEO). Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin. J Natl Cancer Inst. 2021 Apr 6;113(4):496-500. doi: 10.1093/jnci/djaa072. PMID: 32415973; PMCID: PMC8023852. https://pmc.ncbi.nlm.nih.gov/articles/PMC8023852/
11. Vary A, Lebellec L, Di Fiore F, Penel N, Cheymol C, Rad E, El Hajbi F, Lièvre A, Edeline J, Bimbai AM, Le Deley MC, Turpin A. FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma. Ther Adv Med Oncol. 2021 Jul 16;13:17588359211029825. doi: 10.1177/17588359211029825. PMID: 34349842; PMCID: PMC8287268. https://pmc.ncbi.nlm.nih.gov/articles/PMC8287268/
12. Selim J, Hamzaoui M, Boukhalfa I, Djerada Z, Chevalier L, Piton N, Genty D, Besnier E, Clavier T, Dumesnil A, Renet S, Mulder P, Doguet F, Tamion F, Veber B, Richard V, Baste JM. Cardiopulmonary bypass increases endothelial dysfunction after pulmonary ischaemia-reperfusion in an animal model. Eur J Cardiothorac Surg. 2021 May 8;59(5):1037-1047. doi: 10.1093/ejcts/ezaa412. PMID: 33276375. https://academic.oup.com/ejcts/article/59/5/1037/6024430?login=false
13. Thierry AR, Pastor B, Pisareva E, Ghiringhelli F, Bouché O, De La Fouchardière C, Vanbockstael J, Smith D, François E, Dos Santos M, Botsen D, Ellis S, Fonck M, André T, Guardiola E, Khemissa F, Linot B, Martin-Babau J, Rinaldi Y, Assenat E, Clavel L, Dominguez S, Gavoille C, Sefrioui D, Pezzella V, Mollevi C, Ychou M, Mazard T. Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer. JAMA Netw Open. 2021 Sep 1;4(9):e2124483. doi: 10.1001/jamanetworkopen.2021.24483. PMID: 34495337; PMCID: PMC8427376. https://pmc.ncbi.nlm.nih.gov/articles/PMC8427376/
14. Thomas de Montpreville V, Mansuet-Lupo A, Le Naoures C, Chalabreysse L, De Muret A, Hofman V, Rouquette I, Piton N, Dubois R, Benitez JC, Girard N, Besse B, Marx A, Molina TJ. Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC study. Virchows Arch. 2021 Oct;479(4):741-746. doi: 10.1007/s00428-021-03044-2. Epub 2021 Feb 24. PMID: 33629132.
15. Cluzeau T, Sebert M, Rahmé R, Cuzzubbo S, Lehmann-Che J, Madelaine I, Peterlin P, Bève B, Attalah H, Chermat F, Miekoutima E, Rauzy OB, Recher C, Stamatoullas A, Willems L, Raffoux E, Berthon C, Quesnel B, Loschi M, Carpentier AF, Sallman DA, Komrokji R, Walter-Petrich A, Chevret S, Ades L, Fenaux P. Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM). J Clin Oncol. 2021 May 10;39(14):1575-1583. doi: 10.1200/JCO.20.02342. Epub 2021 Feb 18. PMID: 33600210; PMCID: PMC8099409. https://pmc.ncbi.nlm.nih.gov/articles/PMC8099409/
16. Bièche I, Coussy F, El-Botty R, Vacher S, Château-Joubert S, Dahmani A, Montaudon E, Reyes C, Gentien D, Reyal F, Ricci F, Nicolas A, Marchio C, Vincent-Salomon A, Laé M, Marangoni E. HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast. J Hematol Oncol. 2021 Sep 8;14(1):143. doi: 10.1186/s13045-021-01158-3. PMID: 34496925; PMCID: PMC8424935. https://pmc.ncbi.nlm.nih.gov/articles/PMC8424935/
17. Condorelli M, Bruzzone M, Ceppi M, Ferrari A, Grinshpun A, Hamy AS, de Azambuja E, Carrasco E, Peccatori FA, Di Meglio A, Paluch-Shimon S, Poorvu PD, Venturelli M, Rousset-Jablonski C, Senechal C, Livraghi L, Ponzone R, De Marchis L, Pogoda K, Sonnenblick A, Villarreal-Garza C, Córdoba O, Teixeira L, Clatot F, Punie K, Graffeo R, Dieci MV, Pérez-Fidalgo JA, Duhoux FP, Puglisi F, Ferreira AR, Blondeaux E, Peretz-Yablonski T, Caron O, Saule C, Ameye L, Balmaña J, Partridge AH, Azim HA, Demeestere I, Lambertini M. Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer. ESMO Open. 2021 Dec;6(6):100300. doi: 10.1016/j.esmoop.2021.100300. Epub 2021 Nov 12. PMID: 34775302; PMCID: PMC8593447. https://pmc.ncbi.nlm.nih.gov/articles/PMC8593447/
18. Mareschal S, Palau A, Lindberg J, Ruminy P, Nilsson C, Bengtzén S, Engvall M, Eriksson A, Neddermeyer A, Marchand V, Jansson M, Björklund M, Jardin F, Rantalainen M, Lennartsson A, Cavelier L, Grönberg H, Lehmann S. Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML. Blood Adv. 2021 Feb 23;5(4):1003-1016. doi: 10.1182/bloodadvances.2020002517. PMID: 33591326; PMCID: PMC7903223. https://pmc.ncbi.nlm.nih.gov/articles/PMC7903223/
19. Gilard V, Tebani A, Dabaj I, Laquerrière A, Fontanilles M, Derrey S, Marret S, Bekri S. Diagnosis and Management of Glioblastoma: A Comprehensive Perspective. J Pers Med. 2021 Apr 1;11(4):258. doi: 10.3390/jpm11040258. PMID: 33915852; PMCID: PMC8065751. https://pmc.ncbi.nlm.nih.gov/articles/PMC8065751/
20. Renosi F, Roggy A, Giguelay A, Soret L, Viailly PJ, Cheok M, Biichle S, Angelot-Delettre F, Asnafi V, Macintyre E, Geffroy S, Callanan M, Petrella T, Deconinck E, Daguindau E, Harrivel V, Bouyer S, Salaun V, Saussoy P, Feuillard J, Fuseau P, Saas P, Adotévi O, Jardin F, Ferrand C, Preudhomme C, Colinge J, Roumier C, Garnache-Ottou F. Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis. Blood Adv. 2021 Mar 9;5(5):1540-1551. doi: 10.1182/bloodadvances.2020003359. PMID: 33687433; PMCID: PMC7948279. https://pmc.ncbi.nlm.nih.gov/articles/PMC7948279/
21. Grinda T, Antoine A, Jacot W, Blaye C, Cottu PH, Diéras V, Dalenc F, Gonçalves A, Debled M, Patsouris A, Mouret-Reynier MA, Mailliez A, Clatot F, Levy C, Ferrero JM, Desmoulins I, Uwer L, Petit T, Jouannaud C, Lacroix-Triki M, Deluche E, Robain M, Courtinard C, Bachelot T, Brain E, Pérol D, Delaloge S. Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort. ESMO Open. 2021 Jun;6(3):100114. doi: 10.1016/j.esmoop.2021.100114. Epub 2021 Apr 23. PMID: 33895695; PMCID: PMC8095121. https://pmc.ncbi.nlm.nih.gov/articles/PMC8095121/
22. Boussaid I, Le Goff S, Floquet C, Gautier EF, Raimbault A, Viailly PJ, Al Dulaimi D, Burroni B, Dusanter-Fourt I, Hatin I, Mayeux P, Cosson B, Fontenay M. Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cells. Haematologica. 2021 Mar 1;106(3):746-758. doi: 10.3324/haematol.2019.239970. PMID: 32327500; PMCID: PMC7927886. https://pmc.ncbi.nlm.nih.gov/articles/PMC7927886/
23. Pinochet P, Texte E, Stamatoullas-Bastard A, Vera P, Mihailescu SD, Becker S. Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma. Sci Rep. 2021 Dec 1;11(1):23195. doi: 10.1038/s41598-021-02734-w. PMID: 34853386; PMCID: PMC8636481. https://pmc.ncbi.nlm.nih.gov/articles/PMC8636481/
24. Grandal B, Mangiardi-Veltin M, Laas E, Laé M, Meseure D, Bataillon G, El-Alam E, Darrigues L, Dumas E, Daoud E, Vincent-Salomon A, Talagrand LS, Pierga JY, Reyal F, Hamy AS. PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy. Cancers (Basel). 2021 Feb 11;13(4):746. doi: 10.3390/cancers13040746. PMID: 33670162; PMCID: PMC7916886. https://pmc.ncbi.nlm.nih.gov/articles/PMC7916886/
25. Gilard V, Ferey J, Marguet F, Fontanilles M, Ducatez F, Pilon C, Lesueur C, Pereira T, Basset C, Schmitz-Afonso I, Di Fioré F, Laquerrière A, Afonso C, Derrey S, Marret S, Bekri S, Tebani A. Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in Glioblastoma. Cancers (Basel). 2021 Oct 14;13(20):5157. doi: 10.3390/cancers13205157. PMID: 34680306; PMCID: PMC8534284. https://pmc.ncbi.nlm.nih.gov/articles/PMC8534284/
26. Chalabreysse L, Dubois R, Hofman V, Le Naoures C, Mansuet-Lupo A, de Montpréville VT, De Muret A, Parrens M, Piton N, Rouquette I, Secq V, Singeorzan C, Marx A, Girard N, Besse B, Molina TJ. Diagnostic des thymomes et carcinomes thymiques malpighiens ; expérience du réseau RYTHMIC [Thymoma and squamous thymic carcinoma diagnosis; experience from the RYTHMIC network]. Ann Pathol. 2021 Apr;41(2):154-165. French. doi: 10.1016/j.annpat.2020.11.002. Epub 2020 Dec 10. PMID: 33309329. https://www.sciencedirect.com/science/article/pii/S0242649820302686?via%3Dihub
27. Floris G, Richard F, Hamy AS, Jongen L, Wildiers H, Ardui J, Punie K, Smeets A, Berteloot P, Vergote I, De Croze D, Meseure D, Salomon A, Laé M, Reyal F, Biganzoli E, Neven P, Desmedt C. Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. J Natl Cancer Inst. 2021 Feb 1;113(2):146-153. doi: 10.1093/jnci/djaa090. PMID: 33152071; PMCID: PMC7850533. https://pmc.ncbi.nlm.nih.gov/articles/PMC7850533/
28. Addou S, Sarkozy C, Lazarovici J, Champiat S, Stamatoullas A, Jardin F, Ribrag V, Marabelle A, Michot JM. Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation? Hum Vaccin Immunother. 2021 Oct 3;17(10):3502-3510. doi: 10.1080/21645515.2021.1924521. Epub 2021 Jun 8. PMID: 34101538; PMCID: PMC8437539. https://pmc.ncbi.nlm.nih.gov/articles/PMC8437539/
29. Cassinari K, Alessandri-Gradt E, Chambon P, Charbonnier F, Gracias S, Beaussire L, Alexandre K, Sarafan-Vasseur N, Houdayer C, Etienne M, Caron F, Plantier JC, Frebourg T. Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples. Clin Chem. 2021 Apr 29;67(5):736-741. doi: 10.1093/clinchem/hvaa323. PMID: 33331864; PMCID: PMC7799276. https://pmc.ncbi.nlm.nih.gov/articles/PMC7799276/
30. Laot L, Laas E, Girard N, Dumas E, Daoud E, Grandal B, Pierga JY, Coussy F, Kirova Y, El-Alam E, Bataillon G, Lae M, Llouquet F, Reyal F, Hamy AS. The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes. Cancers (Basel). 2021 Jan 6;13(2):171. doi: 10.3390/cancers13020171. PMID: 33418983; PMCID: PMC7825348. https://pmc.ncbi.nlm.nih.gov/articles/PMC7825348/
31. Verrelle P, Meseure D, Berger F, Forest A, Leclère R, Nicolas A, Fortas E, Sastre-Garau X, Lae M, Boudjemaa S, Mbagui R, Calugaru V, Labiod D, De Koning L, Almouzni G, Quivy JP. CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients. Cancers (Basel). 2021 Aug 4;13(16):3928. doi: 10.3390/cancers13163928. PMID: 34439087; PMCID: PMC8391827. https://pmc.ncbi.nlm.nih.gov/articles/PMC8391827/
32. Lemonnier F, Safar V, Beldi-Ferchiou A, Cottereau AS, Bachy E, Cartron G, Fataccioli V, Pelletier L, Robe C, Letourneau A, Missiaglia E, Fourati S, Moles-Moreau MP, Delmer A, Bouabdallah R, Voillat L, Becker S, Bossard C, Parrens M, Casasnovas O, Cacheux V, Régny C, Camus V, Delfau-Larue MH, Meignan M, de Leval L, Gaulard P, Haioun C. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma. Blood Adv. 2021 Jan 26;5(2):539-548. doi: 10.1182/bloodadvances.2020003081. PMID: 33496747; PMCID: PMC7839364. https://pmc.ncbi.nlm.nih.gov/articles/PMC7839364/
33. Labrosse J, Morel C, Lam T, Laas E, Feron JG, Coussy F, Lae M, Reyal F, Hamy AS. The Presence of an In Situ Component on Pre-Treatment Biopsy Is Not Associated with Response to Neoadjuvant Chemotherapy for Breast Cancer. Cancers (Basel). 2021 Jan 10;13(2):235. doi: 10.3390/cancers13020235. PMID: 33435265; PMCID: PMC7827327. https://pmc.ncbi.nlm.nih.gov/articles/PMC7827327/
34. Turpin A, de Baere T, Heurgué A, Le Malicot K, Ollivier-Hourmand I, Lecomte T, Perrier H, Vergniol J, Sefrioui D, Rinaldi Y, Edeline J, Jouve JL, Silvain C, Becouarn Y, Dauvois B, Baconnier M, Debette-Gratien M, Deplanque G, Dharancy S, Lepage C, Hebbar M; PRODIGE 16 investigators Collaborators. Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study. Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101464. doi: 10.1016/j.clinre.2020.05.012. Epub 2020 Jun 21. PMID: 32576496. https://www.sciencedirect.com/science/article/pii/S2210740120301571?via%3Dihub
35. Cordel N, Derambure C, Coutant S, Mariette X, Jullien D, Debarbieux S, Chosidow O, Meyer A, Bessis D, Joly P, Mathian A, Levesque H, Sabourin JC, Tournier I, Boyer O; OncoMyositis Study group. TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis. Rheumatology (Oxford). 2021 Dec 1;60(12):5863-5867. doi: 10.1093/rheumatology/keab260. PMID: 33764396.
36. Dupuis HGA, Chebbi A, Surlemont L, Rigal O, Di Fiore F, Pfister C, Nouhaud FX. Efficacy and safety of anti-vascular endothelial growth factor therapies in older patients for first line treatment of metastatic renal cell carcinoma. Transl Androl Urol. 2021 Jun;10(6):2418-2426. doi: 10.21037/tau-20-1481. PMID: 34295728; PMCID: PMC8261413. https://pmc.ncbi.nlm.nih.gov/articles/PMC8261413/
37. Laas E, Labrosse J, Hamy AS, Benchimol G, de Croze D, Feron JG, Coussy F, Balezeau T, Guerin J, Lae M, Pierga JY, Reyal F. Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore. Br J Cancer. 2021 Apr;124(8):1421-1427. doi: 10.1038/s41416-020-01251-3. Epub 2021 Feb 9. PMID: 33558711; PMCID: PMC8039034. https://pmc.ncbi.nlm.nih.gov/articles/PMC8039034/
38. Taïeb J, André T, El Hajbi F, Barbier E, Toullec C, Kim S, Bouche O, Di Fiore F, Chauvenet M, Perrier H, Evesque L, Laurent-Puig P, Emile JF, Bez J, Lepage C, Tougeron D. Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial. Dig Liver Dis. 2021 Mar;53(3):318-323. doi: 10.1016/j.dld.2020.11.031. Epub 2020 Dec 25. PMID: 33359404. https://www.sciencedirect.com/science/article/pii/S1590865820310525?via%3Dihub
39. Uguen A, Csanyi-Bastien M, Sabourin JC, Penault-Llorca F, Adam J. Recherche de fusions des gènes NTRK : guide pratique pour les pathologistes [How to test for NTRK gene fusions: A practical approach for pathologists]. Ann Pathol. 2021 Jul;41(4):387-398. French. doi: 10.1016/j.annpat.2021.03.005. Epub 2021 Apr 9. PMID: 33846022. https://www.sciencedirect.com/science/article/pii/S0242649821000742?via%3Dihub
40. Raze T, Lacour B, Cowppli-Bony A, Delafosse P, Velten M, Trétarre B, Defossez G, Hammas K, Woronoff AS, Ganry O, Plouvier S, Coureau G, Guizard AV, Bara S, Monnereau A, Daubisse-Marliac L, Troussard X, D’Almeida T, Baldi I, Bouvier V, Boissel N, Clavel J, Desandes E. Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival. J Adolesc Young Adult Oncol. 2021 Feb;10(1):29-45. doi: 10.1089/jayao.2020.0017. Epub 2020 May 15. PMID: 32412825.
41. Grever M, Andritsos L, Banerji V, Barrientos JC, Bhat S, Blachly JS, Call T, Cross M, Dearden C, Demeter J, Dietrich S, Falini B, Forconi F, Gladstone DE, Gozzetti A, Iyengar S, Johnston JB, Juliusson G, Kraut E, Kreitman RJ, Lauria F, Lozanski G, Parikh SA, Park J, Polliack A, Ravandi F, Robak T, Rogers KA, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam CS, Tiacci E, Troussard X, Zent C, Zenz T, Zinzani PL, Wörmann B. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines. Leukemia. 2021 Jul;35(7):1864-1872. doi: 10.1038/s41375-021-01257-7. Epub 2021 May 4. PMID: 33947938; PMCID: PMC8093591. https://pmc.ncbi.nlm.nih.gov/articles/PMC8093591/
42. Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Robak T, le Coutre PD, Gjertsen BT, Troussard X, Roboz GJ, Karlin L, Gladstone DE, Kuptsova-Clarkson N, Liu S, Patel P, Rotolo F, Mitry E, Pastan I, Giles F; Study 1053 investigators. Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial. J Hematol Oncol. 2021 Feb 24;14(1):35. doi: 10.1186/s13045-020-01004-y. PMID: 33627164; PMCID: PMC7905554. https://pmc.ncbi.nlm.nih.gov/articles/PMC7905554/
43. Baicry F, Molinié F, Plouvier S, Colonna M, Daubisse-Marliac L, Grosclaude P, Trétarre B, Bara S, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Marrer E, Klein D, Velten M, Jégu J. What is the most appropriate period to define synchronous cancers? Cancer Epidemiol. 2021 Apr;71(Pt A):101900. doi: 10.1016/j.canep.2021.101900. Epub 2021 Feb 9. PMID: 33578073. https://www.sciencedirect.com/science/article/pii/S1877782121000175?via%3Dihub
44. Jullien M, Tessoulin B, Ghesquières H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Lamy T, Thieblemont C, Villemagne B, Gressin R, Bouabdallah K, Haioun C, Damaj G, Fornecker LM, Schiano De Colella JM, Feugier P, Hermine O, Cartron G, Bonnet C, André M, Bailly C, Casasnovas RO, Le Gouill S. Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years. Cancers (Basel). 2021 Sep 7;13(18):4503. doi: 10.3390/cancers13184503. PMID: 34572728; PMCID: PMC8466314. https://pmc.ncbi.nlm.nih.gov/articles/PMC8466314/
45. Joly F, Rigal O, Guittet L, Lefèvre-Arbogast S, Grellard JM, Binarelli G, Lange M, Rieux C, Fernette M, Tron L, Gernier F, Travers R, Morel A, Richard D, Griffon B, Leconte A, Bastien E, Quilan F, Pépin LF, Jardin F, Leheurteur M, Clarisse B, Lequesne J, Faveyrial A. Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospital. Cancer. 2021 Dec 15;127(24):4636-4645. doi: 10.1002/cncr.33856. Epub 2021 Aug 16. PMID: 34398970; PMCID: PMC8426939. https://pmc.ncbi.nlm.nih.gov/articles/PMC8426939/
46. Faumont N, Taoui O, Collares D, Jais JP, Leroy K, Prévaud L, Jardin F, Molina TJ, Copie-Bergman C, Petit B, Gourin MP, Bordessoule D, Troutaud D, Baud V, Feuillard J. c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study. Front Oncol. 2021 Apr 20;11:638897. doi: 10.3389/fonc.2021.638897. PMID: 33959502; PMCID: PMC8095348. https://pmc.ncbi.nlm.nih.gov/articles/PMC8095348/
47. Ghesquières H, Dalban C, Nicolas-Virelizier E, Jardin F, Le Bras F, Le Gouill S, Casasnovas O, Vizoso S, Hernandez C, Metzger S, Pérol D, Cartron G. BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres†. Br J Haematol. 2021 Feb;192(3):e94-e98. doi: 10.1111/bjh.17279. Epub 2021 Jan 9. PMID: 33421031. https://onlinelibrary.wiley.com/doi/10.1111/bjh.17279
48. Beugniez C, Sauvanet A, Sulpice L, Gaujoux S, Turrini O, Truant S, Schwarz L, Piessen G, Regimbeau JM, Muscari F, Adham M, Pattou F, Schneider L, Clement G, Delpero JR, Pruvot FR, El Amrani M; French-ACHBT Working Group. Root-cause Analysis of Mortality After Pancreatic Resection (CARE Study): A Multicenter Cohort Study. Ann Surg. 2021 Nov 1;274(5):789-796. doi: 10.1097/SLA.0000000000005118. Erratum in: Ann Surg. 2022 Jan 1;275(1):e280. doi: 10.1097/SLA.0000000000005273. PMID: 34334643. https://journals.lww.com/annalsofsurgery/fulltext/2021/11000/root_cause_analysis_of_mortality_after_pancreatic.16.aspx
49. Lachkar S, Salaün M, Perrot L, Gervereau D, De Marchi M, Le Bouar G, Morisse-Pradier H, Dominique S, Piton N, Guisier F, Thiberville L. Virtual Bronchoscopy Planner and Radial-EBUS Guided Biopsy for Organizing Pneumonia Diagnosis. J Clin Med. 2021 Dec 25;11(1):104. doi: 10.3390/jcm11010104. PMID: 35011844; PMCID: PMC8745414. https://pmc.ncbi.nlm.nih.gov/articles/PMC8745414/
50. Sella N, Hamy AS, Cabeli V, Darrigues L, Laé M, Reyal F, Isambert H. Interactive exploration of a global clinical network from a large breast cancer cohort. NPJ Digit Med. 2022 Aug 10;5(1):113. doi: 10.1038/s41746-022-00647-0. PMID: 35948579; PMCID: PMC9365762. https://pmc.ncbi.nlm.nih.gov/articles/PMC9365762/
51. Grandal B, Aljehani A, Dumas E, Daoud E, Jochum F, Gougis P, Hotton J, Lemoine A, Michel S, Laas E, Laé M, Pierga JY, Alaoui Ismaili K, Lerebours F, Reyal F, Hamy AS. No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC. Cancers (Basel). 2022 Jun 23;14(13):3080. doi: 10.3390/cancers14133080. PMID: 35804852; PMCID: PMC9264787. https://pmc.ncbi.nlm.nih.gov/articles/PMC9264787/
52. Le Calvez B, Tessoullin B, Renaud L, Botella-Garcia C, Srour M, Le Gouill S, Guillerm G, Gressin R, Nguyen Quoc S, Furst S, Chauchet A, Sibon D, Lewalle P, Poiré X, Maillard N, Villate A, Loschi M, Paillassa J, Beguin Y, Dulery R, Tudesq JJ, Fayard A, Béné MC, Camus V, Chevallier P, Le Bourgeois A. Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. Acta Oncol. 2022 Nov;61(11):1332-1338. doi: 10.1080/0284186X.2022.2130709. Epub 2022 Oct 10. PMID: 36214787. https://orbi.uliege.be/handle/2268/297868
53. Broccoli A, Argnani L, Cross M, Janus A, Maitre E, Troussard X, Robak T, Dearden C, Else M, Catovsky D, Zinzani PL. A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia. Blood Adv. 2022 Jul 26;6(14):4224-4227. doi: 10.1182/bloodadvances.2022007854. PMID: 35584397; PMCID: PMC9327549. https://pmc.ncbi.nlm.nih.gov/articles/PMC9327549/
54. Bagacean C, Letestu R, Al-Nawakil C, Brichler S, Lévy V, Sritharan N, Delmer A, Dartigeas C, Leblond V, Roos-Weil D, Tomowiak C, Merabet F, Béné MC, Clavert A, Chaoui D, Genet P, Guieze R, Laribi K, Drénou B, Willems L, Puppinck C, Legendre H, Troussard X, Malartre S, Cymbalista F, Michallet AS. Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia. Blood Adv. 2022 Jan 11;6(1):207-211. doi: 10.1182/bloodadvances.2021006215. PMID: 34844264; PMCID: PMC8632355. https://pmc.ncbi.nlm.nih.gov/articles/PMC8632355/
55. Leflon M, Rives-Feraille A, Letailleur M, Petrovic CH, Martin B, Marpeau L, Jardin F, Aziz M, Stamatoulas-Bastard A, Dumont L, Rondanino C, Rives N. Experience, and gynaecological and reproductive health follow-up of young adult women who have undergone ovarian tissue cryopreservation. Reprod Biomed Online. 2022 Nov;45(5):913-922. doi: 10.1016/j.rbmo.2022.06.016. Epub 2022 Jun 23. PMID: 36085268. https://www.sciencedirect.com/science/article/pii/S1472648322004266?via%3Dihub
56. Togami K, Chung SS, Madan V, Booth CAG, Kenyon CM, Cabal-Hierro L, Taylor J, Kim SS, Griffin GK, Ghandi M, Li J, Li YY, Angelot-Delettre F, Biichle S, Seiler M, Buonamici S, Lovitch SB, Louissaint A Jr, Morgan EA, Jardin F, Piccaluga PP, Weinstock DM, Hammerman PS, Yang H, Konopleva M, Pemmaraju N, Garnache-Ottou F, Abdel-Wahab O, Koeffler HP, Lane AA. Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis. Cancer Discov. 2022 Feb;12(2):522-541. doi: 10.1158/2159-8290.CD-20-1513. Epub 2021 Oct 6. PMID: 34615655; PMCID: PMC8831459. https://pmc.ncbi.nlm.nih.gov/articles/PMC8831459/
57. Selim J, Hamzaoui M, Ghemired A, Djerada Z, Chevalier L, Piton N, Besnier E, Clavier T, Dumesnil A, Renet S, Mulder P, Doguet F, Tamion F, Veber B, Bellien J, Richard V, Baste JM. Priming of Cardiopulmonary Bypass with Human Albumin Decreases Endothelial Dysfunction after Pulmonary Ischemia-Reperfusion in an Animal Model. Int J Mol Sci. 2022 Aug 11;23(16):8938. doi: 10.3390/ijms23168938. PMID: 36012201; PMCID: PMC9408928. https://pmc.ncbi.nlm.nih.gov/articles/PMC9408928/
58. Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R; Lymphoma Study Association (LYSA). Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA). Br J Haematol. 2022 Jul;198(1):203-206. doi: 10.1111/bjh.18198. Epub 2022 Apr 21. PMID: 35445392. https://onlinelibrary.wiley.com/doi/10.1111/bjh.18198
59. Marouf A, Cottereau AS, Kanoun S, Deschamps P, Meignan M, Franchi P, Sibon D, Antoine C, Gastinne T, Borel C, Hammoud M, Sicard G, Gille R, Cavalieri D, Stamatoullas A, Filliatre-Clement L, Lazarovici J, Chauchet A, Fornecker LM, Amorin S, Rocquet M, Raus N, Burroni B, Rubio MT, Bouscary D, Quittet P, Casasnovas RO, Brice P, Ghesquieres H, Tamburini J, Deau B. Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study. Haematologica. 2022 Jul 1;107(7):1681-1686. doi: 10.3324/haematol.2021.279564. PMID: 34965701; PMCID: PMC9244814. https://pmc.ncbi.nlm.nih.gov/articles/PMC9244814/
60. Bidard FC, Hardy-Bessard AC, Dalenc F, Bachelot T, Pierga JY, de la Motte Rouge T, Sabatier R, Dubot C, Frenel JS, Ferrero JM, Ladoire S, Levy C, Mouret-Reynier MA, Lortholary A, Grenier J, Chakiba C, Stefani L, Plaza JE, Clatot F, Teixeira L, D’Hondt V, Vegas H, Derbel O, Garnier-Tixidre C, Canon JL, Pistilli B, André F, Arnould L, Pradines A, Bièche I, Callens C, Lemonnier J, Berger F, Delaloge S; PADA-1 investigators. Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol. 2022 Nov;23(11):1367-1377. doi: 10.1016/S1470-2045(22)00555-1. Epub 2022 Sep 29. PMID: 36183733. https://www.sciencedirect.com/science/article/pii/S1470204522005551?via%3Dihub
61. Casasnovas RO, Bouabdallah R, Brice P, Lazarovici J, Ghesquieres H, Stamatoullas A, Dupuis J, Gac AC, Gastinne T, Joly B, Bouabdallah K, Nicolas-Virelizier E, Feugier P, Morschhauser F, Sibon D, Bonnet C, Berriolo-Riedinger A, Edeline V, Parrens M, Damotte D, Coso D, André M, Meignan M, Rossi C. Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study. J Clin Oncol. 2022 Apr 1;40(10):1091-1101. doi: 10.1200/JCO.21.01777. Epub 2022 Jan 6. PMID: 34990281. https://ascopubs.org/doi/10.1200/JCO.21.01777?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
62. Lours C, Cottin L, Wiber M, Andrieu V, Baccini V, Baseggio L, Brouzes C, Chatelain B, Daliphard S, Fenneteau O, Geneviève F, Girard S, Leymarie V, Maloum K, Rieu JB, Sebahoun G, Sudaka I, Troussard X, Wagner-Ballon O, Wuilleme S, Bardet V, Lesesve JF. Perls’ Stain Guidelines from the French-Speaking Cellular Hematology Group (GFHC). Diagnostics (Basel). 2022 Jul 12;12(7):1698. doi: 10.3390/diagnostics12071698. PMID: 35885602; PMCID: PMC9318570. https://pmc.ncbi.nlm.nih.gov/articles/PMC9318570/
63. Andritsos LA, Anghelina M, Neal J, Blachly JS, Mathur P, Lele O, Dearden C, Iyengar S, Cross M, Zent CS, Rogers KA, Epperla N, Lozanski G, Oakes CC, Kraut E, Ruppert AS, Zhao Q, Bhat SA, Forconi F, Banerji V, Handunnetti S, Tam CS, Seymour JF, Else M, Kreitman RJ, Saven A, Call T, Parikh SA, Ravandi F, Johnston JB, Tiacci E, Troussard X, Tallman MS, Dietrich S, Tadmor T, Gozzetti A, Zinzani PL, Robak T, Quest G, Demeter J, Rai K, Fernandez SA, Grever M. Development of a distributed international patient data registry for hairy cell leukemia. Leuk Lymphoma. 2022 Dec;63(13):3021-3031. doi: 10.1080/10428194.2022.2109157. Epub 2022 Sep 7. PMID: 36070610; PMCID: PMC9990910. https://pmc.ncbi.nlm.nih.gov/articles/PMC9990910/
64. Lepage C, Phelip JM, Lievre A, Le-Malicot K, Dahan L, Tougeron D, Toumpanakis C, Di-Fiore F, Lombard-Bohas C, Borbath I, Coriat R, Lecomte T, Guimbaud R, Petorin C, Legoux JL, Michel P, Scoazec JY, Smith D, Walter T. Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study. Eur J Cancer. 2022 Nov;175:31-40. doi: 10.1016/j.ejca.2022.07.033. Epub 2022 Sep 7. PMID: 36087395. https://www.sciencedirect.com/science/article/pii/S0959804922004804?via%3Dihub
65. Thieblemont C, Chartier L, Dührsen U, Vitolo U, Barrington SF, Zaucha JM, Vercellino L, Gomes Silva M, Patrocinio-Carvalho I, Decazes P, Viailly PJ, Tilly H, Berriolo-Riedinger A, Casasnovas O, Hüttmann A, Ilyas H, Mikhaeel NG, Dunn J, Cottereau AS, Schmitz C, Kostakoglu L, Paulson JN, Nielsen T, Meignan M. A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma. Blood Adv. 2022 Dec 13;6(23):5995-6004. doi: 10.1182/bloodadvances.2021006923. PMID: 36044385; PMCID: PMC9691911. https://pmc.ncbi.nlm.nih.gov/articles/PMC9691911/
66. Rossi C, André M, Dupuis J, Morschhauser F, Joly B, Lazarovici J, Ghesquières H, Stamatoullas A, Nicolas-Virelizier E, Feugier P, Gac AC, Moatti H, Fornecker LM, Deau B, Joubert C, Fortpied C, Raemaekers J, Federico M, Kanoun S, Meignan M, Traverse-Glehen A, Cottereau AS, Casasnova RO. High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline. Haematologica. 2022 Dec 1;107(12):2897-2904. doi: 10.3324/haematol.2021.280004. PMID: 35638548; PMCID: PMC9713544. https://haematologica.org/article/view/haematol.2021.280004
67. Torregrosa C, Pernot S, Vaflard P, Perret A, Tournigand C, Randrian V, Doat S, Neuzillet C, Moulin V, Stouvenot M, Roth G, Darbas T, Auberger B, Godet T, Jaffrelot M, Lambert A, Dubreuil O, Gluszak C, Bernard-Tessier A, Turpin A, Palmieri LJ, Bouche O, Goujon G, Lecomte T, Sefrioui D, Locher C, Grados L, Gignoux P, Trager S, Nassif E, Saint A, Hammel P, Lecaille C, Bureau M, Perrier M, Botsen D, Bourgeois V, Taieb J, Auclin E. FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study. Int J Cancer. 2022 Dec 1;151(11):1978-1988. doi: 10.1002/ijc.34166. Epub 2022 Jul 14. PMID: 35833561. https://onlinelibrary.wiley.com/doi/10.1002/ijc.34166
68. Hofman V, Heeke S, Bontoux C, Chalabreysse L, Barritault M, Bringuier PP, Fenouil T, Benzerdjeb N, Begueret H, Merlio JP, Caumont C, Piton N, Sabourin JC, Evrard S, Syrykh C, Vigier A, Brousset P, Mazieres J, Long-Mira E, Benzaquen J, Boutros J, Allegra M, Tanga V, Lespinet-Fabre V, Salah M, Bonnetaud C, Bordone O, Lassalle S, Marquette CH, Ilié M, Hofman P. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC. JTO Clin Res Rep. 2022 Dec 29;4(2):100457. doi: 10.1016/j.jtocrr.2022.100457. PMID: 36718140; PMCID: PMC9883235. https://pmc.ncbi.nlm.nih.gov/articles/PMC9883235/
69. Steimlé T, Dourthe ME, Alcantara M, Touzart A, Simonin M, Mondesir J, Lhermitte L, Bond J, Graux C, Grardel N, Cayuela JM, Arnoux I, Gandemer V, Balsat M, Vey N, Macintyre E, Ifrah N, Dombret H, Petit A, Baruchel A, Ruminy P, Boissel N, Asnafi V. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins. Blood Cancer J. 2022 Jan 26;12(1):14. doi: 10.1038/s41408-022-00613-9. PMID: 35082269; PMCID: PMC8791998. https://pmc.ncbi.nlm.nih.gov/articles/PMC8791998/
70. Drabent P, Polivka L, Agopian J, Duong Van Huyen JP, Thiebaut PA, Dubreuil P, Hermine O, Molina TJ, Fraitag S. Establishing diagnostic criteria for mastocytosis in skin biopsies. Histopathology. 2022 Feb;80(3):501-514. doi: 10.1111/his.14573. Epub 2021 Dec 14. PMID: 34637148. https://onlinelibrary.wiley.com/doi/10.1111/his.14573
71. Coutance G, Zouhry I, Racapé M, Drieux F, Viailly PJ, Rouvier P, François A, Chenard MP, Toquet C, Rabant M, Berry GJ, Angelini A, Bruneval P, Duong Van Huyen JP. Correlation Between Microvascular Inflammation in Endomyocardial Biopsies and Rejection Transcripts, Donor-specific Antibodies, and Graft Dysfunction in Antibody-mediated Rejection. Transplantation. 2022 Jul 1;106(7):1455-1464. doi: 10.1097/TP.0000000000004008. Epub 2021 Dec 21. PMID: 34954735. https://journals.lww.com/transplantjournal/fulltext/2022/07000/correlation_between_microvascular_inflammation_in.25.aspx
72. Evrard C, Messina S, Sefrioui D, Frouin É, Auriault ML, Chautard R, Zaanan A, Jaffrelot M, De La Fouchardière C, Aparicio T, Coriat R, Godet J, Silvain C, Randrian V, Sabourin JC, Guimbaud R, Miquelestorena-Standley E, Lecomte T, Moulin V, Karayan-Tapon L, Tachon G, Tougeron D. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers. Int J Mol Sci. 2022 Apr 17;23(8):4427. doi: 10.3390/ijms23084427. PMID: 35457245; PMCID: PMC9032866. https://pmc.ncbi.nlm.nih.gov/articles/PMC9032866/
73. Anderson RA, Cameron D, Clatot F, Demeestere I, Lambertini M, Nelson SM, Peccatori F. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Hum Reprod Update. 2022 May 2;28(3):417-434. doi: 10.1093/humupd/dmac004. PMID: 35199161; PMCID: PMC9071067. https://pmc.ncbi.nlm.nih.gov/articles/PMC9071067/
74. Eluard B, Nuan-Aliman S, Faumont N, Collares D, Bordereaux D, Montagne A, Martins I, Cagnard N, Caly M, Taoui O, Lordello L, Lehmann-Che J, Tesson B, Martinez-Climent JA, Copie-Bergman C, Haioun C, Tilly H, Bonsang B, Vincent-Salomon A, Jais JP, Jardin F, Leroy K, Maiuri MC, Kroemer G, Molina TJ, Feuillard J, Baud V. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma. Blood. 2022 Jan 20;139(3):384-398. doi: 10.1182/blood.2020010039. PMID: 34232979. https://www.sciencedirect.com/science/article/pii/S0006497121013203?via%3Dihub
75. Brugel M, Letrillart L, Evrard C, Thierry A, Tougeron D, El Amrani M, Piessen G, Truant S, Turpin A, d’Engremont C, Roth G, Hautefeuille V, Regimbeau JM, Williet N, Schwarz L, Di Fiore F, Borg C, Doussot A, Lambert A, Moulin V, Trelohan H, Bolliet M, Topolscki A, Ayav A, Lopez A, Botsen D, Piardi T, Carlier C, Bouché O. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID). Eur J Cancer. 2022 May;166:8-20. doi: 10.1016/j.ejca.2022.01.040. Epub 2022 Feb 10. PMID: 35259629; PMCID: PMC8828421. https://pmc.ncbi.nlm.nih.gov/articles/PMC8828421/
76. Corbaux P, Lardy-Cleaud A, Alexandre M, Fontanilles M, Lévy C, Viansone AA, Mailliez A, Debled M, Goncalves A, Le Du F, Lerebours F, Ferrero JM, Eymard JC, Mouret-Reynier MA, Petit T, Frenel JS, Dalenc F, Courtinard C, Chaix M, Bachelot T. Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer. Breast Cancer Res Treat. 2022 Jan;191(1):191-207. doi: 10.1007/s10549-021-06382-6. Epub 2021 Oct 23. PMID: 34687411. https://link.springer.com/article/10.1007/s10549-021-06382-6
77. Jouzier C, Cherait A, Cony-Makhoul P, Hamel JF, Veloso M, Thepot S, Cluzeau T, Stamatoullas A, Garnier A, Guerci-Bresler A, Dimicoli-Salazar S, Pica GM, Cheze S, Santana C, Chermat F, Fenaux P, Park S. Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM). Transfusion. 2022 May;62(5):961-973. doi: 10.1111/trf.16884. Epub 2022 Apr 22. PMID: 35452143. https://onlinelibrary.wiley.com/doi/10.1111/trf.16884
78. Le Mestre J, Thomas M, Duparc C, Val P, Bures C, Tuech JJ, Sabourin JC, Baert-Desurmont S, Lefebvre H, Louiset E. β-Catenin activation and illicit receptor expression in adrenocortical cells. Endocr Relat Cancer. 2022 Feb 7;29(3):151-162. doi: 10.1530/ERC-21-0298. PMID: 34935630.
79. Adès L, Duployez N, Guerci-Bresler A, Laribi K, Peterlin P, Vey N, Thepot S, Wickenhauser S, Zerazhi H, Stamatoullas A, Wattel E, Recher C, Toma A, Dimicoli-Salazar S, Braun T, Beyne-Rauzy O, Marolleau JP, Cheze S, Park S, Cluzeau T, Nimubona S, Bordessoule D, Benramdane R, Quesnel B, Amé S, de Botton S, Chermat F, Preudhomme C, Chevret S, Fenaux P. A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM’s « pick a winner » trial, with the impact of somatic mutations. Br J Haematol. 2022 Aug;198(3):535-544. doi: 10.1111/bjh.18193. Epub 2022 Apr 19. PMID: 35438802. https://onlinelibrary.wiley.com/doi/10.1111/bjh.18193
80. Callens C, Bidard FC, Curto-Taribo A, Trabelsi-Grati O, Melaabi S, Delaloge S, Hardy-Bessard AC, Bachelot T, Clatot F, De La Motte Rouge T, Canon JL, Arnould L, Andre F, Marques S, Stern MH, Pierga JY, Vincent-Salomon A, Benoist C, Jeannot E, Berger F, Bieche I, Pradines A. Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS. Anal Chem. 2022 Apr 26;94(16):6297-6303. doi: 10.1021/acs.analchem.2c00446. Epub 2022 Apr 13. PMID: 35416669.
81. Berger F, Marce M, Delaloge S, Hardy-Bessard AC, Bachelot T, Bièche I, Pradines A, De La Motte Rouge T, Canon JL, André F, Arnould L, Clatot F, Lemonnier J, Marques S, Bidard FC; PADA-1 investigators. Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1. BMJ Open. 2022 Mar 3;12(3):e055821. doi: 10.1136/bmjopen-2021-055821. PMID: 35241469; PMCID: PMC8896060. https://pmc.ncbi.nlm.nih.gov/articles/PMC8896060/
82. Magnin J, Fournel I, Doussot A, Régimbeau JM, Zerbib P, Piessen G, Beyer-Berjot L, Deguelte S, Lakkis Z, Schwarz L, Orry D, Ayav A, Muscari F, Mauvais F, Passot G, Trelles N, Venara A, Benoist S, Messager M, Fuks D, Borraccino B, Trésallet C, Valverde A, Souche FR, Herrero A, Gaujoux S, Lefevre J, Bourredjem A, Cransac A, Ortega-Deballon P. Benefit of a flash dose of corticosteroids in digestive surgical oncology: a multicenter, randomized, double blind, placebo-controlled trial (CORTIFRENCH). BMC Cancer. 2022 Aug 23;22(1):913. doi: 10.1186/s12885-022-09998-z. PMID: 35999521; PMCID: PMC9400297. https://pmc.ncbi.nlm.nih.gov/articles/PMC9400297/
83. Lachkar S, Perrot L, Gervereau D, De Marchi M, Morisse Pradier H, Dantoing E, Piton N, Thiberville L, Guisier F, Salaün M. Radial-EBUS and virtual bronchoscopy planner for peripheral lung cancer diagnosis: How it became the first-line endoscopic procedure. Thorac Cancer. 2022 Oct;13(20):2854-2860. doi: 10.1111/1759-7714.14629. Epub 2022 Aug 29. PMID: 36054681; PMCID: PMC9575082. https://pmc.ncbi.nlm.nih.gov/articles/PMC9575082/
84. Schenone L, Houillier C, Tanguy ML, Choquet S, Agbetiafa K, Ghesquières H, Damaj G, Schmitt A, Bouabdallah K, Ahle G, Gressin R, Cornillon J, Houot R, Marolleau JP, Fornecker LM, Chinot O, Peyrade F, Bouabdallah R, Moluçon-Chabrot C, Gyan E, Chauchet A, Casasnovas O, Oberic L, Delwail V, Abraham J, Roland V, Waultier-Rascalou A, Willems L, Morschhauser F, Fabbro M, Ursu R, Thieblemont C, Jardin F, Tempescul A, Malaise D, Touitou V, Nichelli L, Le Garff-Tavernier M, Plessier A, Bourget P, Bonmati C, Wantz-Mézières S, Giordan Q, Dorvaux V, Charron C, Jabeur W, Hoang-Xuan K, Taillandier L, Soussain C; French network for oculocerebral lymphoma (LOC network). Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network. Bone Marrow Transplant. 2022 Jun;57(6):966-974. doi: 10.1038/s41409-022-01648-z. Epub 2022 Apr 14. PMID: 35422077.
85. Lopez AG, Duparc C, Renouf S, Machevin E, Le Guillou V, Sabourin JC, Defortescu G, Buffet A, Gimenez-Roqueplo AP, Dubessy C, Louiset E, Lefebvre H. Expression of LHCGR in Pheochromocytomas Unveils an Endocrine Mechanism Connecting Pregnancy and Epinephrine Overproduction. Hypertension. 2022 May;79(5):1006-1016. doi: 10.1161/HYPERTENSIONAHA.121.18864. Epub 2022 Feb 22. PMID: 35189708. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.121.18864?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
86. Javed S, Benoist S, Devos P, Truant S, Guimbaud R, Lièvre A, Sefrioui D, Cohen R, Artru P, Dupré A, Bachet JB, de la Fouchardière C, Ploquin A, Turpin A. Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study. World J Surg Oncol. 2022 Apr 23;20(1):131. doi: 10.1186/s12957-022-02594-2. PMID: 35461290; PMCID: PMC9034502. https://pmc.ncbi.nlm.nih.gov/articles/PMC9034502/
87. Vener C, Rossi S, Minicozzi P, Marcos-Gragera R, Poirel HA, Maynadié M, Troussard X, Pravettoni G, De Angelis R, Sant M; EUROCARE-6 Working Group. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol. 2022 Jul 14;12:892684. doi: 10.3389/fonc.2022.892684. PMID: 35912208; PMCID: PMC9333088. https://pmc.ncbi.nlm.nih.gov/articles/PMC9333088/
88. Garin E, Pinaquy JB, Bailly C, Sengel C, Mariano-Goulart D, Edeline J, Blanc JF, Bouvier A, Tordo J, Rode A, Becker S, Sefrioui D, de Baere T, Somma C, Mastier C, Goupil J, Chevallier P, Regnault H, Vibert E, Manfredi S, Vicaut E, Patel B, Boucher E, Guiu B; PROACTIF registry group. Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France. Cardiovasc Intervent Radiol. 2022 Jan;45(1):1-11. doi: 10.1007/s00270-021-03002-0. Epub 2021 Nov 18. PMID: 34796373; PMCID: PMC9014840. https://pmc.ncbi.nlm.nih.gov/articles/PMC9014840/
89. Allart M, Leroy F, Kim S, Sefrioui D, Nayeri M, Zaanan A, Rousseau B, Ben Abdelghani M, de la Fouchardière C, Cacheux W, Legros R, Louafi S, Tougeron D, Bouché O, Fares N, Roquin G, Bignon AL, Maillet M, Pozet A, Hautefeuille V; AGEO investigators. Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort. Dig Liver Dis. 2022 Mar;54(3):391-399. doi: 10.1016/j.dld.2021.06.031. Epub 2021 Aug 9. PMID: 34384712. https://www.sciencedirect.com/science/article/pii/S1590865821003662?via%3Dihub
90. Ravandi F, Kreitman RJ, Tiacci E, Andritsos L, Banerji V, Barrientos JC, Bhat SA, Blachly JS, Broccoli A, Call T, Chihara D, Dearden C, Demeter J, Dietrich S, Else M, Epperla N, Falini B, Forconi F, Gladstone DE, Gozzetti A, Iyengar S, Johnston JB, Jorgensen J, Juliusson G, Lauria F, Lozanski G, Parikh SA, Park JH, Polliack A, Quest G, Robak T, Rogers KA, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam CS, Thompson PA, Troussard X, Zent CS, Zenz T, Zinzani PL, Wörmann B, Rai K, Grever M. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood Cancer J. 2022 Dec 13;12(12):165. doi: 10.1038/s41408-022-00760-z. PMID: 36509740; PMCID: PMC9744664. https://pmc.ncbi.nlm.nih.gov/articles/PMC9744664/
91. Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, Ferreri A, Morel P, Stilgenbauer S, Fox C, Maria Ribera J, Zweegman S, Aurer I, Bödör C, Burkhardt B, Buske C, Dollores Caballero M, Campo E, Chapuy B, Davies A, de Leval L, Doorduijn J, Federico M, Gaulard P, Gay F, Ghia P, Grønbæk K, Goldschmidt H, Kersten MJ, Kiesewetter B, Landman-Parker J, Le Gouill S, Lenz G, Leppä S, Lopez-Guillermo A, Macintyre E, Mantega MVM, Moreau P, Moreno C, Nadel B, Okosun J, Owen R, Pospisilova S, Pott C, Robak T, Spina M, Stamatopoulos K, Stary J, Tarte K, Tedeschi A, Thieblemont C, Trappe RU, Trümper LH, Salles G. The EHA Research Roadmap: Malignant Lymphoid Diseases. Hemasphere. 2022 May 19;6(6):e726. doi: 10.1097/HS9.0000000000000726. PMID: 35620592; PMCID: PMC9126526. https://pmc.ncbi.nlm.nih.gov/articles/PMC9126526/
92. Bonnet C, Dupuis J, Tilly H, Lamy T, Fruchart C, le Gouill S, Thieblemont C, Morschhauser F, Casasnovas O, Bouabdallah K, Ghesquieres H, Van Den Neste E, André M, Cartron G, Salles G. Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group. Cancers (Basel). 2022 Mar 30;14(7):1761. doi: 10.3390/cancers14071761. PMID: 35406532; PMCID: PMC8997053. https://pmc.ncbi.nlm.nih.gov/articles/PMC8997053/
93. Bachy E, Houot R, Feugier P, Bouabdallah K, Bouabdallah R, Virelizier EN, Maerevoet M, Fruchart C, Snauwaert S, Le Gouill S, Marolleau JP, Molina L, Moluçon-Chabrot C, Thieblemont C, Tilly H, Bijou F, Haioun C, Van den Neste E, Fabiani B, Meignan M, Cartron G, Salles G, Casasnovas O, Morschhauser F. Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study. Blood. 2022 Apr 14;139(15):2338-2346. doi: 10.1182/blood.2021013526. PMID: 34936697. https://www.sciencedirect.com/science/article/pii/S0006497121070397?via%3Dihub
94. Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, García-Sancho AM, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gkasiamis A, Crowe R, Xerri L, Fowler NH, Salles G. Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma. J Clin Oncol. 2022 Oct 1;40(28):3239-3245. doi: 10.1200/JCO.22.00843. Epub 2022 Aug 10. PMID: 35947804; PMCID: PMC9553375. https://pmc.ncbi.nlm.nih.gov/articles/PMC9553375/
95. Houot R, Poeschel V, Altmann B, Angel S, Thurner L, Illmer T, Andre M, Dreyling M, Maisonneuve H, Tilly H, Mayer S, Casasnovas O, Le Gouill S, Offner F, Cartron G, Kerkhoff A, Weber T, Hoffmann J, Ziepert M, Klapper W, Itti E, Hellwig D, Natchkebia G, de Leval L, Rosenwald A, Haioun C, Dercle L, Gaulard P, Held G. Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma. Hemasphere. 2022 Jan 10;6(2):e672. doi: 10.1097/HS9.0000000000000672. PMID: 35028526; PMCID: PMC8751801. https://pmc.ncbi.nlm.nih.gov/articles/PMC8751801/
96. Nerich V, Guyeux C, Henry-Amar M, Couturier R, Thieblemont C, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Morschhauser F, Feugier P, Sibon D, Ysebaert L, Nicolas-Virelizier E, Broussais-Guillaumot F, Damaj GL, Jais JP, Salles G, Woronoff-Lemsi M, Mounier N. Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study. Cancer. 2022 Feb 1;128(3):519-528. doi: 10.1002/cncr.33938. Epub 2021 Oct 4. PMID: 34605020. https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33938
97. Morschhauser F, Salles G, Batlevi CL, Tilly H, Chaidos A, Phillips T, Burke J, Melnick A. Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas. Blood Rev. 2022 Nov;56:100988. doi: 10.1016/j.blre.2022.100988. Epub 2022 Jul 9. PMID: 35851487; PMCID: PMC10372876. https://pmc.ncbi.nlm.nih.gov/articles/PMC10372876/
98. Bailly S, Cartron G, Chaganti S, Córdoba R, Corradini P, Düll J, Ferrarini I, Osborne W, Rosenwald A, Sancho JM, Tilly H, Van Den Neste E, Viardot A, Visco C. Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper. Hematol Oncol. 2022 Oct;40(4):505-517. doi: 10.1002/hon.3013. Epub 2022 Jun 7. PMID: 35488888; PMCID: PMC9796473. https://pmc.ncbi.nlm.nih.gov/articles/PMC9796473/
99. Drozd-Sokołowska J, Gras L, Zinger N, Snowden JA, Arat M, Basak G, Pouli A, Crawley C, Wilson KMO, Tilly H, Byrne J, Bulabois CE, Passweg J, Ozkurt ZN, Schroyens W, Lioure B, Colorado Araujo M, Poiré X, Van Gorkom G, Gurman G, de Wreede LC, Hayden PJ, Beksac M, Schönland SO, Yakoub-Agha I. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT. Bone Marrow Transplant. 2022 Apr;57(4):633-640. doi: 10.1038/s41409-022-01592-y. Epub 2022 Feb 15. PMID: 35169284; PMCID: PMC8993690. https://pmc.ncbi.nlm.nih.gov/articles/PMC8993690/
100. Younan N, Soussain C, Choquet S, Cassoux N, Touitou V, Schmitt A, Chinot O, Oberic L, Damaj G, Houot R, Ghesquières H, Laribi K, Ahle G, Taillandier L, Paillassa J, Gyan E, Jardin F, Delwail V, Marolleau JP, Tempescul A, Agapé P, Bourniquel M, Vacheret F, Jdid I, Le Garff-Tavernier M, Malaise D, Alentorn A, Xuan KH, Houillier C. Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study. Hematol Oncol. 2022 Dec;40(5):976-986. doi: 10.1002/hon.3044. Epub 2022 Jul 14. PMID: 35789106. https://onlinelibrary.wiley.com/doi/10.1002/hon.3044
101. Pirosa MC, Borchmann S, Jardin F, Gaidano G, Rossi D. Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma. Hemasphere. 2022 May 13;6(6):e727. doi: 10.1097/HS9.0000000000000727. PMID: 35747846; PMCID: PMC9208882. https://pmc.ncbi.nlm.nih.gov/articles/PMC9208882/
102. Durin T, Marchese U, Sauvanet A, Dokmak S, Cherkaoui Z, Fuks D, Laurent C, André M, Ayav A, Magallon C, Turrini O, Sulpice L, Robin F, Bachellier P, Addeo P, Souche FR, Bardol T, Perinel J, Adham M, Tzedakis S, Birnbaum DJ, Facy O, Gagniere J, Gaujoux S, Tribillon E, Roussel E, Schwarz L, Barbier L, Doussot A, Regenet N, Iannelli A, Regimbeau JM, Piessen G, Lenne X, Truant S, El Amrani M. Defining Benchmark Outcomes for Distal Pancreatectomy: Results of a French Multicentric Study. Ann Surg. 2023 Jul 1;278(1):103-109. doi: 10.1097/SLA.0000000000005539. Epub 2022 Jun 28. PMID: 35762617. https://journals.lww.com/annalsofsurgery/fulltext/2023/07000/defining_benchmark_outcomes_for_distal.16.aspx
103. Zwart K, van der Baan FH, Cohen R, Aparicio T, de la Fouchardiére C, Lecomte T, Punt CJA, Sefrioui D, Verheijden RJ, Vink GR, Wensink GE, Zaanan A, Koopman M, Tougeron D, Roodhart JML. Prognostic value of Lynch syndrome, BRAFV600E, and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts. Cancer Med. 2023 Aug;12(15):15841-15853. doi: 10.1002/cam4.6223. Epub 2023 Jun 16. PMID: 37326121; PMCID: PMC10469760. https://pmc.ncbi.nlm.nih.gov/articles/PMC10469760/
104. Thieblemont C, Altmann B, Frontzek F, Renaud L, Chartier L, Ketterer N, Récher C, Poeschel V, Fitoussi O, Held G, Casasnovas O, Haioun C, Morschhauser F, Glass B, Mounier N, Tilly H, Rosenwald A, Ott G, Lenz G, Molina T, Ziepert M, Schmitz N. Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis. Blood Adv. 2023 Aug 8;7(15):3968-3977. doi: 10.1182/bloodadvances.2022008888. PMID: 36716220; PMCID: PMC10410133. https://pmc.ncbi.nlm.nih.gov/articles/PMC10410133/
105. Karam E, Hollenbach M, Ali EA, Auriemma F, Gulla A, Heise C, Regner S, Gaujoux S; on the Pancreas 2000 Research Group; Regimbeau JM, Kähler G, Seyfried S, Vaillant JC, De Ponthaud C, Sauvanet A, Birnbaum D, Regenet N, Truant S, Pérez-Cuadrado-Robles E, Bruzzi M, Lupinacci RM, Brunel M, Belfiori G, Barbier L, Salamé E, Souche FR, Schwarz L, Maggino L, Salvia R, Gagniére J, Del Chiaro M, Leung G, Hackert T, Kleemann T, Paik WH, Caca K, Dugic A, Muehldorfer S, Schumacher B, Albers D. Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study. Surgery. 2023 May;173(5):1254-1262. doi: 10.1016/j.surg.2022.12.011. Epub 2023 Jan 13. PMID: 36642655. https://www.sciencedirect.com/science/article/pii/S003960602201039X?via%3Dihub
106. Costentin C, Audureau E, Park YN, Langella S, Vibert E, Laurent A, Cauchy F, Scatton O, Chirica M, Rhaiem R, Boleslawski E, di Tommaso L, Ferrero A, Yano H, Akiba J, Donadon M, Nebbia M, Detry O, Honoré P, Di Martino M, Schwarz L, Barbier L, Nault JC, Rhee H, Lim C, Brustia R, Paradis V, Guettier C, Le Bail B, Okumura S, Blanc JF, Calderaro J. ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma. Liver Int. 2023 Nov;43(11):2538-2547. doi: 10.1111/liv.15683. Epub 2023 Aug 14. PMID: 37577984. https://orbi.uliege.be/handle/2268/305771
107. Karam E, Hollenbach M, Abou Ali E, Auriemma F, Anderloni A, Barbier L, Belfiori G, Caillol F, Crippa S, Del Chiaro M, De Ponthaud C, Dahel Y, Falconi M, Giovannini M, Heling D, Inoue Y, Jarnagin WR, Leung G, Lupinacci RM, Mariani A, Masaryk V, Miksch RC, Musquer N, Napoleon B, Oba A, Partelli S, Petrone MC, Prat F, Repici A, Sauvanet A, Salzmann K, Schattner MA, Schulick R, Schwarz L, Soares K, Souche FR, Truant S, Vaillant JC, Wang T, Wedi E, Werner J, Weismüller TJ, Wichmann D, Will U, Zaccari P, Gulla A, Heise C, Regner S, Gaujoux S; Pancreas 2000 Research Group. Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study. Neuroendocrinology. 2023;113(10):1024-1034. doi: 10.1159/000531712. Epub 2023 Jun 27. PMID: 37369186. https://karger.com/nen/article-abstract/113/10/1024/853632/Endoscopic-and-Surgical-Management-of-Non?redirectedFrom=fulltext
108. Janet J, Albouys J, Napoleon B, Jacques J, Mathonnet M, Magne J, Fontaine M, de Ponthaud C, Durand Fontanier S, Bardet SSM, Bourdariat R, Sulpice L, Lesurtel M, Legros R, Truant S, Robin F, Prat F, Palazzo M, Schwarz L, Buc E, Sauvanet A, Gaujoux S, Taibi A. Pancreatoduodenectomy Following Preoperative Biliary Drainage Using Endoscopic Ultrasound-Guided Choledochoduodenostomy Versus a Transpapillary Stent: A Multicenter Comparative Cohort Study of the ACHBT-FRENCH-SFED Intergroup. Ann Surg Oncol. 2023 Aug;30(8):5036-5046. doi: 10.1245/s10434-023-13466-8. Epub 2023 Apr 17. PMID: 37069476. https://link.springer.com/article/10.1245/s10434-023-13466-8
109. Buisseret L, Loirat D, Aftimos P, Maurer C, Punie K, Debien V, Kristanto P, Eiger D, Goncalves A, Ghiringhelli F, Taylor D, Clatot F, Van den Mooter T, Ferrero JM, Bonnefoi H, Canon JL, Duhoux FP, Mansi L, Poncin R, Barthélémy P, Isambert N, Denis Z, Catteau X, Salgado R, Agostinetto E, de Azambuja E, Rothé F, Craciun L, Venet D, Romano E, Stagg J, Paesmans M, Larsimont D, Sotiriou C, Ignatiadis M, Piccart-Gebhart M. Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nat Commun. 2023 Dec 12;14(1):8223. doi: 10.1038/s41467-023-44071-8. Erratum for: Nat Commun. 2023 Nov 2;14(1):7018. doi: 10.1038/s41467-023-42744-y. PMID: 38086864; PMCID: PMC10716375. https://www.nature.com/articles/s41467-023-44071-8
110. Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nat Med. 2023 Oct;29(10):2665. doi: 10.1038/s41591-023-02624-w. Erratum for: Nat Med. 2023 Oct;29(10):2593-2601. doi: 10.1038/s41591-023-02572-5. PMID: 37814064; PMCID: PMC10579050. https://pmc.ncbi.nlm.nih.gov/articles/PMC10579050/
111. Cherifi F, Gernier F, Jardin F, Lefevre-Arbogast S, Bastien E, Lequesne J, Rigal O, Quilan F, Clarisse B, Grellard JM, Binarelli G, Fernette M, Lange M, Richard D, Morel A, Griffon B, Pepin LF, Leconte A, Faveyrial A, Leheurteur M, Beauplet B, Joly F. Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic. J Geriatr Oncol. 2023 Nov;14(8):101634. doi: 10.1016/j.jgo.2023.101634. Epub 2023 Sep 25. PMID: 37757587. https://linkinghub.elsevier.com/retrieve/pii/S1879-4068(23)00231-X
112. Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nat Med. 2023 Oct;29(10):2593-2601. doi: 10.1038/s41591-023-02572-5. Epub 2023 Sep 14. Erratum in: Nat Med. 2023 Oct;29(10):2665. doi: 10.1038/s41591-023-02624-w. Erratum in: Nat Med. 2024 Jul;30(7):2089. doi: 10.1038/s41591-024-03053-z. PMID: 37710005; PMCID: PMC10579056. https://pmc.ncbi.nlm.nih.gov/articles/PMC10579056/
113. Houot R, Bay JO, Chevallier P, Choquet S, Fornecker LM, Ianotto JC, Jaccard A, Jardin F, Legros L, Lemonnier F, Park S, Pascal L, Soussain C, Gyan E. Créer une communauté de chefs de service pour répondre aux défis du système hospitalier : première expérience en hématologie [Creating a community of heads of department to meet hospital system challenges: First experience in haematology]. Bull Cancer. 2023 Sep;110(9):950-954. French. doi: 10.1016/j.bulcan.2023.06.003. Epub 2023 Jul 26. PMID: 37507237. https://www.sciencedirect.com/science/article/pii/S0007455123002989?via%3Dihub
114. Bastien E, Lefèvre-Arbogast S, Lequesne J, Gernier F, Cherifi F, Rigal O, Guittet L, Grellard JM, Binarelli G, Lange M, Fernette M, Tron L, Morel A, Richard D, Griffon B, Leconte A, Quilan F, Pépin LF, Jardin F, Leheurteur M, Faveyrial A, Clarisse B, Joly F. Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study. J Natl Compr Canc Netw. 2023 Feb 22;21(3):265-272.e7. doi: 10.6004/jnccn.2023.7085. PMID: 36812938. https://jnccn.org/view/journals/jnccn/21/3/article-p265.xml
115. Galmiche A, Saidak Z, Babin E, Brenet E, Davrou J, Fournier I, Devauchelle B, Testelin S, Dakpe S, Pellet A, Thariat J, Bastit V, Clatot F, Saintigny P, Bouaoud J, Foy JP. From precise surgery to precision surgery: The multiple dimensions of therapeutic precision for head and neck cancer. J Stomatol Oral Maxillofac Surg. 2023 Feb;124(1S):101342. doi: 10.1016/j.jormas.2022.11.018. Epub 2022 Nov 22. PMID: 36423829. https://www.sciencedirect.com/science/article/pii/S2468785522003561?via%3Dihub
116. Agaimy A, Baněčková M, De Almeida J, Dickson BC, Dimmler A, Hartmann W, Laé M, Pablik J, Schubart C, Skálová A, Stoehr R, Trautmann M, Wardelmann E, Wassef M, Weinreb I. Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal Tract. Am J Surg Pathol. 2023 Mar 1;47(3):361-369. doi: 10.1097/PAS.0000000000002000. Epub 2022 Nov 14. PMID: 36580038. https://journals.lww.com/ajsp/fulltext/2023/03000/recurrent_ewsr1__colca2_fusions_define_a_novel.10.aspx
117. Klubíčková N, Mosaieby E, Ptáková N, Trinquet A, Laé M, Costes-Martineau V, Skálová A. High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology. Virchows Arch. 2023 Aug;483(2):187-195. doi: 10.1007/s00428-023-03587-6. Epub 2023 Jul 6. PMID: 37415052; PMCID: PMC10412680. https://pmc.ncbi.nlm.nih.gov/articles/PMC10412680/
118. Buske C, Dimopoulos MA, Grunenberg A, Kastritis E, Tomowiak C, Mahé B, Troussard X, Hajek R, Viardot A, Tournilhac O, Aurran T, Lepretre S, Zerazhi H, Hivert B, Leblond V, de Guibert S, Brandefors L, Garcia-Sanz R, Gomes da Silva M, Kimby E, Schmelzle B, Kaszynski D, Dreyhaupt J, Muche R, Morel P. Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström’s Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström’s Macroglobulinemia. J Clin Oncol. 2023 May 10;41(14):2607-2616. doi: 10.1200/JCO.22.01805. Epub 2023 Feb 10. PMID: 36763945. https://ascopubs.org/doi/10.1200/JCO.22.01805?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
119. Atsou KM, Rachet B, Cornet E, Chretien ML, Rossi C, Remontet L, Roche L, Giorgi R, Gauthier S, Girard S, Böckle J, Wasse SK, Rachou H, Bouzid L, Poncet JM, Orazio S, Monnereau A, Troussard X, Mounier M, Maynadie M. Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France. Cancer Med. 2023 Apr;12(7):8911-8923. doi: 10.1002/cam4.5645. Epub 2023 Jan 29. PMID: 36710405; PMCID: PMC10134294. https://pmc.ncbi.nlm.nih.gov/articles/PMC10134294/
120. Fornecker LM, Lazarovici J, Aurer I, Casasnovas RO, Gac AC, Bonnet C, Bouabdallah K, Feugier P, Specht L, Molina L, Touati M, Borel C, Stamatoullas A, Nicolas-Virelizier E, Pascal L, Lugtenburg P, Di Renzo N, Vander Borght T, Traverse-Glehen A, Dartigues P, Hutchings M, Versari A, Meignan M, Federico M, André M; LYSA-FIL-EORTC Intergroup. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. J Clin Oncol. 2023 Jan 10;41(2):327-335. doi: 10.1200/JCO.21.01281. Epub 2022 Jul 22. PMID: 35867960. https://orbi.uliege.be/handle/2268/299780
121. François-Martin H, Lardy-Cléaud A, Pistilli B, Levy C, Diéras V, Frenel JS, Guiu S, Mouret-Reynier MA, Mailliez A, Eymard JC, Petit T, Ung M, Desmoulins I, Augereau P, Bachelot T, Uwer L, Debled M, Ferrero JM, Clatot F, Goncalves A, Chevrot M, Chabaud S, Cottu P. Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study. Cancers (Basel). 2023 Feb 13;15(4):1191. doi: 10.3390/cancers15041191. PMID: 36831532; PMCID: PMC9954606. https://pmc.ncbi.nlm.nih.gov/articles/PMC9954606/
122. Walter T, Lievre A, Coriat R, Malka D, Elhajbi F, Di Fiore F, Hentic O, Smith D, Hautefeuille V, Roquin G, Perrier M, Dahan L, Granger V, Sobhani I, Mineur L, Niccoli P, Assenat E, Scoazec JY, Le Malicot K, Lepage C, Lombard-Bohas C. Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial. Lancet Oncol. 2023 Mar;24(3):297-306. doi: 10.1016/S1470-2045(23)00001-3. Epub 2023 Feb 2. PMID: 36739879. https://www.sciencedirect.com/science/article/pii/S1470204523000013?via%3Dihub
123. Oliva EN, Riva M, Niscola P, Santini V, Breccia M, Giai V, Poloni A, Patriarca A, Crisà E, Capodanno I, Salutari P, Reda G, Cascavilla N, Ferrero D, Guarini A, Tripepi G, Iannì G, Russo E, Castelli A, Fattizzo B, Beltrami G, Bocchia M, Molteni A, Fenaux P, Germing U, Ricco A, Palumbo GA, Impera S, Di Renzo N, Rivellini F, Buccisano F, Stamatoullas-Bastard A, Liberati AM, Candoni A, Delfino IM, Arcadi MT, Cufari P, Rizzo L, Bova I, D’Errigo MG, Zini G, Latagliata R. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9. PMID: 37294914; PMCID: PMC10552995. https://pmc.ncbi.nlm.nih.gov/articles/PMC10552995/
124. Itzykson R, Santini V, Thepot S, Ades L, Chaffaut C, Giagounidis A, Morabito M, Droin N, Lübbert M, Sapena R, Nimubona S, Goasguen J, Wattel E, Zini G, Torregrosa Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, Metzgeroth G, Onida F, Navarro R, Patriarca A, Stamatoullas A, Götze K, Puttrich M, Mossuto S, Solary E, Gloaguen S, Chevret S, Chermat F, Platzbecker U, Fenaux P. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network. J Clin Oncol. 2023 Apr 1;41(10):1888-1897. doi: 10.1200/JCO.22.00437. Epub 2022 Dec 1. PMID: 36455187. https://ascopubs.org/doi/10.1200/JCO.22.00437?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
125. Itzykson R, Santini V, Thepot S, Ades L, Chaffaut C, Giagounidis A, Morabito M, Droin N, Lübbert M, Sapena R, Nimubona S, Goasguen J, Wattel E, Zini G, Torregrosa Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, Metzgeroth G, Onida F, Navarro R, Patriarca A, Stamatoullas A, Götze K, Puttrich M, Mossuto S, Solary E, Gloaguen S, Chevret S, Chermat F, Platzbecker U, Fenaux P. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network. J Clin Oncol. 2023 Apr 1;41(10):1888-1897. doi: 10.1200/JCO.22.00437. Epub 2022 Dec 1. PMID: 36455187. https://ascopubs.org/doi/10.1200/JCO.22.00437?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
126. Buisseret L, Loirat D, Aftimos P, Maurer C, Punie K, Debien V, Kristanto P, Eiger D, Goncalves A, Ghiringhelli F, Taylor D, Clatot F, Van den Mooter T, Ferrero JM, Bonnefoi H, Canon JL, Duhoux FP, Mansi L, Poncin R, Barthélémy P, Isambert N, Denis Z, Catteau X, Salgado R, Agostinetto E, de Azambuja E, Rothé F, Craciun L, Venet D, Romano E, Stagg J, Paesmans M, Larsimont D, Sotiriou C, Ignatiadis M, Piccart-Gebhart M. Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nat Commun. 2023 Nov 2;14(1):7018. doi: 10.1038/s41467-023-42744-y. Erratum in: Nat Commun. 2023 Dec 12;14(1):8223. doi: 10.1038/s41467-023-44071-8. PMID: 37919269; PMCID: PMC10622534. https://pmc.ncbi.nlm.nih.gov/articles/PMC10622534/
127. Rogé M, Kirova Y, Loap P, Amar S, Servagi S, Nebbache R, Rivin Del Campo E, Clatot F, Thureau S, Thariat J. Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast Cancer. Pract Radiat Oncol. 2023 Nov-Dec;13(6):e491-e498. doi: 10.1016/j.prro.2023.05.011. Epub 2023 Jun 8. PMID: 37295726.
128. Taïeb J, Bouche O, André T, Le Malicot K, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Perrier H, Buecher B, Di Fiore F, Gallois C, Emile JF, Lepage C, Elhajbi F, Tougeron D; SAMCO-PRODIGE 54 Investigators. Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial. JAMA Oncol. 2023 Oct 1;9(10):1356-1363. doi: 10.1001/jamaoncol.2023.2761. PMID: 37535388; PMCID: PMC10401392. https://pmc.ncbi.nlm.nih.gov/articles/PMC10401392/
129. Taïeb J, Bouche O, André T, Le Malicot K, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Perrier H, Buecher B, Di Fiore F, Gallois C, Emile JF, Lepage C, Elhajbi F, Tougeron D; SAMCO-PRODIGE 54 Investigators. Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial. JAMA Oncol. 2023 Oct 1;9(10):1356-1363. doi: 10.1001/jamaoncol.2023.2761. PMID: 37535388; PMCID: PMC10401392. https://pmc.ncbi.nlm.nih.gov/articles/PMC10401392/
130. Leuillier M, Duflot T, Ménoret S, Messaoudi H, Djerada Z, Groussard D, Denis RGP, Chevalier L, Karoui A, Panthu B, Thiébaut PA, Schmitz-Afonso I, Nobis S, Campart C, Henry T, Sautreuil C, Luquet SH, Beseme O, Féliu C, Peyret H, Nicol L, Henry JP, Renet S, Mulder P, Wan D, Tesson L, Heslan JM, Duché A, Jacques S, Ziegler F, Brunel V, Rautureau GJP, Monteil C, do Rego JL, do Rego JC, Afonso C, Hammock B, Madec AM, Pinet F, Richard V, Anegon I, Guignabert C, Morisseau C, Bellien J. CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury. J Adv Res. 2023 Jan;43:163-174. doi: 10.1016/j.jare.2022.03.004. Epub 2022 Mar 12. PMID: 36585106; PMCID: PMC9811321. https://pmc.ncbi.nlm.nih.gov/articles/PMC9811321/
131. Taïeb J, Bouche O, André T, Le Malicot K, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Perrier H, Buecher B, Di Fiore F, Gallois C, Emile JF, Lepage C, Elhajbi F, Tougeron D; SAMCO-PRODIGE 54 Investigators. Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial. JAMA Oncol. 2023 Oct 1;9(10):1356-1363. doi: 10.1001/jamaoncol.2023.2761. PMID: 37535388; PMCID: PMC10401392. https://pmc.ncbi.nlm.nih.gov/articles/PMC10401392/
132. Sarfati S, Eugène Norbert M, Hérault A, Giry M, Makké J, Grall M, Savouré A, Camus V, Alani M, Tamion F, Latouche JB, Girault C. Case report: CAR-T cell therapy-induced cardiac tamponade. Front Cardiovasc Med. 2023 Mar 20;10:1132503. doi: 10.3389/fcvm.2023.1132503. PMID: 37020516; PMCID: PMC10067676. https://pmc.ncbi.nlm.nih.gov/articles/PMC10067676/
133. Neuzillet C, Artru P, Assenat E, Edeline J, Adhoute X, Sabourin JC, Turpin A, Coriat R, Malka D. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Target Oncol. 2023 Jan;18(1):51-76. doi: 10.1007/s11523-022-00942-6. Epub 2023 Feb 6. PMID: 36745342; PMCID: PMC9928940. https://pmc.ncbi.nlm.nih.gov/articles/PMC9928940/
134. de Nattes T, Beadle J, Toulza F, Candon E, Ruminy P, François A, Bertrand D, Guerrot D, Drieux F, Roufosse C, Candon S. A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies. Clin J Am Soc Nephrol. 2023 Apr 1;18(4):499-509. doi: 10.2215/CJN.0000000000000100. Epub 2023 Mar 8. PMID: 36723289; PMCID: PMC10103338. https://pmc.ncbi.nlm.nih.gov/articles/PMC10103338/
135. Grinda T, Antoine A, Jacot W, Cottu PH, de la Motte Rouge T, Frenel JS, Mailliez A, Dalenc F, Goncalves A, Clatot F, Mouret Reynier MA, Levy C, Ferrero JM, Desmoulins I, Uwer L, Petit T, Jouannaud C, Arnedos M, Chevrot M, Courtinard C, Tredan O, Brain E, Pérol D, Pistilli B, Delaloge S. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. Eur J Cancer. 2023 Aug;189:112935. doi: 10.1016/j.ejca.2023.05.023. Epub 2023 Jun 7. PMID: 37385070. https://www.sciencedirect.com/science/article/pii/S0959804923002769?via%3Dihub
136. A, Mutka A, Normanno N, Ovidiu P, Panizo A, Papotti MG, Parobkova E, Pasello G, Pauwels P, Pelosi G, Penault-Llorca F, Picot T, Piton N, Pittaro A, Planchard G, Poté N, Radonic T, Rapa I, Rappa A, Roma C, Rot M, Sabourin JC, Salmon I, Prince SS, Scarpa A, Schuuring E, Serre I, Siozopoulou V, Sizaret D, Smojver-Ježek S, Solassol J, Steinestel K, Stojšić J, Syrykh C, Timofeev S, Troncone G, Uguen A, Valmary-Degano S, Vigier A, Volante M, Wahl SGF, Stenzinger A, Ilié M. Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe. ESMO Open. 2023 Oct;8(5):101628. doi: 10.1016/j.esmoop.2023.101628. Epub 2023 Sep 14. PMID: 37713929; PMCID: PMC10594022. https://pmc.ncbi.nlm.nih.gov/articles/PMC10594022/
137. Hamy AS, Abécassis J, Driouch K, Darrigues L, Vandenbogaert M, Laurent C, Zaccarini F, Sadacca B, Delomenie M, Laas E, Mariani O, Lam T, Grandal B, Laé M, Bieche I, Vacher S, Pierga JY, Brain E, Vallot C, Hotton J, Richer W, Rocha D, Tariq Z, Becette V, Meseure D, Lesage L, Vincent-Salomon A, Filmann N, Furlanetto J, Loibl S, Dumas E, Waterfall JJ, Reyal F. Evolution of synchronous female bilateral breast cancers and response to treatment. Nat Med. 2023 Mar;29(3):646-655. doi: 10.1038/s41591-023-02216-8. Epub 2023 Mar 6. PMID: 36879128; PMCID: PMC10033420. https://pmc.ncbi.nlm.nih.gov/articles/PMC10033420/
138. Ducray F, Ramirez C, Robert M, Fontanilles M, Bronnimann C, Chinot O, Estrade F, Durando X, Cartalat S, Bastid J, Bienayme H, Lemarchand C. A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules. Pharmaceutics. 2023 Nov 24;15(12):2664. doi: 10.3390/pharmaceutics15122664. PMID: 38140005; PMCID: PMC10747054. https://pmc.ncbi.nlm.nih.gov/articles/PMC10747054/
139. Falette-Puisieux M, Nault JC, Bouattour M, Lequoy M, Amaddeo G, Decaens T, Di Fiore F, Manfredi S, Merle P, Baron A, Locher C, Pellat A, Coriat R. Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting. Ther Adv Med Oncol. 2023 Aug 1;15:17588359231189425. doi: 10.1177/17588359231189425. PMID: 37547443; PMCID: PMC10399252. https://pmc.ncbi.nlm.nih.gov/articles/PMC10399252/
140. Tao Y, Sun XS, Pointreau Y, Le Tourneau C, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Calderon B, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, Gherga E, Nguyen F, Lafond C, Bera G, Calugaru V, Geoffrois L, Chauffert B, Damstrup L, Crompton P, Ennaji A, Gollmer K, Nauwelaerts H, Bourhis J. Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial. Eur J Cancer. 2023 Apr;183:24-37. doi: 10.1016/j.ejca.2022.12.015. Epub 2023 Jan 9. PMID: 36796234. https://www.sciencedirect.com/science/article/pii/S0959804922018172?via%3Dihub
141. Thomssen C, Vetter M, Kantelhardt EJ, Meisner C, Schmidt M, Martin PM, Clatot F, Augustin D, Hanf V, Paepke D, Meinerz W, Hoffmann G, Wiest W, Sweep FCGJ, Schmitt M, Jänicke F, Loibl S, Minckwitz GV, Harbeck N; NNBC 3-Europe Study Group. Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers (Basel). 2023 Mar 3;15(5):1580. doi: 10.3390/cancers15051580. PMID: 36900372; PMCID: PMC10001055. https://pmc.ncbi.nlm.nih.gov/articles/PMC10001055/
142. Césaire M, Rambeau A, Clatot F, Johnson A, Heutte N, Thariat J. Impact of lymphopenia on efficacy of nivolumab in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2023 May;280(5):2453-2461. doi: 10.1007/s00405-022-07800-1. Epub 2022 Dec 23. PMID: 36564669.
143. Adam J, Stang NL, Uguen A, Badoual C, Chenard MP, Lantuéjoul S, Maran-Gonzalez A, Robin YM, Rochaix P, Sabourin JC, Soubeyran I, Sturm N, Svrcek M, Vincent-Salomon A, Radosevic-Robin N, Penault-Llorca F. Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions. Mod Pathol. 2023 Aug;36(8):100192. doi: 10.1016/j.modpat.2023.100192. Epub 2023 Apr 20. PMID: 37084942. https://www.sciencedirect.com/science/article/pii/S0893395223000972?via%3Dihub
144. Martins-Branco D, Nader-Marta G, Gombos A, Barthelemy P, Goncalves A, Borcoman E, Clatot F, Holbrechts S, De Maio D’Esposito E, Cheymol C, Vanhaudenarde V, Duhoux FP, Duhem C, Decoster L, Denys H, Lefranc F, Canon JL, Clement PM, Gligorov J, Paesmans M, Kindt N, Awada A, Kotecki N. BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors. Nat Med. 2023 Dec;29(12):2981-2982. doi: 10.1038/s41591-023-02595-y. PMID: 37857713.
145. Oudard S, Ratta R, Voog E, Barthelemy P, Thiery-Vuillemin A, Bennamoun M, Hasbini A, Aldabbagh K, Saldana C, Sevin E, Amela E, Von Amsberg G, Houede N, Besson D, Feyerabend S, Boegemann M, Pfister D, Schostak M, Huillard O, Di Fiore F, Quivy A, Lange C, Phan L, Belhouari H, Tran Y, Kotti S, Helissey C. Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial. JAMA Oncol. 2023 Dec 1;9(12):1629-1638. doi: 10.1001/jamaoncol.2023.4255. PMID: 37883073; PMCID: PMC10603579. https://pmc.ncbi.nlm.nih.gov/articles/PMC10603579/
146. Juul SJ, Rossetti S, Kicinski M, van der Kaaij MAE, Giusti F, Meijnders P, Aleman BMP, Raemaekers JMM, Kluin-Nelemans HC, Spina M, Fermé C, Renaud L, Casasnovas O, Stamatoullas A, André M, Le Bras F, Plattel WJ, Henry-Amar M, Hutchings M, Maraldo MV. Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials. Acta Oncol. 2023 Jul;62(7):744-752. doi: 10.1080/0284186X.2023.2195561. Epub 2023 Apr 11. PMID: 37039661.
147. Blay JY, Cropet C, Mansard S, Loriot Y, De La Fouchardière C, Haroche J, Topart D, Tougeron D, You B, Italiano A, Le Brun-Ly V, Ferrero JM, Penel N, Fabbro M, Troussard X, Malka D, Ray-Coquard I, Leboulleux S, Fléchon A, Maubec E, Charles J, Dalle S, Taieb S, Garcia GCTE, Mandache AM, Colignon N, Gavrel M, Nowak F, Hoog Labouret N, Mahier Aït Oukhatar C, Gomez-Roca C. Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma. ESMO Open. 2023 Dec;8(6):102038. doi: 10.1016/j.esmoop.2023.102038. Epub 2023 Nov 1. PMID: 37922690; PMCID: PMC10774964. https://pmc.ncbi.nlm.nih.gov/articles/PMC10774964/
148. Malard F, Loschi M, Huynh A, Cluzeau T, Guenounou S, Legrand F, Magro L, Orvain C, Charbonnier A, Panz-Klapuch M, Desmier D, Mear JB, Cornillon J, Robin C, Daguindau E, Bilger K, Vehreschild MJGT, Chevallier P, Labussière-Wallet H, Mediavilla C, Couturier MA, Bulabois CE, Camus V, Chantepie S, Ceballos P, Gaugler B, Holler E, Doré J, Prestat E, Gasc C, Plantamura E, Mohty M. Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial. EClinicalMedicine. 2023 Jul 26;62:102111. doi: 10.1016/j.eclinm.2023.102111. PMID: 37654670; PMCID: PMC10466244. https://pmc.ncbi.nlm.nih.gov/articles/PMC10466244/
149. Drozd-Sokolowska J, Gras L, Zinger N, Zahrani MA, Passweg J, Byrne J, Ho A, Huang XJ, Kröger N, Mayer J, Russo D, De Becker A, Tbakhi A, Stamatoullas A, Valerius T, Hayden P, McLornan DP, Onida F, Scheid C, Robin M, Yakoub-Agha I. Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable – a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplant. 2023 Feb;58(2):222-225. doi: 10.1038/s41409-022-01870-9. Epub 2022 Nov 19. PMID: 36402922.
150. Marolleau P, Tougeron D, Allignet B, Cohen R, Sefrioui D, Gallet B, Dumont F, Guimbaud R, Alouani E, Passot G, Desolneux G, Ghiringhelli F, Marchal F, Mourthadhoi F, Coriat R, Desgrippes R, Locher C, Goujon G, Des Guetz G, Aparicio T, Paubelle E, Dupré A, de la Fouchardière C. Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study. Int J Cancer. 2023 Oct 1;153(7):1376-1385. doi: 10.1002/ijc.34636. Epub 2023 Jul 5. PMID: 37403609. https://onlinelibrary.wiley.com/doi/10.1002/ijc.34636
151. Al Tabaa Y, Casasnovas RO, Baillet C, Bachy E, Nicolas-Virelizier E, Schiano De Colella JM, Bailly C, Kanoun S, Guidez S, Gyan E, Gressin R, Morineau N, Ysebaert L, Le Gouill S, Tilly H, Houot R, Morschhauser F, Cartron G, Herbaux C. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group. Blood Adv. 2023 Jul 25;7(14):3735-3738. doi: 10.1182/bloodadvances.2023009911. Erratum in: Blood Adv. 2024 Jun 25;8(12):3225. doi: 10.1182/bloodadvances.2024013536. PMID: 37067945; PMCID: PMC10368761. https://pmc.ncbi.nlm.nih.gov/articles/PMC10368761/
152. Kambhampati S, Shumilov E, Saumoy M, Herrera AF, Tilly H, Lenz G, Thiruvengadam NR. Cost-effectiveness of polatuzumab vedotin in combination with chemoimmunotherapy (pola-R-CHP) in previously untreated diffuse large B-cell lymphoma in Germany. Br J Haematol. 2023 Aug;202(4):771-775. doi: 10.1111/bjh.18869. Epub 2023 May 15. PMID: 37188351. https://onlinelibrary.wiley.com/doi/10.1111/bjh.18869
153. Cartron G, Bachy E, Tilly H, Daguindau N, Pica GM, Bijou F, Mounier C, Clavert A, Damaj GL, Slama B, Casasnovas O, Houot R, Bouabdallah K, Sibon D, Fitoussi O, Morineau N, Herbaux C, Gastinne T, Fornecker LM, Haioun C, Launay V, Araujo C, Benbrahim O, Sanhes L, Gressin R, Gonzalez H, Morschhauser F, Ternant D, Xerri L, Tarte K, Pranger D. Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study. J Clin Oncol. 2023 Jul 1;41(19):3523-3533. doi: 10.1200/JCO.22.02327. Epub 2023 Apr 18. Erratum in: J Clin Oncol. 2023 Sep 1;41(25):4187. doi: 10.1200/JCO.23.01377. PMID: 37071836.
154. Beldi-Ferchiou A, Jais JP, Ghesquieres H, Casasnovas RO, Tilly H, Fruchart C, Morschhauser F, Haioun C, Lazarovici J, Perrot A, Nicolas-Virelizier E, Salles G, Godard N, Zamali I, De Colella JS, Claudel A, Corront B, Oberic L, Briere J, Gaulard P, Thieblemont C, Delfau-Larue MH. Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study. Br J Haematol. 2023 Apr;201(2):256-266. doi: 10.1111/bjh.18642. Epub 2023 Feb 6. PMID: 36740991.
155. Zinzani PL, Mayer J, Flowers CR, Bijou F, De Oliveira AC, Song Y, Zhang Q, Merli M, Bouabdallah K, Ganly P, Zhang H, Johnson R, Martín García-Sancho A, Provencio Pulla M, Trněný M, Yuen S, Tilly H, Kingsley E, Tumyan G, Assouline SE, Auer R, Ivanova E, Kim P, Huang S, Delarue R, Trotman J. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. J Clin Oncol. 2023 Nov 20;41(33):5107-5117. doi: 10.1200/JCO.23.00775. Epub 2023 Jul 28. PMID: 37506346.
156. Walczak P, Choquet S, Dantal J, Boutboul D, Suarez F, Baron M, Morel V, Cluzeau T, Touati M, Elias M, Bachy E, Nicolas-Virelizier E, Houot R, Venton G, Jacquet C, Moles-Moreau MP, Jardin F, Durot E, Balegroune N, Ecotiere L, Guieze R, Kamar N, Ysebaert L, Couzi L, Gonzalez H, Roulin L, Ou K, Caillard S, Zimmermann H, Trappe RU, Roos-Weil D. Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients. Haematologica. 2023 Oct 1;108(10):2814-2819. doi: 10.3324/haematol.2022.282297. PMID: 36891749; PMCID: PMC10543171. https://haematologica.org/article/view/haematol.2022.282297
157. Chantepie SP, Mear JB, Briant AR, Vilque JP, Gac AC, Cheze S, Girault S, Turlure P, Marolleau JP, Lebon D, Charbonnier A, Jardin F, Lenain P, Peyro-Saint-Paul L, Abonnet V, Dutheil JJ, Chene Y, Bazin A, Reman O, Parienti JJ. Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial. Leuk Res. 2023 Jun;129:107058. doi: 10.1016/j.leukres.2023.107058. Epub 2023 Mar 18. PMID: 37080000.
158. Felli E, Boleslawski E, Sommacale D, Scatton O, Brustia R, Schwarz L, Cherqui D, Zacharias T, Laurent A, Mabrut JY, Schuster C, Gallix B, Pessaux P. Paradigm shift: should preoperative 3D reconstruction models become mandatory before hepatectomy for hepatocellular carcinoma (HCC)? Results of a multicenter prospective trial. HPB (Oxford). 2023 Mar;25(3):293-300. doi: 10.1016/j.hpb.2022.11.007. Epub 2022 Nov 17. PMID: 36710089. https://www.sciencedirect.com/science/article/pii/S1365182X22016665?via%3Dihub
159. Cailly L, Gruchet C, Maitre E, Guidez S, Delwail V, Systchenko T, Moya N, Sabirou F, Levy A, Bobin A, Gardeney H, Nsiala L, Vonfeld M, Chacon A, Pichon A, Bouyer S, Baslé C, Dindinnaud E, Chomel JC, Raimbault A, Borde-Mougenot F, Troussard X, Tomowiak C. Hairy cell leukemia with isolated bone lesions. Clin Case Rep. 2023 May 16;11(5):e7343. doi: 10.1002/ccr3.7343. PMID: 37207087; PMCID: PMC10188895. https://pmc.ncbi.nlm.nih.gov/articles/PMC10188895/
160. De Schepper M, Nguyen HL, Richard F, Rosias L, Lerebours F, Vion R, Clatot F, Berghian A, Maetens M, Leduc S, Isnaldi E, Molinelli C, Lambertini M, Grillo F, Zoppoli G, Dirix L, Punie K, Wildiers H, Smeets A, Nevelsteen I, Neven P, Vincent-Salomon A, Larsimont D, Duhem C, Viens P, Bertucci F, Biganzoli E, Vermeulen P, Floris G, Desmedt C. Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy. Cancer Res Commun. 2024 Jan 24;4(1):186-199. doi: 10.1158/2767-9764.CRC-23-0285. PMID: 38147006; PMCID: PMC10807408. https://pmc.ncbi.nlm.nih.gov/articles/PMC10807408/
161. Rabian F, Beauvais D, Marchand T, Fürst S, Huynh A, Brissot E, Maury S, Gabellier L, Chevallier P, Loschi M, Nguyen S, Balsat M, Lafon I, Fayard A, Camus V, Simand C, Moya N, Castilla-Llorente C, Joris M, Berceanu A, Thiebaut-Bertrand A, Lhéritier V, Gehlkopf E, Roth-Guépin G, Leguay T, Boissel N. Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry. Blood Adv. 2024 Nov 12;8(21):5493-5496. doi: 10.1182/bloodadvances.2024013962. PMID: 39207868; PMCID: PMC11532742. https://pmc.ncbi.nlm.nih.gov/articles/PMC11532742/
162. Baulier C, Popoff B, Wood G, Schwarz L, Tuech JJ, Dureuil B, Compère V, Clavier T. Comparison of Two Dexmedetomidine Administration Strategies on the Incidence of Postoperative Respiratory Complications: A Retrospective, Inverse Probability of Treatment Weighted Study. J Clin Pharmacol. 2024 Feb;64(2):196-204. doi: 10.1002/jcph.2354. Epub 2023 Oct 24. PMID: 37752624. https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.2354
163. Frontzek F, Renaud L, Dührsen U, Poeschel V, Bernard S, Chartier L, Ketterer N, Récher C, Fitoussi O, Held G, Casasnovas O, Haioun C, Mounier N, Tilly H, Morschhauser F, Le Gouill S, Karsten IE, Duns G, Steidl C, Scott DW, Klapper W, Rosenwald A, Ott G, Molina T, Lenz G, Ziepert M, Altmann B, Thieblemont C, Schmitz N. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration. Leukemia. 2024 Oct;38(10):2225-2234. doi: 10.1038/s41375-024-02371-y. Epub 2024 Aug 16. PMID: 39152324.
164. Botsen D, Chabaud S, Perrier H, Ammarguellat H, Jestin-Le-Tallec V, Olesinski J, Toullec C, Aparicio T, Ben Abdelghani M, Borg C, Bouche O, Coutzac C, Devaud H, Di Fiore F, Dubreuil O, Evesque L, Huguenin B, Muller M, Poureau PG, Oularue E, Tougeron D, Zaanan A, Ammari S, De Sousa Carvalho N, Decazes P, De La Fouchardiere C. Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial. Dig Liver Dis. 2024 Aug;56(8):1281-1287. doi: 10.1016/j.dld.2024.04.032. Epub 2024 May 17. PMID: 38762353. https://www.sciencedirect.com/science/article/pii/S1590865824007333?via%3Dihub
165. Hammel P, Smith D, Afchain P, Dominguez-Tinajero S, Seitz JF, Lievre A, Van Cutsem E, Assenat E, Di Fiore F, Peeters M, Sobhani I, Raymond E, Charton E, Vernerey D, De Mestier L, Lombard-Bohas C. SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors. Ther Adv Med Oncol. 2024 Nov 19;16:17588359241290140. doi: 10.1177/17588359241290140. PMID: 39563716; PMCID: PMC11574894. https://pmc.ncbi.nlm.nih.gov/articles/PMC11574894/
166. Juul SJ, Rossetti S, Kicinski M, van der Kaaij MAE, Giusti F, Meijnders P, Aleman BMP, Raemaekers JMM, Kluin-Nelemans HC, Spina M, Fermé C, Renaud L, Casasnovas O, Stamatoullas A, André M, Le Bras F, Plattel WJ, Henry-Amar M, Hutchings M, Maraldo MV. Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials. J Cancer Surviv. 2024 Jun;18(3):727-738. doi: 10.1007/s11764-022-01305-w. Epub 2022 Nov 28. PMID: 36441393.
167. Al Jamal I, Parquet M, Guiyedi K, Aoufouchi S, Le Guillou M, Rizzo D, Pollet J, Dupont M, Boulin M, Faumont N, Boutouil H, Jardin F, Ruminy P, El Hamel C, Lerat J, Al Hamaoui S, Makdissy N, Feuillard J, Gachard N, Peron S. IGH 3’RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IGH rearrangement in unmutated chronic lymphocytic leukemia. Haematologica. 2024 Feb 1;109(2):466-478. doi: 10.3324/haematol.2023.282897. PMID: 37496419; PMCID: PMC10828775. https://pmc.ncbi.nlm.nih.gov/articles/PMC10828775/
168. Roth G, Pellat A, Piessen G, le Malicot K, Schwarz L, Gallois C, Tougeron D, Hautefeuille V, Jary M, Benoist S, Amil M, Desgrippes R, Muller M, Lecomte T, Guillet M, Locher C, Genet C, Manfredi S, Bouché O, Taieb J. A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohort. ESMO Open. 2024 Dec;9(12):103988. doi: 10.1016/j.esmoop.2024.103988. Epub 2024 Nov 18. PMID: 39561623; PMCID: PMC11617226. https://pmc.ncbi.nlm.nih.gov/articles/PMC11617226/
169. Grancher A, Cuissy S, Girot H, Gillibert A, Di Fiore F, Guittet L. Where do we stand with screening for colorectal cancer and advanced adenoma based on serum protein biomarkers? A systematic review. Mol Oncol. 2024 Nov;18(11):2629-2648. doi: 10.1002/1878-0261.13734. Epub 2024 Sep 30. PMID: 39344882; PMCID: PMC11547240. https://pmc.ncbi.nlm.nih.gov/articles/PMC11547240/
170. Moreau M, Alouani E, Flecchia C, Falcoz A, Gallois C, Auclin E, André T, Cohen R, Hollebecque A, Turpin A, Pernot S, Masson T, Di Fiore F, Dutherge M, Mazard T, Hautefeuille V, Van Laethem JL, De la Fouchardière C, Perkins G, Ben-Abdelghani M, Sclafani F, Aparicio T, Kim S, Vernerey D, Taieb J, Guimbaud R, Tougeron D. A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability. Eur J Cancer. 2024 May;202:114033. doi: 10.1016/j.ejca.2024.114033. Epub 2024 Mar 21. PMID: 38537314. https://www.sciencedirect.com/science/article/pii/S0959804924006890?via%3Dihub
171. Moreno-Arciniegas A, García A, Kelm M, D’Amore F, da Silva MG, Sánchez-González J, Sánchez PL, López-Fernández T, Córdoba R, Asteggiano R, Camus V, Smink J, Ferreira A, Kersten MJ, Bolaños N, Escalera N, Pacella E, Gómez-Talavera S, Quesada A, Rosselló X, Ibanez B; RESILIENCE Trial Investigators. Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity. Eur J Heart Fail. 2024 Oct;26(10):2213-2222. doi: 10.1002/ejhf.3395. Epub 2024 Aug 30. PMID: 39212445. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3395
172. De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0. Epub 2024 Jan 30. PMID: 38307102.
173. Lambertini M, Blondeaux E, Agostinetto E, Hamy AS, Kim HJ, Di Meglio A, Bernstein Molho R, Hilbers F, Pogoda K, Carrasco E, Punie K, Bajpai J, Ignatiadis M, Moore HCF, Phillips KA, Toss A, Rousset-Jablonski C, Peccatori FA, Renaud T, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Del Mastro L, Puglisi F, Del Pilar Estevez-Diz M, Rodriguez-Wallberg KA, Mrinakova B, Meister S, Livraghi L, Clatot F, Yerushalmi R, De Angelis C, Sánchez-Bayona R, Meattini I, Cichowska-Cwalinska N, Berlière M, Salama M, De Giorgi U, Sonnenblick A, Chiodi C, Lee YJ, Maria C, Azim HA Jr, Boni L, Partridge AH; BRCA BCY Collaboration. Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study. JAMA. 2024 Jan 2;331(1):49-59. doi: 10.1001/jama.2023.25463. PMID: 38059899; PMCID: PMC10704340.
174. Chabane K, Charlot C, Gugenheim D, Simonet T, Armisen D, Viailly PJ, Codet de Boisse G, Huet S, Hayette S, Alcazer V, Sujobert P. Real life evaluation of AlphaMissense predictions in hematological malignancies. Leukemia. 2024 Feb;38(2):420-423. doi: 10.1038/s41375-023-02116-3. Epub 2023 Dec 22. PMID: 38135759.
175. Marchand T, Pastoret C, Damaj G, Lebouvier A, Herbaux C, Moignet A, Pavlosky M, Pavlosky A, Blouet A, Eloit M, Launay V, Lebreton P, Stamatoullas A, Nilsson C, Ochmann M, Prola J, Lamy T. Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia. Br J Haematol. 2024 Sep;205(3):915-923. doi: 10.1111/bjh.19476. Epub 2024 Apr 19. PMID: 38639192. https://onlinelibrary.wiley.com/doi/10.1111/bjh.19476
176. Alsugair Z, Donzel M, Macagno N, Tantot J, Harou O, Battistella M, Sohier P, Kervarrec T, de la Fouchardière A, Balme B, Champagnac A, Lanic MD, Lopez J, Laé M, Descotes F, Tirode F, Pissaloux D, Thamphya B, Costes-Martineau V, Benzerdjeb N. Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1::PLAG1 gene fusion. J Pathol. 2024 Dec;264(4):448-456. doi: 10.1002/path.6359. Epub 2024 Oct 29. PMID: 39468990.
177. Alsugair Z, Lépine C, Descotes F, Lanic MD, Pissaloux D, Tirode F, Lopez J, Céruse P, Philouze P, Fieux M, Wassef M, Baglin AC, Mihaela O, Castain C, Sudaka A, Uro-Coste E, Champagnac A, Costes-Martineau V, Laé M, Benzerdjeb N; REFCOR network*. Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights. Hum Pathol. 2024 Oct;152:105633. doi: 10.1016/j.humpath.2024.105633. Epub 2024 Jul 30. PMID: 39089476. https://www.sciencedirect.com/science/article/pii/S0046817724001424?via%3Dihub
178. Moreno-Arciniegas A, García A, Kelm M, D’Amore F, da Silva MG, Sánchez-González J, Sánchez PL, López-Fernández T, Córdoba R, Asteggiano R, Camus V, Smink J, Ferreira A, Kersten MJ, Bolaños N, Escalera N, Pacella E, Gómez-Talavera S, Quesada A, Rosselló X, Ibanez B; RESILIENCE Trial Investigators. Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity. Eur J Heart Fail. 2024 Oct;26(10):2213-2222. doi: 10.1002/ejhf.3395. Epub 2024 Aug 30. PMID: 39212445. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3395
179. De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0. Epub 2024 Jan 30. PMID: 38307102.
180. Tourniaire P, Ilie M, Mazières J, Vigier A, Ghiringhelli F, Piton N, Sabourin JC, Bibeau F, Hofman P, Ayache N, Delingette H. WhARIO: whole-slide-image-based survival analysis for patients treated with immunotherapy. J Med Imaging (Bellingham). 2024 May;11(3):037502. doi: 10.1117/1.JMI.11.3.037502. Epub 2024 May 11. PMID: 38737491; PMCID: PMC11088447. https://pmc.ncbi.nlm.nih.gov/articles/PMC11088447/
181. Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, Palombi F, Baseggio L, Traverse-Glehen A, Tripodo C, Liberati AM, Parolini M, Usai S, Patti C, Federico M, Musso M, Ladetto M, Zucca E, Thieblemont C. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study. Haematologica. 2024 Jul 1;109(7):2297-2302. doi: 10.3324/haematol.2023.284109. Erratum in: Haematologica. 2025 Apr 1;110(4):1048-1049. doi: 10.3324/haematol.2024.287031. PMID: 38497158; PMCID: PMC11215346. https://pmc.ncbi.nlm.nih.gov/articles/PMC11215346/
182. Grever M, Andritsos L, Anghelina M, Arons E, Banerji V, Barrientos J, Bhat SA, Blachly J, Broccoli A, Call T, Dearden C, Dietrich S, Else M, Epperla N, Fagarasanu A, Falini B, Forconi F, Gozzetti A, Hampel P, Hermel DJ, Iyengar S, Johnston JB, Juliusson G, Kreitman RJ, Lauria F, Lozanski G, Oakes CC, Parikh SA, Park J, Quest G, Rai K, Ravandi F, Robak T, Rogers KA, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam CS, Tiacci E, Troussard X, Wörmann B, Zent CS, Zenz T, Zinzani PL. Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia. 2024 Jul;38(7):1642-1644. doi: 10.1038/s41375-024-02280-0. Epub 2024 Jun 8. PMID: 38851853; PMCID: PMC11216987. https://pmc.ncbi.nlm.nih.gov/articles/PMC11216987/
183. Hofman P, Calabrese F, Kern I, Adam J, Alarcão A, Alborelli I, Anton NT, Arndt A, Avdalyan A, Barberis M, Bégueret H, Bisig B, Blons H, Boström P, Brcic L, Bubanovic G, Buisson A, Caliò A, Cannone M, Carvalho L, Caumont C, Cayre A, Chalabreysse L, Chenard MP, Conde E, Copin MC, Côté JF, D’Haene N, Dai HY, de Leval L, Delongova P, Denčić-Fekete M, Fabre A, Ferenc F, Forest F, de Fraipont F, Garcia-Martos M, Gauchotte G, Geraghty R, Guerin E, Guerrero D, Hernandez S, Hurník P, Jean-Jacques B, Kashofer K, Kazdal D, Lantuejoul S, Leonce C, Lupo A, Malapelle U, Matej R, Merlin JL, Mertz KD, Morel
184. Alsugair Z, Perrot J, Descotes F, Lopez J, Champagnac A, Pissaloux D, Castain C, Onea M, Céruse P, Philouze P, Lépine C, Lanic MD, Laé M, Costes-Martineau V, Benzerdjeb N; and REFCOR Members. Characterization of a Molecularly Distinct Subset of Oncocytic Pleomorphic Adenomas/Myoepitheliomas Harboring Recurrent ZBTB47-AS1::PLAG1 Gene Fusion. Am J Surg Pathol. 2024 May 1;48(5):551-561. doi: 10.1097/PAS.0000000000002206. Epub 2024 Mar 18. PMID: 38497430.
185. Dolivet G, Barry B, Abdeddaim C, Baujat B, Blanchard N, Calais G, Carrat X, Chatellier A, Clatot F, Coste F, Cupissol D, Cuvelier P, de Mones Del Pujol E, Deneuve S, Duffas O, Dupret-Bories A, Even C, Evrard C, Evrard D, Faivre S, Fakhry N, Garrel R, Gorphe P, Houliat T, Huguet F, Kaminsky MC, Krebs L, Lapeyre M, Lindas P, Malard O, Mirghani H, Mondina M, Moriniere S, Mouawad F, Pestre-Munier J, Pham Dang N, Picard A, Ramin L, Renard S, Salvan D, Schernberg A, Sire C, Thariat J, Vanbockstael J, Vo Tan D, Wojcik T, Klein I, Block V, Baumann-Bouscaud L, de Raucourt D. Référentiel national de traitement des carcinomes épidermoïdes des voies aérodigestives supérieures [National standard for the treatment of squamous cell carcinoma of upper aerodigestive tract]. Bull Cancer. 2024 Apr;111(4):327-332. French. doi: 10.1016/j.bulcan.2023.08.015. Epub 2024 Feb 9. PMID: 38336530.
186. Tougeron D, Dahan L, Evesque L, Le Malicot K, El Hajbi F, Aparicio T, Bouché O, Bonichon Lamichhane N, Chibaudel B, Angelergues A, Bodere A, Phelip JM, Mabro M, Kaluzinski L, Petorin C, Breysacher G, Rinaldi Y, Zaanan A, Smith D, Gouttebel MC, Perret C, Etchepare N, Emile JF, Sanfourche I, Di Fiore F, Lepage C, Artru P, Louvet C; PRODIGE 59-FFCD 1707-DURIGAST Investigators/Collaborators. FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial. JAMA Oncol. 2024 Jun 1;10(6):709-717. doi: 10.1001/jamaoncol.2024.0207. PMID: 38573643; PMCID: PMC11190792. https://pmc.ncbi.nlm.nih.gov/articles/PMC11190792/
187. Durand M, Cabaud Gibouin V, Duplomb L, Salmi L, Caillot M, Sola B, Camus V, Jardin F, Garrido C, Jego G. A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma. J Exp Clin Cancer Res. 2024 May 22;43(1):148. doi: 10.1186/s13046-024-03068-x. PMID: 38773631; PMCID: PMC11110392. https://pmc.ncbi.nlm.nih.gov/articles/PMC11110392/
188. Hautefeuille V, Williet N, Turpin A, Napoleon B, Dupré A, Huguet F, Bignon AL, Camus M, Chevaux JB, Coriat R, Cros J, Edeline J, Koch S, Neuzillet C, Perkins G, Regimbeau JM, Sefrioui D, Vitellius C, Vullierme MP, Bouché O, Gaujoux S; Thésaurus National de Cancérologie Digestive (TNCD); Société Nationale Française de Gastroentérologie (SNFGE); Fédération Francophone de Cancérologie Digestive (FFCD); Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER); Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR); Société Française de Chirurgie Digestive (SFCD); Société Française d’Endoscopie Digestive (SFED); Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation (ACHBT); Société́ Française de Pathologie (SFP); Société Française de Radiothérapie Oncologique (SFRO); Réseau National de Référence des Tumeurs Rares du Péritoine (RENAPE); Société Nationale Française de Colo-Proctologie (SNFCP); Association Française pour l’Étude du Foie (AFEF); Société Française de Radiologie (SFR). Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR). Dig Liver Dis. 2024 Sep;56(9):1452-1460. doi: 10.1016/j.dld.2024.04.027. Epub 2024 Jun 6. PMID: 38845233. https://www.sciencedirect.com/science/article/pii/S159086582400728X
189. Nguyen-Khac F, Baron M, Guièze R, Feugier P, Fayault A, Raynaud S, Troussard X, Droin N, Damm F, Smagghe L, Susin S, Leblond V, Dartigeas C, Van den Neste E, Leprêtre S, Bernard OA, Roos-Weil D; on behalf the FILO (French Innovative Leukaemia Organization) Group. Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study). Br J Haematol. 2024 Aug;205(2):495-502. doi: 10.1111/bjh.19459. Epub 2024 Apr 23. PMID: 38654616.
190. Aparicio T, Henriques J, Svrcek M, Zaanan A, Manfredi S, Casadei-Gardini A, Tougeron D, Gornet JM, Jary M, Terrebonne E, Piessen G, Afchain P, Lecaille C, Pocard M, Lecomte T, Rimini M, Di Fiore F, Le Brun Ly V, Cascinu S, Vernerey D, Laurent Puig P. Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. Br J Cancer. 2024 Jul;131(1):49-62. doi: 10.1038/s41416-024-02687-7. Epub 2024 May 14. PMID: 38745088; PMCID: PMC11231144. https://pmc.ncbi.nlm.nih.gov/articles/PMC11231144/
191. Khiar H, Lévêque E, Lopez AG, Moreau-Grangé L, Richard L, Brunel V, Perdrix A, Takhlidjt S, Devère M, Tavolacci MP, Houivet E, Huet E, Degrimaudet B, Travers C, Leprince J, Picot M, Chartrel N, Prévost G. Serum levels of the incretin-like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa-Ba-S study. Diabetes Obes Metab. 2024 Dec;26(12):5556-5568. doi: 10.1111/dom.15871. Epub 2024 Sep 30. PMID: 39350486. https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15871
192. Esparragosa Vazquez I, Sanson M, Chinot OL, Fontanilles M, Rivoirard R, Thomas-Maisonneuve L, Cartalat S, Tabouret E, Appay R, Bonneville-Levard A, Darlix A, Meyronet D, Barritault M, Gueyffier F, Remontet L, Maucort-Boulch D, Honnorat J, Dehais C, Ducray F; POLA Network. Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network. Neurooncol Adv. 2024 May 27;6(1):vdae078. doi: 10.1093/noajnl/vdae078. PMID: 38855053; PMCID: PMC11157627. https://pmc.ncbi.nlm.nih.gov/articles/PMC11157627/
193. Barry B, Dolivet G, Clatot F, Huguet F, Abdeddaim C, Baujat B, Blanchard N, Calais G, Carrat X, Chatellier A, Coste F, Cupissol D, Cuvelier P, De Mones Del Pujol E, Deneuve S, Duffas O, Dupret-Bories A, Even C, Evrard C, Evrard D, Faivre S, Fakhry N, Garrel R, Gorphe P, Houliat T, Kaminsky MC, Krebs L, Lapeyre M, Lindas P, Malard O, Mirghani H, Mondina M, Moriniere S, Mouawad F, Pestre-Munier J, Pham Dang N, Picard A, Ramin L, Renard S, Salvan D, Schernberg A, Sire C, Thariat J, Vanbockstael J, Vo Tan D, Wojcik T, Klein I, Block V, Baumann-Bouscaud L, De Raucourt D. Référentiel national de traitement des carcinomes épidermoïdes des voies aérodigestives supérieures – Principes généraux de traitement [French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract – General principles of treatment]. Bull Cancer. 2024 Apr;111(4):393-415. French. doi: 10.1016/j.bulcan.2023.12.007. Epub 2024 Feb 28. PMID: 38418334.
194. Rossetti S, Juul SJ, van der Kaaij MAE, Fortpied C, Meijnders P, Aleman BMP, Raemaekers JMM, Kluin-Nelemans HC, Spina M, Fermé C, Renaud L, Casasnovas O, Stamatoullas A, Plattel WJ, Hutchings M, Maraldo MV. Relationships, marriage, and partner abandonment among Hodgkin lymphoma survivors treated in nine EORTC-GELA Lymphoma Group trials. Leuk Lymphoma. 2024 Dec;65(13):2035-2039. doi: 10.1080/10428194.2024.2390565. Epub 2024 Aug 12. PMID: 39133256.
195. Syrykh C, Di Proietto V, Brion E, Copie-Bergman C, Jardin F, Dartigues P, Gaulard P, Molina TJ, Briere J, Oberic L, Haioun C, Tilly H, Maussion C, Morel M, Schiratti JB, Laurent C. MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning Models. Mod Pathol. 2024 Dec;37(12):100610. doi: 10.1016/j.modpat.2024.100610. Epub 2024 Sep 10. PMID: 39265953. https://www.sciencedirect.com/science/article/pii/S089339522400190X
196. Lachkar S, Gervereau D, Loïc P, De Marchi M, Morisse H, Dantoing E, Piton N, Thiberville L, Salaün M, Guisier F. Correlation of programmed death-ligand 1 expression in tumour cells between diagnostic small biopsies performed by radial EBUS and surgical specimens of peripheral lung cancer. BMJ Open Respir Res. 2024 Oct 15;11(1):e002312. doi: 10.1136/bmjresp-2024-002312. PMID: 39414327; PMCID: PMC11481116. https://pmc.ncbi.nlm.nih.gov/articles/PMC11481116/
197. MacPhail A, Nguyen A, Camus V, Chraïti MN, Dalex E, Chalandon Y, Catho G, Bosetti D, Masouridi-Levrat S, Harbarth S, Zanella MC, Buetti N. Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients: a quasi-experimental study. J Hosp Infect. 2024 Sep;151:21-28. doi: 10.1016/j.jhin.2024.05.021. Epub 2024 Jun 28. PMID: 38945400. https://www.sciencedirect.com/science/article/pii/S0195670124002202
198. Alcantara M, Chevrier M, Jardin F, Schmitt A, Houillier C, Oberic L, Chinot O, Morschhauser F, Peyrade F, Houot R, Hoang-Xuan K, Ghesquieres H, Soussain C. Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. J Hematol Oncol. 2024 Sep 19;17(1):86. doi: 10.1186/s13045-024-01606-w. Erratum in: J Hematol Oncol. 2024 Oct 19;17(1):98. doi: 10.1186/s13045-024-01620-y. PMID: 39300447; PMCID: PMC11414093. https://pmc.ncbi.nlm.nih.gov/articles/PMC11414093/
199. Sarkozy C, Thieblemont C, Oberic L, Moreau A, Bouabdallah K, Damaj G, Gastinne T, Tessoulin B, Ribrag V, Casasnovas O, Haioun C, Houot R, Jardin F, Van Den Neste E, Cheminant M, Morschhauser F, Callanan M, Safar V, Gressin R, Hermine O, Le Gouill S. Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study. J Clin Oncol. 2024 Mar 1;42(7):769-773. doi: 10.1200/JCO.23.01586. Epub 2023 Dec 18. PMID: 38109684.
200. Carras S, Torroja A, Emadali A, Montaut E, Daguindau N, Tempescul A, Moreau A, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Barbieux S, Corm S, Banos A, Fouillet L, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouabdallah K, Amorim S, Garidi R, Voillat L, Joly B, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Burroni B, Callanan M, Le Gouill S, Gressin R. Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group. Haematologica. 2024 Jun 1;109(6):1857-1865. doi: 10.3324/haematol.2023.283724. PMID: 38031755; PMCID: PMC11141646. https://pmc.ncbi.nlm.nih.gov/articles/PMC11141646/
201. Linton KM, Vitolo U, Jurczak W, Lugtenburg PJ, Gyan E, Sureda A, Christensen JH, Hess B, Tilly H, Cordoba R, Lewis DJ, Okada C, Hutchings M, Clausen MR, Sancho JM, Cochrane T, Leppä S, Chamuleau MED, Gernhardt D, Altıntaş I, Liu Y, Ahmadi T, Dinh MH, Hoehn D, Favaro E, Elliott B, Thieblemont C, Vose JM. Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study. Lancet Haematol. 2024 Aug;11(8):e593-e605. doi: 10.1016/S2352-3026(24)00166-2. Epub 2024 Jun 15. PMID: 38889737.
202. Hoster E, Delfau-Larue MH, Macintyre E, Jiang L, Stilgenbauer S, Vehling-Kaiser U, Salles G, Thieblemont C, Tilly H, Wirths S, Feugier P, Hübel K, Schmidt C, Ribrag V, Kluin-Nelemans JC, Dreyling M, Pott C; European MCL MRD Working Group and the European MCL Network. Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial. J Clin Oncol. 2024 Feb 10;42(5):538-549. doi: 10.1200/JCO.23.00899. Epub 2023 Nov 22. PMID: 37992261.
203. Alcantara M, Chevrier M, Jardin F, Schmitt A, Houillier C, Oberic L, Chinot O, Morschhauser F, Peyrade F, Houot R, Hoang-Xuan K, Ghesquieres H, Soussain C. Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. J Hematol Oncol. 2024 Oct 19;17(1):98. doi: 10.1186/s13045-024-01620-y. Erratum for: J Hematol Oncol. 2024 Sep 19;17(1):86. doi: 10.1186/s13045-024-01606-w. PMID: 39427203; PMCID: PMC11490990. https://pmc.ncbi.nlm.nih.gov/articles/PMC11490990/
204. Gaujoux S, Regimbeau JM, Piessen G, Truant S, Foissac F, Barbier L, Buc E, Adham M, Fuks D, Deguelte S, Muscari F, Sulpice L, Vaillant JC, Schwarz L, Sa Cunha A, Muzzolini M, Dousset B, Sauvanet A; Collaborators. Somatostatin Versus Octreotide for Prevention of Postoperative Pancreatic Fistula: The PREFIPS Randomized Clinical Trial: A FRENCH 007-ACHBT Study. Ann Surg. 2024 Aug 1;280(2):179-187. doi: 10.1097/SLA.0000000000006313. Epub 2024 Apr 25. PMID: 38662619.
205. Stathis A, Pirosa MC, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FG, Merli F, Guièze R, Gyan E, Gini G, Marino D, Gressin R, Morschhauser F, Cavallo F, Palombi F, Conconi A, Tessoulin B, Tilly H, Zanni M, Cabras MG, Capochiani E, Califano C, Celli M, Pulsoni A, Angrilli F, Occhini U, Casasnovas RO, Cartron G, Devizzi L, Haioun C, Liberati AM, Houot R, Merli M, Pietrantuono G, Re F, Spina M, Landi F, Cavalli F, Bertoni F, Rossi D, Ielmini N, Borgo E, Luminari S, Zucca E, Thieblemont C. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918. PMID: 38385243; PMCID: PMC11290511. https://pmc.ncbi.nlm.nih.gov/articles/PMC11290511/
206. Cottereau AS, Rebaud L, Trotman J, Feugier P, Nastoupil LJ, Bachy E, Flinn IW, Haioun C, Ysebaert L, Bartlett NL, Tilly H, Casasnovas O, Ricci R, Portugues C, Buvat I, Meignan M, Morschhauser F. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial. Ann Oncol. 2024 Jan;35(1):130-137. doi: 10.1016/j.annonc.2023.10.121. Epub 2023 Oct 28. PMID: 37898239. https://www.sciencedirect.com/science/article/pii/S0923753423043272?via%3Dihub
207. Bommier C, Donzel M, Rossi C, Fornecker LM, Bijou F, Chauchet A, Lebras L, Ysabaert L, Haioun C, Bouabdallah K, Gastinne T, Morineau N, Amorim S, Jardin F, Abraham J, Lamy de la Chapelle T, Gressin R, Fouillet L, Fruchart C, Olivier G, Morschhauser F, Cherblanc F, Belot A, Le Guyader S, Monnereau A, Ghesquieres H, Thieblemont C. Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study. Hematol Oncol. 2024 Nov;42(6):e3314. doi: 10.1002/hon.3314. PMID: 39351974; PMCID: PMC11590051. https://pmc.ncbi.nlm.nih.gov/articles/PMC11590051/
208. Trinquet A, Laé M, Lépine C, Lanic MD, Lacheretz-Szablewski V, Shaar Chneker C, Goujon JM, Favier V, Costes-Martineau V. Sinonasal Squamous Cell Carcinoma with DEK::AFF2 Rearrangement : An Aggressive Cancer with Bland Morphology. Am J Surg Pathol. 2024 Nov 1;48(11):1408-1416. doi: 10.1097/PAS.0000000000002281. Epub 2024 Aug 12. PMID: 39132684. https://journals.lww.com/ajsp/fulltext/2024/11000/sinonasal_squamous_cell_carcinoma_with_dek__aff2.8.aspx
209. Houot R, Calmettes C, Park S, Pascal L, Peffault de Latour R, Pigneux A, Quinquenel A, Raffoux E, Thieblemont C, Touati M, Trebouet A, Vaida I, Wémeau M, Bastie JN, Bay JO, Cluzeau T, Cornillon J, Damaj G, Deconinck E, Feugier P, Fornecker LM, Gay J, Hermine O, Hospital MA, Hunault M, Jaccard A, Jardin F, Le Calloch R, Legros L, Leleu X, Lemonnier F, Malfuson JV, Morel P, Ochmann M, Orsini-Piocelle F, Gyan E. Faire vivre et grandir une communauté de chefs de service : acte 2 en hématologie [Nurturing and growing a community of department heads: Act 2 in haematology]. Bull Cancer. 2024 Oct;111(10):980-986. French. doi: 10.1016/j.bulcan.2024.06.014. Epub 2024 Sep 11. PMID: 39266427. https://www.sciencedirect.com/science/article/pii/S0007455124002753?via%3Dihub
210. André A, Montes L, Roos-Weil D, Frenzel L, Vignon M, Chalopin T, Debureaux PE, Talbot A, Farge A, Jardin F, Belhadj K, Royer B, Marolleau JP, Arnulf B, Morel P, Harel S. Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study. Hemasphere. 2024 Jul 29;8(8):e106. doi: 10.1002/hem3.106. PMID: 39081803; PMCID: PMC11285034. https://pmc.ncbi.nlm.nih.gov/articles/PMC11285034/
211. Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nat Med. 2024 Jul;30(7):2089. doi: 10.1038/s41591-024-03053-z. Erratum for: Nat Med. 2023 Oct;29(10):2593-2601. doi: 10.1038/s41591-023-02572-5. PMID: 38745012; PMCID: PMC11259554. https://pmc.ncbi.nlm.nih.gov/articles/PMC11259554/
212. Addeo P, de Mathelin P, Doussot A, Durin T, Canali G, Marchese U, Sauvanet A, Dokmak S, Cherkaoui Z, Fuks D, Laurent C, André M, Ayav A, Magallon C, Turrini O, Sulpice L, Robin F, Bachellier P, Souche FR, Bardol T, Perinel J, Adham M, Tzedakis S, Birnbaum DJ, Facy O, Gagniere J, Gaujoux S, Tribillon E, Roussel E, Schwarz L, Barbier L, Regenet N, Iannelli A, Regimbeau JM, Piessen G, Truant S, El Amrani M. Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study. Surgery. 2024 Aug;176(2):433-439. doi: 10.1016/j.surg.2024.04.005. Epub 2024 May 25. PMID: 38797604.
213. Duclos C, Durin T, Marchese U, Sauvanet A, Laurent C, Ayav A, Turrini O, Sulpice L, Addeo P, Souche FR, Perinel J, Birnbaum DJ, Facy O, Gagnière J, Gaujoux S, Schwarz L, Regenet N, Iannelli A, Regimbeau JM, Piessen G, Lenne X, El Amrani M, Heyd B, Doussot A; Collaborators. Management and outcomes of hemorrhage after distal pancreatectomy: a multicenter study at high volume centers. HPB (Oxford). 2024 Feb;26(2):234-240. doi: 10.1016/j.hpb.2023.10.008. Epub 2023 Oct 26. PMID: 37951805. https://www.sciencedirect.com/science/article/pii/S1365182X23019494
214. Coinsin B, Durin T, Marchese U, Sauvanet A, Dokmak S, Cherkaoui Z, Fuks D, Laurent C, Magallon C, Turrini O, Sulpice L, Robin F, Bachellier P, Addeo P, Birnbaum DJ, Roussel E, Schwarz L, Regimbeau JM, Piessen G, Liddo G, Girard E, Cailliau É, Truant S, El Amrani M. The impact of cirrhosis on short and long postoperative outcomes after distal pancreatectomy. Surgery. 2024 Aug;176(2):447-454. doi: 10.1016/j.surg.2024.03.038. Epub 2024 May 29. PMID: 38811323.
215. Amory B, Goumard C, Laurent A, Langella S, Cherqui D, Salame E, Barbier L, Soubrane O, Farges O, Hobeika C, Kawai T, Regimbeau JM, Faitot F, Pessaux P, Truant S, Boleslawski E, Herrero A, Mabrut JY, Chiche L, Di Martino M, Rhaiem R, Schwarz L, Resende V, Calderaro J, Augustin J, Caruso S, Sommacale D, Hofmeyr S, Ferrero A, Fuks D, Vibert E, Torzilli G, Scatton O, Brustia R; AFC-ICC-2009, AFC-LLR-2018, and PRS-2019 Study Group. Combined hepatocellular-cholangiocarcinoma compared to hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Different survival, similar recurrence: Report of a large study on repurposed databases with propensity score matching. Surgery. 2024 Feb;175(2):413-423. doi: 10.1016/j.surg.2023.09.040. Epub 2023 Nov 18. PMID: 37981553. https://orbi.uliege.be/handle/2268/316688
216. Draye-Carbonnier S, Mihailescu SD, Pinochet P, Texte E, Stamatoullas-Bastard A, Vera P, Becker S, Decazes P. Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced-Stage Hodgkin Lymphoma. Cancer Med. 2025 Dec;14(24):e71462. doi: 10.1002/cam4.71462. PMID: 41388928; PMCID: PMC12701620. https://pmc.ncbi.nlm.nih.gov/articles/PMC12701620/
217. Broussais F, Pennings E, Bolanos N, Warwick L, Doeswijk R, Quinonez G, Lebeda A, Da Silva MG, Leppä S, Lenz G, Cottereau AS, Fox C, Lopez-Guillermo A, Illidge T, Jurczak W, Eich H, Aurer I, Trneny M, Rosenwald AA, Davies A, Zwezerijnen BG, Jais JP, Dreyling M, Vitolo U, Tilly H, Thieblemont C, Kersten MJ. Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe. Hemasphere. 2025 Sep 23;9(9):e70204. doi: 10.1002/hem3.70204. PMID: 40995467; PMCID: PMC12455876. https://pmc.ncbi.nlm.nih.gov/articles/PMC12455876/
218. Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, Palombi F, Baseggio L, Traverse-Glehen A, Tripodo C, Liberati AM, Parolini M, Usai S, Patti C, Federico M, Musso M, Ladetto M, Zucca E, Thieblemont C. Erratum to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study. Haematologica. 2025 Apr 1;110(4):1048-1049. doi: 10.3324/haematol.2024.287031. Epub 2025 Apr 1. Erratum for: Haematologica. 2024 Jul 01;109(7):2297-2302. doi: 10.3324/haematol.2023.284109. PMID: 40165734; PMCID: PMC11959258. https://pmc.ncbi.nlm.nih.gov/articles/PMC11959258/
219. Bach CLT, Tallet A, Bonenfant C, Lecomte T, Piton N, Samimi M, Guyétant S, Kervarrec T. Cutaneous hybrid cysts with matrical differentiation are mostly sporadic and related to CTNNB1 mutation. Virchows Arch. 2025 May;486(5):1023-1032. doi: 10.1007/s00428-024-03986-3. Epub 2024 Nov 23. PMID: 39579263.
220. Herbaux C, Bachy E, Bouabdallah R, Guidez S, Casasnovas O, Feugier P, Damaj G, Tilly H, Ysebaert L, Le Gouill S, Morineau N, Gyan E, Gressin R, Houot R, Cheminant M, Morschhauser F, Thieblemont C, Haioun C, Nicolas-Virelizier E, Fornecker LM, Daguindau N, Cartron G. Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group. Br J Haematol. 2025 Jul;207(1):110-122. doi: 10.1111/bjh.20109. Epub 2025 Apr 26. PMID: 40285420; PMCID: PMC12234259. https://pmc.ncbi.nlm.nih.gov/articles/PMC12234259/
221. Feraille A, Etancelin P, Troche S, Jardin F, Buchbinder N, Schneider P, Dugay M, Rives N, Rondanino C, Dumont L. Detection of minimal residual disease in cryopreserved testicular tissue from (pre)pubertal boys with acute leukemia following first-line therapy. Hum Reprod. 2025 Aug 1;40(8):1476-1484. doi: 10.1093/humrep/deaf093. PMID: 40389239. https://academic.oup.com/humrep/article-abstract/40/8/1476/8137987
222. Pastier C, Ben Hmida W, Lefèvre JH, Denost Q, Schwarz L, Berdah S, Cotte E, Karoui M, Maggiori L, Abdalla S, Brouquet A, Benoist S. Management of Low Colorectal/Coloanal Anastomotic Leak: Results of a French National Intergroups Practice Survey (FRENCH-GRECCAR-SFCD). World J Surg. 2025 Jul;49(7):1747-1756. doi: 10.1002/wjs.12634. Epub 2025 May 21. PMID: 40397486; PMCID: PMC12282568. https://pmc.ncbi.nlm.nih.gov/articles/PMC12282568/
223. De Ponthaud C, Nassar A, Dokmak S, Bertrand T, De Martino J, Pastier C, Castel A, De Rosa R, Boubaddi M, Iben-Khayat A, Giannone F, Jolly E, Garnier J, Louis-Gaubert C, Mazzotta AD, André M, Gagnière J, Viennet M, Souche FR, Kianmanesh R, Lupinacci RM, Regimbeau JM, Paye F, Addeo P, Laurent A, Vandermeulen M, Caiazzo R, El Amrani M, Tresallet C, Doussot A, Brunel M, Jouffret L, Pinto A, Valverde A, Romero Vece R, Fara R, Mahfouf S, Darnis B, Chamakhi A, Thereaux J, Lubrano J, Girard E, Veziant J, Birnbaum DJ, Danion J, Corté H, Zemour J, Piardi T, de Carbonnières A, Ragot E, Zarzavadjian Le Bian A, David P, Brunaud L, Lermite E, Chreim L, Charlaix AL, Gugenheim J, Schwarz L, Bigourdan JM, Le Roy B, Karam E, Rhaiem R, Fabre JM, Lequeu JB, Noirault M, Ayav A, Soubrane O, Regenet N, Turrini O, Muscari F, Pessaux P, Thébault B, Laurent C, Sulpice L, Sauvanet A, Fuks D, Gaujoux S; AFC- study group. Conversion during Minimally Invasive Left Pancreatectomy: A Nationwide Study of Causes and Consequences. Ann Surg. 2025 Feb 28. doi: 10.1097/SLA.0000000000006685. Epub ahead of print. PMID: 40018739. https://orbi.uliege.be/handle/2268/330844
224. Touioui S, Desandes E, Jannot L, Mansuy L, Clabaut D, Peuchmaur M, Rioux-Leclercq N, Khneisser P, Thiebaut PA, Gallo M, Nemos C, Schleiermacher G, Chastagner P, Sartelet H. Expression evaluated by digital image analysis techniques of PRAME more than MCM6 is associated with poor prognosis in neuroblastoma: A pilot study with 84 cases. Hum Pathol. 2025 Jan;155:105718. doi: 10.1016/j.humpath.2025.105718. Epub 2025 Jan 20. PMID: 39842731.
225. Trama A, Geerdes EE, Demuru E, De Angelis R, Karim-Kos HE, Troussard X, Bennett D, Marcos-Gragera R, Kuehni CE, Liu H, Bernasconi A, Vener C, Guevara M, Zwaan CM, Mayer-da-Silva A, Paapsi K, Ragusa R, Smith OP; EUROCARE-6 Working Group. Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based study. Eur J Cancer. 2025 Jun 3;222:115336. doi: 10.1016/j.ejca.2025.115336. Epub 2025 Mar 1. PMID: 40334304. https://www.sciencedirect.com/science/article/pii/S0959804925001170?via%3Dihub
226. Samalin E, Evesque L, Turpin A, De La Fouchardiere C, Khemissa-Akouz F, Bouché O, Muller M, Dermeche S, Botsen D, Tougeron D, Zaanan A, Ben Abdelghani M, Guardiola E, Dubreuil O, Le Brun Ly V, Hennequin A, Watson S, Sefrioui D, Lecomte T, De Sousa Carvalho N, Hulin A, Crapez E, Castan F, Senellart H. Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study. ESMO Open. 2025 May;10(5):105096. doi: 10.1016/j.esmoop.2025.105096. Epub 2025 May 12. PMID: 40359707; PMCID: PMC12141891. https://pmc.ncbi.nlm.nih.gov/articles/PMC12141891/
227. Thomas-de-Montpréville V, Chalabreysse L, Hofman V, de-Muret A, Sizaret D, Dubois R, Piton N, Mansuet-Lupo A, Molina TJ. Micronodular thymic epithelial tumors with lymphoid hyperplasia and mimicking lesions. Histol Histopathol. 2025 Jan;40(1):1-10. doi: 10.14670/HH-18-755. Epub 2024 May 2. PMID: 38725394. https://www.hh.um.es/Abstracts/Vol_40/40_1/40_1_1.htm
228. Oudard S, Tran Y, Helissey C, Vauchier C, Ratta R, Bennamoun M, Voog E, Hasbini A, Thiery-Vuillemin A, Aldabbagh K, Saldana C, Sevin E, Amela E, Von Amsberg G, Houede N, Besson D, Feyerabend S, Boegemann M, Pfister D, Schostak M, Huillard O, Di Fiore F, Quivy A, Vernerey D, Falcoz A, Youcef-Ali K, Kotti S, Lepicard EM, Barthelemy P. Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial. Eur Urol Oncol. 2025 Feb;8(1):126-134. doi: 10.1016/j.euo.2024.07.011. Epub 2024 Aug 13. PMID: 39143002. https://www.sciencedirect.com/science/article/pii/S2588931124001846?via%3Dihub
229. Güller U, Hayoz S, Horber D, Jochum W, De Dosso S, Koeberle D, Schacher S, Inauen R, Stahl M, Delaunoit T, Ettrich T, Bodoky G, Michel P, Koessler T, Rothgiesser K, Calmonte S, Joerger M. Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial. Clin Cancer Res. 2025 Aug 1;31(15):3142-3149. doi: 10.1158/1078-0432.CCR-24-4048. PMID: 40067142; PMCID: PMC7617601. https://pmc.ncbi.nlm.nih.gov/articles/PMC7617601/
230. Pastier C, De Ponthaud C, Nassar A, Soubrane O, Mazzotta AD, Souche FR, Brunaud L, Kianmanesh R, Sulpice L, Schwarz L, Karam E, Lermite E, Dokmak S, Fuks D, Gaujoux S. Laparoscopic pancreatic enucleation: how far should we go for parenchyma preservation? A study by the French National Association of Surgery. Surg Endosc. 2025 Mar;39(3):1696-1708. doi: 10.1007/s00464-024-11453-y. Epub 2025 Jan 13. PMID: 39806174.
231. Ssenyonga N, Stiller CA, Marcos-Gragera R, Kuehni CE, Saint-Jacques N, Bulliard JL, Redaniel MT, Nakata K, Schwartz S, De P, Ragusa R, Troussard X, Curado MP, Girardi F, Maynadié M, Valkov M, Guilloteau A, Lima C, Coleman MP, Allemani C; CONCORD Working Group. Conditional survival of children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 world-wide: (CONCORD-3). Eur J Cancer. 2025 Jul 25;225:115445. doi: 10.1016/j.ejca.2025.115445. Epub 2025 May 23. PMID: 40578047. https://www.sciencedirect.com/science/article/pii/S0959804925002266?via%3Dihub
232. Louis J, Rolain M, Levacher C, Baudry K, Pujol P, Ruminy P, Baert Desurmont S, Bou J, Bouvignies E, Coutant S, Kasper E, Lienard G, Vasseur S, Vezain M, Houdayer C, Charbonnier F, Bougeard G. Li-Fraumeni syndrome: a germline TP53 splice variant reveals a novel physiological alternative transcript. J Med Genet. 2025 Feb 26;62(3):160-168. doi: 10.1136/jmg-2024-110449. PMID: 39788694.
233. Sarkozy C, Molina TJ, Dubois S, Portugues C, Bohers E, Ysebaert L, Houot R, Pica GM, Ruminy P, Herbaux C, Gastinne T, Thieblemont C, Haioun C, Guidez S, Bonnet C, Crochet G, Veresezan L, Choquet S, Bachy E, Jardin F, Morschhauser F, Ribrag V. Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA. EClinicalMedicine. 2025 Mar 18;82:103157. doi: 10.1016/j.eclinm.2025.103157. PMID: 40166656; PMCID: PMC11957796. https://pmc.ncbi.nlm.nih.gov/articles/PMC11957796/
234. Ducreux M, Desgrippes R, Rinaldi Y, Di Fiore F, Guimbaud R, Evesque L, Bachet JB, Vanelslander P, Lecomte T, Capitain O, Parzy A, Bolliet M, Etienne PL, Forestier J, El Hajbi F, Bignon AL, Lebrun-Ly V, De Sousa Carvalho N, Texier M, Bouche O. PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma. J Clin Oncol. 2025 Jul 10;43(20):2255-2264. doi: 10.1200/JCO-24-02210. Epub 2025 May 16. PMID: 40378359.
235. Taïeb J, Sullo FG, Lecanu A, Bourreau C, Barbier E, Gandini A, Bez J, Mulot C, Di Fiore F, Elhajbi F, Borg C, Bouché O, Aparicio T, Zaanan A, André T, Tougeron D, Taly V, Laurent-Puig P. Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial. JAMA Oncol. 2025 Aug 1;11(8):874-882. doi: 10.1001/jamaoncol.2025.1646. PMID: 40531517; PMCID: PMC12177728. https://pmc.ncbi.nlm.nih.gov/articles/PMC12177728/
236. Claudel A, Cottereau AS, Bachy E, Itti E, Feugier P, Rossi C, Lemonnier F, Camus V, Daguindau N, Cartron G, Nicolas-Virelizier E, Mboumba DL, Cardoso C, Bommier C, Tessoulin B, Fruchart C, Gilbert A, Durot E, Fleck E, Pica GM, Zerazhi H, Guidez S, Cheminant M, Sarkozy C, Xerri L, Vercellino L, Trabelsi N, Gomes L, Portugues C, Viailly PJ, Delfau-Larue MH, Morschhauser F. Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment. Blood. 2025 Aug 21;146(8):913-925. doi: 10.1182/blood.2024027727. PMID: 40499012.
237. Vion R, Roulleaux-Dugage M, Flippot R, Ouali K, Rouanne M, Clatot F, Sellars M, Champiat S, Chaput N, Massard C, Danlos FX. Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy. Eur J Cancer. 2025 Jul 25;225:115572. doi: 10.1016/j.ejca.2025.115572. Epub 2025 Jun 9. PMID: 40517527. https://www.sciencedirect.com/science/article/pii/S0959804925003545?via%3Dihub
238. Mukhtar RA, Gottipati S, Yau C, López-Tarruella S, Earl H, Hayward L, Hiller L, Osdoit M, van der Noordaa M, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, Boughey JC, Goetz MP, Hoskin T, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Provenzano E, Sammut SJ, Thomas JS, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, J van ‘t Veer L, Cameron D, Esserman LJ, Fraser Symmans W. A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer. NPJ Breast Cancer. 2025 Feb 13;11(1):14. doi: 10.1038/s41523-025-00720-3. PMID: 39948079; PMCID: PMC11825822. https://pmc.ncbi.nlm.nih.gov/articles/PMC11825822/
239. Sallman DA, Komrokji RS, Dezern AE, Sebert M, Garcia-Manero G, Rahmé R, Winer ES, Lehmann-Che J, Roboz GJ, Madelaine I, Sekeres MA, Peterlin P, Chan O, Beyne-Rauzy O, Kuykendall A, Recher C, McLemore A, Stamatoullas A, Zhang L, Willems L, Mo Q, Raffoux E, Nardelli L, Berthon C, Al Ali NH, Quesnel B, Padron E, Kantarjian HM, List AF, Ades L, Lancet JE, Fenaux P, Cluzeau T. Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML. Hemasphere. 2025 Jul 13;9(7):e70164. doi: 10.1002/hem3.70164. PMID: 40657305; PMCID: PMC12255903. https://pmc.ncbi.nlm.nih.gov/articles/PMC12255903/
240. Michot A, Giraud A, Karanian M, Laé M, Fau M, Adam D, Wernert R, Valentin T, Guilloit JM, Calais G, Rios M, Le Cesne A, Thyss A, Causeret S, Italiano A, Sunyach MP, Tzanis D, Blay JY, Sargos P, Bonvalot S, Le Loarer F, Stoeckle E. Radiation-associated angiosarcoma of the breast: consider chemotherapy. Eur J Surg Oncol. 2025 Sep;51(9):110202. doi: 10.1016/j.ejso.2025.110202. Epub 2025 Jun 19. PMID: 40753683.
241. Pilati C, Soulabaille A, Gallois C, Blons H, Cayre A, Sroussi M, Le Corre D, Mouillet-Richard S, Mulot C, Le Malicot K, De Reynies A, Bachet JB, Borg C, Di Fiore F, Guimbaud R, Bennouna J, André T, Taieb J, Penault-Llorca F, Laurent-Puig P. ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts. Gastroenterology. 2025 Apr;168(4):714-724.e4. doi: 10.1053/j.gastro.2024.10.046. Epub 2024 Nov 28. PMID: 39612956. https://www.sciencedirect.com/science/article/pii/S0016508524057457?via%3Dihub
242. Galtier J, Mesguich C, Sesques P, Dupont V, Bachy E, Di Blasi R, Thieblemont C, Gastinne T, Cartron G, Brisou G, Gros FX, Decroocq J, Morschhauser F, Rubio MT, Drieu La Rochelle L, Le Bras F, Carras S, Chauchet A, Bay JO, Joris M, Loschi M, Tanguy-Schmidt A, Marquet A, Camus V, Le Gouill S, Houot R, Bouabdallah K. Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry. Hemasphere. 2025 Feb 18;9(2):e70091. doi: 10.1002/hem3.70091. PMID: 39968186; PMCID: PMC11833168. https://pmc.ncbi.nlm.nih.gov/articles/PMC11833168/
243. Krings G, Shamir ER, Laé M, Bean GR, Post MD, Schnitt SJ, Chen YY. Serous-like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours. Histopathology. 2025 Apr;86(5):779-792. doi: 10.1111/his.15385. Epub 2024 Dec 9. PMID: 39654368.
244. Robin M, D’Aveni M, Stamatoullas A, Raffoux E, Chevallier P, Garnier A, Mediavilla C, Carre M, Himberlin C, Sébert M, Ravinet A, Desseaux K, Labussière H, Alani M, Rubio MT, Huynh A, Adès L, de Latour RP, Paul F, Chermat F, Petit R, Mokeddem C, Charbonnier A, Thépot S, Chevret S, Fenaux P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Groupe Francophone des Myélodysplasies (GFM). Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2025 Sep;12(9):e705-e716. doi: 10.1016/S2352-3026(25)00172-3. Epub 2025 Aug 7. PMID: 40784355.
245. Ye-Tran X, Bouattour M, Fresneau B, Turpin A, Perret A, Vitellius C, Coriat R, Blanc JF, Lequoy M, Regnault H, Pietrasz D, Sefrioui D, Lecomte T, Moati E, Caliez O, Nguyen-Khac E, Walter T, Hautefeuille V. Response to systemic treatments and survival of fibrolamellar carcinomas: An AGEO-SFCE French multicenter retrospective cohort. Dig Liver Dis. 2025 Jul;57(7):1495-1500. doi: 10.1016/j.dld.2025.04.016. Epub 2025 May 1. PMID: 40316454. https://www.sciencedirect.com/science/article/pii/S1590865825003287?via%3Dihub
246. Goliot N, Jouglar E, Jacob J, Christy F, Seutin E, Schiappa R, Dumont S, Mohssine S, Stefan D, Leclerc A, Emery E, Moignier C, Riverain J, Missohou F, Fontanilles M, Valable S, Balosso J, Doyen J, Lesueur P. Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study. Radiat Oncol. 2025 Aug 5;20(1):124. doi: 10.1186/s13014-025-02702-y. PMID: 40764578; PMCID: PMC12326604. https://pmc.ncbi.nlm.nih.gov/articles/PMC12326604/
247. Tougeron D, Mineur L, Zaanan A, Kadi M, Poisson Ligeza C, Bourgeois V, Martin-Babau J, Fadin A, Jestin le Tallec V, Ly Lebrun V, Dubreuil O, Khemissa Akouz F, Thimonier E, Bouché O, Lièvre A, Di Fiore F, Lecomte T, Lepage C, Hautefeuille V; PRODIGE 62-FFCD 1701-OESIRI investigators/collaborators. Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (PRODIGE 62-FFCD 1701-OESIRI). Eur J Cancer. 2025 Oct 1;228:115741. doi: 10.1016/j.ejca.2025.115741. Epub 2025 Aug 22. PMID: 40876084. https://www.sciencedirect.com/science/article/pii/S0959804925005246?via%3Dihub
248. Ssenyonga N, Stiller CA, Marcos-Gragera R, Kuehni CE, Saint-Jacques N, Bulliard JL, Redaniel MT, Nakata K, Schwartz S, De P, Ragusa R, Troussard X, Curado MP, Girardi F, Maynadié M, Valkov M, Guilloteau A, Lima C, Coleman MP, Allemani C; CONCORD Working Group. Conditional survival of children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 world-wide: (CONCORD-3). Eur J Cancer. 2025 Jul 25;225:115445. doi: 10.1016/j.ejca.2025.115445. Epub 2025 May 23. PMID: 40578047. https://www.sciencedirect.com/science/article/pii/S0959804925002266?via%3Dihub
249. D’Aveni M, Schenone L, Torregrosa JM, Pardo J, Stamatoullas A, Saillard C, Thépot S, Dimicoli S, Santana C, Daguindau E, Paul F, Le Clech L, Park S, Cluzeau T, Paubelle E, Taksin-Bressot AL, Chermat F, Adès L, Fenaux P, Comont T. Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM. Br J Haematol. 2025 Sep;207(3):1122-1126. doi: 10.1111/bjh.20247. Epub 2025 Jul 2. PMID: 40599042; PMCID: PMC12436241. https://pmc.ncbi.nlm.nih.gov/articles/PMC12436241/
250. Borremans K, Nguyen HL, De Schepper M, Lerebours F, Vion R, Clatot F, Berghian A, Maetens M, Isnaldi E, Molinelli C, Lambertini M, Grillo F, Zoppoli G, Dirix L, Punie K, Wildiers H, Smeets A, Nevelsteen I, Neven P, Vincent-Salomon A, Larsimont D, Duhem C, Viens P, Bertucci F, Biganzoli E, Vermeulen P, Floris G, Richard F, Desmedt C. The role of body mass index at diagnosis in patients with inflammatory breast cancer. Breast. 2025 Dec;84:104599. doi: 10.1016/j.breast.2025.104599. Epub 2025 Oct 12. PMID: 41109066; PMCID: PMC12554222. https://pmc.ncbi.nlm.nih.gov/articles/PMC12554222/
251. Allaume P, Bourgade R, Uguen A, Pécot T, Prevot S, Guettier C, Selves J, Bertheau P, Franchet C, Svrcek M, Sabourin JC, Brevet M, Calderaro J, Rioux-Leclercq N, Loussouarn D, Kammerer-Jacquet SF. Enquête nationale de la Société française de pathologie sur la recherche et l’utilisation de l’intelligence artificielle (IA) appliquée à la pathologie [A national survey from the French Society of Pathology on research and application of artificial intelligence in pathology]. Ann Pathol. 2025 May;45(3):224-232. French. doi: 10.1016/j.annpat.2024.12.008. Epub 2024 Dec 31. PMID: 39743406.
252. Bobée V, Ravel-Chapuis R, Souissi M, Boutet C, Bigot D, Paquin C, Gruchet J, Barbay V, Camus V, Bera E, Daliphard S. Overestimation of Automated Platelet Counts by Blast Fragments in Acute Hypercellular Leukemias: A Retrospective Study Comparing Impedance, Optical (PLT-O), Fluorescent (PLT-F), and CD41/CD61 Flow Cytometry Methods. Int J Lab Hematol. 2025 Aug;47(4):622-631. doi: 10.1111/ijlh.14464. Epub 2025 Apr 1. PMID: 40165766; PMCID: PMC12239704. https://pmc.ncbi.nlm.nih.gov/articles/PMC12239704/
253. Amiot J, Levacher C, Thibaut LM, Lienard G, Vasseur S, Quenez O, Coutant S, Fourneaux S, Charbonnier F, Thorn H, Legros A, Aucouturier C, Castéra L, Leman R, Kasper E, Baert-Desurmont S, Krieger S, Ruminy P, Houdayer C. Bridging the Diagnostic Gap in Hereditary Cancers with Simple, Cost-Effective, High-Throughput RNA Splicing Analysis. J Mol Diagn. 2025 Oct;27(10):954-968. doi: 10.1016/j.jmoldx.2025.06.003. Epub 2025 Jul 23. PMID: 40712994; PMCID: PMC12597563. https://pmc.ncbi.nlm.nih.gov/articles/PMC12597563/
254. Papet J, Augusto-Pelegrin L, Christy F, Lequesne J, Di Fiore F, Joly F, Pfister C. Real-world treatment patterns and survival outcomes in patients with metastatic castration-resistant prostate cancer in France: lessons from the prospective OPALE study. Anticancer Drugs. 2025 Nov 1;36(10):805-811. doi: 10.1097/CAD.0000000000001756. Epub 2025 Oct 8. PMID: 41082589.
255. Trama A, Rossi S, Bennet D, Stiller C, Paapsi K, Troussard X, Giudici F, Karim-Kos HE, Cerza F, Trallero J, Ragusa R, Blum M, Mayer-da-Silva A, Peters F, Didonè F, Botta L; EUROCARE-6 Working Group. Corrigendum to « Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study » [Eur. J. Cancer 2025 Aug 26;226:115535. PMID: 40743655]. Eur J Cancer. 2025 Oct 16;229:115767. doi: 10.1016/j.ejca.2025.115767. Epub 2025 Sep 12. Erratum for: Eur J Cancer. 2025 Aug 26;226:115535. doi: 10.1016/j.ejca.2025.115535. PMID: 40945300. https://www.sciencedirect.com/science/article/pii/S0959804925005532?via%3Dihub
256. Trama A, Rossi S, Bennet D, Stiller C, Paapsi K, Troussard X, Giudici F, Karim-Kos HE, Cerza F, Trallero J, Ragusa R, Blum M, Mayer-da-Silva A, Peters F, Didonè F, Botta L; EUROCARE-6 Working Group. Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study. Eur J Cancer. 2025 Aug 26;226:115535. doi: 10.1016/j.ejca.2025.115535. Epub 2025 Jun 11. Erratum in: Eur J Cancer. 2025 Oct 16;229:115767. doi: 10.1016/j.ejca.2025.115767. PMID: 40743655. https://www.sciencedirect.com/science/article/pii/S095980492500317X?via%3Dihub
257. Bussot L, Poulain S, Nudel Ortmans M, Davi F, Roos-Weil D, Lepretre S, Richard D, Pastoret C, Desmares A, Ferrant E, Huet S, Sujobert P, Delabesse E, Ysebaert L, Lazarian G, Michallet AS, Bidet A, Dilhuydy MS, Delfau-Larue MH, Dupuis J, Clavert A, Drenou B, Maitre E, Troussard X, Cornet E, Le Bris Y, Lok A, Villemagne B, Barbier H, Béné MC, Tomowiak C, Tardy S, Cornillet-Lefebvre P, Quinquenel A, Guièze R, Barbieux S, Plantier I, Hieulle J, Gresta PF, Cornillon J, Dupire S, Laribi K, Feugier P, Algrin C, Lachenal F, Caillet A, Murati A, Inchiappa L, Lechat C, Dartigeas C, Montaut É, Molina L, Carras S. Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study. Leukemia. 2025 May;39(5):1247-1251. doi: 10.1038/s41375-025-02555-0. Epub 2025 Apr 1. PMID: 40169763; PMCID: PMC12055600. https://pmc.ncbi.nlm.nih.gov/articles/PMC12055600/
258. Vener C, Lillini R, De Angelis R, Bonfarnuzzo S, Poirel HA, Trama A, Visser O, Troussard X, Marcos-Gragera R, Maynadié M, Demuru E, Di Benedetto C, Johannesen TB, Solans M, Paapsi K, Guevara M, Mousavi SM, Blum M, Von Moos R, Bennett D, Ragusa R, Guilloteau A, McShane CM, Rossi S, Sant M; EUROCARE-6 Working Group (appendix pp 34-35). Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study. Eur J Cancer. 2025 May 2;220:115231. doi: 10.1016/j.ejca.2025.115231. Epub 2025 Jan 16. PMID: 40056559.
259. Tournilhac O, Bouabdallah K, Lecolant S, Hacini M, Laribi K, Bailly S, Belmondo T, Maerevoet M, Ysebaert L, Guidez S, Le Gouill S, Bonnet C, André M, Dupuis J, Thieblemont C, Bachy E, Daguindau N, Morschhauser F, Tricot S, Moulin C, Banos A, Houot R, Chauchet A, Gyan E, Cartron G, Farhat H, Camus V, Drenou B, Zerazhi H, Sibon D, Nicolas-Virelizier E, Delette C, Snauwaert S, Bailly S, Delarue R, Carras S, Ledoux-Pilon A, Parrens MC, Griolet S, Gaulard P, Delfau-Larue MH, de Leval L, Damaj GL. Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study. Blood Adv. 2025 Dec 23;9(24):6292-6304. doi: 10.1182/bloodadvances.2024015787. PMID: 40758949; PMCID: PMC12744279. https://pmc.ncbi.nlm.nih.gov/articles/PMC12744279/
260. Pénault-Llorca F, Audigier-Valette C, Lamy PJ, Stoppa Lyonnet D, Camparo P, Beaupère S, Troussard X, Gueroult Accolas L, Raymond G, Auday A, Blay JY, Sarkozy F. La médecine de précision en cancérologie : une réalité… sans équité [Precision medicine in oncology: A reality… without equity]. Bull Cancer. 2025 Jan;112(1):15-18. French. doi: 10.1016/j.bulcan.2024.08.008. Epub 2024 Oct 9. PMID: 39384522.
261. Crocetti E, Bennett D, Jooste V, Rossi S, Maso LD, Marcos-Gragera R, Smits S, Zagar T, Troussard X, Mayer-da-Silva A, Daubisse-Marliac L, Lourenço A, Katalinic A, Sanchez MJ, Vener C, Mousavi M, Ziliani V, Gatta G; EUROCARE-6 Working Group (appendix p 11). Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study. Eur J Cancer. 2025 Dec 9;231:116061. doi: 10.1016/j.ejca.2025.116061. Epub 2025 Oct 19. PMID: 41172568.
262. Desandes E, Clavel J, Molinié F, Delafosse P, Trétarre B, Systchenko T, Velten M, Coureau G, Hammas K, Cowppli-Bony A, Woronoff AS, Démaret V, Ganry O, Vigneron N, Bara S, Daubisse-Marliac L, Huré-Papaïconomou F, Monnereau A, Troussard X, Baldi I, Launoy G, Lacour B, Marec-Berard P. Trends in the Incidence of Cancer Among Adolescents and Young Adults Between 2000 and 2020: A Study Based on French Population-Based Registry Data. J Adolesc Young Adult Oncol. 2025 Dec;14(6):494-503. doi: 10.1089/jayao.2024.0136. Epub 2025 Mar 17. PMID: 40094816.
263. Wasse SK, Assogba E, Orazio S, Atsou KM, Rossi C, Guilloteau A, Gauthier S, Girard S, Poncet JM, Damaj G, Troussard X, Monnereau A, Dabakuyo-Yonli ST, Maynadie M. Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based Study. Cancers (Basel). 2025 Feb 19;17(4):711. doi: 10.3390/cancers17040711. PMID: 40002304; PMCID: PMC11853344. https://pmc.ncbi.nlm.nih.gov/articles/PMC11853344/
264. Damian L, Langlois V, Jardin F, Kerleau JM, Grall M, Levesque H, Benhamou Y, Sauvetre G. Predictors of progression to chronicity in newly diagnosed primary immune thrombocytopenia: a retrospective multicenter French study. Expert Rev Hematol. 2025 Apr-May;18(5):409-415. doi: 10.1080/17474086.2025.2495669. Epub 2025 Apr 24. PMID: 40259850.
265. Phina-Ziebin X, Bachy E, Gros FX, Di Blasi R, Herbaux C, Bay JO, Carras S, Bories P, Casasnovas O, Jardin F, Morschhauser F, Guffroy B, Mohty M, Gat E, Calvani J, Parrens MC, Poullot E, Traverse-Glehen A, Roulin L. Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study. Blood Adv. 2025 May 27;9(10):2500-2510. doi: 10.1182/bloodadvances.2024014732. PMID: 39874518; PMCID: PMC12148394. https://pmc.ncbi.nlm.nih.gov/articles/PMC12148394/
266. Valyraki N, Ahle G, Tabouret E, Houot R, Jardin F, Ghesquières H, Schmitt A, Paillassa J, Choquet S, Soussain C, Ursu R, Nichelli L, Legarff-Tavernier M, Mathon B, Rozenblum L, Mokhtari K, Hoang-Xuan K, Houillier C. Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study. Rev Neurol (Paris). 2025 Mar;181(3):200-209. doi: 10.1016/j.neurol.2024.11.003. Epub 2024 Dec 19. PMID: 39706697.
267. Cartron G, Houot R, Al Tabaa Y, Le Bras F, Ysebaert L, Choquet S, Jardin F, Bay JO, Gros FX, Morschhauser F, Casasnovas O, Gastinne T, Thieblemont C, Joris M, Ricard L, Regny C, Drieu La Rochelle L, Feugier P, Marcais A, Griolet S, Tarte K, Laurent C, Sesques P. Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study. Nat Cancer. 2025 Jul;6(7):1173-1183. doi: 10.1038/s43018-025-00941-2. Epub 2025 Apr 3. PMID: 40181090.
268. Mainguy A, Soussain C, Touitou V, Bennedjai A, Kodjikian L, Ghesquières H, Damaj G, Gressin R, Ducloyer JB, Chinot O, Vautier A, Moluçon-Chabrot C, Ahle G, Taillandier L, Marolleau JP, Chauchet A, Jardin F, Cassoux N, Malaise D, Toutée A, Touhami S, Le Garff-Tavernier M, Hoang-Xuan K, Choquet S, Houillier C. High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study. Bone Marrow Transplant. 2025 Mar;60(3):297-304. doi: 10.1038/s41409-024-02477-y. Epub 2024 Nov 19. PMID: 39562715; PMCID: PMC11893470. https://pmc.ncbi.nlm.nih.gov/articles/PMC11893470/
269. Clément E, Addeo P, Sauvanet A, Turco C, Marchese U, Dokmak S, Laurent C, Ayav A, Turrini O, Sulpice L, Souche R, Perinel J, Birnbaum DJ, Facy O, Gagnière J, Schwarz L, Piessen G, Regenet N, Iannelli A, Regimbeau JM, Lenne X, Heyd B, Gaujoux S, El Amrani M, Doussot A; Collaborators. Benefit of splenectomy in distal pancreatectomy for neuroendocrine tumours: multicentre retrospective study. BJS Open. 2025 May 7;9(3):zraf038. doi: 10.1093/bjsopen/zraf038. PMID: 40357650; PMCID: PMC12070039. https://pmc.ncbi.nlm.nih.gov/articles/PMC12070039/
270. Dananai C, Alaux M, Vibert E, Facy O, Schwarz L, Boleslawski E, Scatton O, Iannelli A, Le Roy B, Mohkam K, Truant S, Herrero A, Saleh NB, Millet G. Radioembolization prior to liver resection may increase the risk of severe biliary complications: A multicenter, retrospective cohort study performed in France. Surg Oncol. 2025 Feb;58:102186. doi: 10.1016/j.suronc.2025.102186. Epub 2025 Jan 20. PMID: 39862683. https://www.sciencedirect.com/science/article/pii/S0960740425000015?via%3Dihub
271. Sesques P, Manson G, Dubois S, Gros FX, Brisou G, Sarkozy C, Bernard S, Bourbon E, Fornecker LM, Durot E, Martin L, Chassagne-Clément C, Llamas Gutierrez F, Syrykh C, Delfau-Larue MH, Kanoun S, Vercellino L, Bodet-Milin C, Bahri H, Zhang Yin J, Dony A, Lebras L, Ochmann M, Baron M, Monjanel H, Le Calloch R, Claves F, Kirova Y, Gisselbrecht C, Guidez S, Bossard JB, Di Blasi R, Delette C, Fouillet L, Rhomdani M, Belhadj M, Crochet G, Amorim S, Safa F, Drieu La Rochelle L, Abraham J, Thieblemont C, Jardin F, Noel R, Bailly S, Renaud L, Guillermin Y, Delapierre B, Choquet S, Roulin L, Lamure S, Galicier L, Al Tabaa Y, Soussain C, Guièze R, Houot R, Tessoulin B. Large B-cell lymphoma: The LYSA pragmatic guidelines. Eur J Cancer. 2026 Jan;232:116070. doi: 10.1016/j.ejca.2025.116070. Epub 2025 Dec 3. PMID: 41352004.4 https://www.sciencedirect.com/science/article/pii/S0959804925009566?via%3Dihub
272. Charton E, Anota A, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Dulery R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Llamas Gutierrez F, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F, Houot R. Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma. Blood Adv. 2026 Mar 10;10(5):1773-1782. doi: 10.1182/bloodadvances.2025018057. PMID: 41512176; PMCID: PMC12969397. https://pmc.ncbi.nlm.nih.gov/articles/PMC12969397/
273. Mirghani H, Aupérin A, Even C, Larive A, Fayette J, Geoffrois L, Clatot F, Calderon B, Tao Y, Nguyen F, Fabiano E, Kreps S, Gaultier AL, Bidault F, Puech J, Morin B, Picavet L, Tartour E, Ben Hariz A, Chevrot M, Monard L, Veyer D, Badoual C, Péré H, Blanchard P. Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial. J Clin Oncol. 2026 Mar 20;44(9):787-800. doi: 10.1200/JCO-25-00835. Epub 2026 Jan 22. PMID: 41570275.
274. Selimoglu-Buet D, Chevret S, Santini V, Thépot S, Morabito M, Adès L, Laplane L, Giagounidis A, Droin N, Lübbert M, Sapena R, Nimubona S, Torregrosa-Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, Metzgeroth G, Onida F, Paul F, Patriarca A, Stamatoullas A, Götze K, Chermat F, Platzbecker U, Fenaux P, Solary E, Itzykson R. Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia? Leukemia. 2026 Apr;40(4):806-815. doi: 10.1038/s41375-026-02901-w. Epub 2026 Mar 9. PMID: 41803403; PMCID: PMC13056520. https://pmc.ncbi.nlm.nih.gov/articles/PMC13056520/
275. Fayette J, Cropet C, Toullec C, Burgy M, Bruyas A, Sire C, Lagrange A, Clatot F, Vinches M, Iacob M, Martin L, Kaminsky MC, Vansteene D, Salas S, Champagnac A, Saintigny P, Gautier J, Pérol D, Bourhis J. Durvalumab combined with weekly carboplatin/paclitaxel as first-line treatment of patients with recurrent and/or metastatic HNSCC not eligible for cisplatin-based chemotherapies: results of the multicenter prospective study FRAIL-IMMUNE. ESMO Open. 2026 Apr;11(4):106946. doi: 10.1016/j.esmoop.2026.106946. Epub 2026 Apr 9. PMID: 41962312; PMCID: PMC13091201. https://pmc.ncbi.nlm.nih.gov/articles/PMC13091201/
276. Dieudonné A, Terro A, Dumouchel A, Perret S, Pommier A, Edet-Sanson A, Vera P, Di Fiore F, Augusto L, Decazes P, Tonnelet D. Clinical value of per-treatment whole-body single-time-point automated dosimetry for [177Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 2026 Mar 7. doi: 10.1007/s00259-026-07823-4. Epub ahead of print. PMID: 41792565.
277. Lagrue E, Benzerdjeb N, Laé M, Lanic MD, Pissaloux D, Narducci F, Benderradji H, Champagnac A, Decamps C, Nicaise Y, Uro-Coste E, Costes-Martineau V, Lépine C; REFCOR. Low-Grade Nasopharyngeal Papillary Adenocarcinoma: Toward a Better Molecular, Epigenetic, and Clinicopathological Understanding With Ontological Perspective. Am J Surg Pathol. 2026 Apr 21. doi: 10.1097/PAS.0000000000002561. Epub ahead of print. PMID: 42012880.
278. Haw Y, Krings G, Hsiao WY, Zhan H, Hou Y, Zhang G, Zhang H, Wei S, Yang W, Laé M, Post MD, Liu Y, Shamir ER, Rosa M, Siziopikou K, Schnitt S, Chen YY, Li X. Clinicopathologic Analyses of 34 Cases of High-Grade Serous-Like Carcinoma (HG-SL-Ca) of the Breast. Am J Surg Pathol. 2026 May 1;50(5):543-549. doi: 10.1097/PAS.0000000000002516. Epub 2026 Feb 25. PMID: 41735183. https://journals.lww.com/ajsp/fulltext/2026/05000/clinicopathologic_analyses_of_34_cases_of.8.aspx
279. Watson S, Botsen D, Djelouah M, Bibeau F, Bieche I, Deleval N, Di Fiore F, Gornet JM, Pocard M, Ducreux M, Bouché O. Liver and peritoneal metastases of unknown primary site: French Intergroup Clinical Practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, SFP, SFR, ACHBT, SFRO, SNFCP, AFEF, RENAPE, NET-CAPI). Eur J Cancer. 2026 May 15;239:116696. doi: 10.1016/j.ejca.2026.116696. Epub 2026 Mar 25. PMID: 41905243.
280. Juul SJ, Rossetti S, Aleman BMP, van Leeuwen FE, van der Kaaij MAE, Giusti F, Meijnders P, Raemaekers JMM, Kluin-Nelemans HC, Spina M, Krzisch D, Bigenwald C, Stamatoullas A, André M, Plattel WJ, Hutchings M, Maraldo MV. Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials. J Cancer Surviv. 2026 Jun;20(3):883-894. doi: 10.1007/s11764-024-01694-0. Epub 2024 Oct 18. PMID: 39422824; PMCID: PMC13144188. https://pmc.ncbi.nlm.nih.gov/articles/PMC13144188/
281. Deschamps A, Marin C, Gerbault Q, Toullec C, Clatot F, Bernadach M, Fayette J, Daste A, Ceruse P, Burgy M, Champetier C, Abdeddaim C, Saada-Bouzid E, Tchiknavorian X, Zanetta S, Auquier P, Ciccolini J, Salas S. The CetuxIMAX study: a population pharmacokinetic approach to modelling the pharmacokinetics and pharmacodynamics relationships of Cetuximab in patients with head and neck cancer. Cancer Chemother Pharmacol. 2026 Apr 29;96(1):44. doi: 10.1007/s00280-026-04892-y. PMID: 42053579.
282. Zent CS, Tiacci E, Kreitman RJ, Tadmor T, Tallman MS, Wörmann BJ, Andritsos LA, Arons E, Banerji V, Barrientos JC, Bhat SA, Blachly JS, Broccoli A, Call TG, Dearden C, Demeter J, Dietrich S, El-Sharkawi D, Fagarasanu A, Falini B, Forconi F, Gerrie AS, Gladstone DE, Gozzetti A, Hampel PJ, Hermel DJ, Iyengar S, Johnston JB, Juliusson G, Kipps TJ, Lauria F, Lozanski G, Parikh SA, Park JH, Polliack A, Quest G, Rai KR, Ravandi F, Robak T Prof, Rogers KA, Saven A, Seymour JF, Tam CS, Troussard X, Zenz T, Zinzani PL, Grever MR. Updated consensus guidelines for the diagnosis and management of patients with hairy cell leukemia (HCL) and HCL-variant. Blood. 2026 Apr 14:blood.2025032757. doi: 10.1182/blood.2025032757. Epub ahead of print. PMID: 41980020. https://ashpublications.org/blood/article/doi/10.1182/blood.2025032757/567757/Updated-consensus-guidelines-for-the-diagnosis-and?guestAccessKey=
283. Gower N, Feugier P, Westin JR, Schiano de Colella JS, Tilly H, Palomba ML, Julia E, Damaj GL, Durand A, Flinn IW, Lemonnier F, Morineau N, Ysebaert L, Bartlett N, Thieblemont C, Ribrag V, Gastinne T, Arthur D, Fouillet L, Guidez S, Houot R, da Silva MG, Barnes J, Bijou F, Cartron G, Martin Garcia-Sancho AM, Eradat HA, Cheminant M, López-Guillermo AL, Abrisqueta P, Abraham J, Sarkozy C, Izutsu K, Crochet G, Sehn LH, Gkasiamis A, Yge ML, Chartier L, Fowler NH, Xerri L, Salles GA, Morschhauser F. Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis. Blood. 2026 Mar 31:blood.2026033126. doi: 10.1182/blood.2026033126. Epub ahead of print. PMID: 41915772.
284. Thompson C, Trněný M, Morschhauser F, Salles G, Reagan PM, Hertzberg M, Zhang H, Thieblemont C, Hu B, Fonseca G, Kim WS, Martelli M, Mehta A, Singh A, Yan M, Hirata J, Sugidono M, Lee C, Sharman JP, Mehta-Shah N, Flowers CR, Tilly H, Chua N, Casasnovas RO, Miall F, Kim TM, Tsai XC, Nasta S, Lee ST, Friedberg JW. PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study. Blood. 2026 Jan 15;147(3):254-265. doi: 10.1182/blood.2025028848. PMID: 40997297; PMCID: PMC12824648. https://pmc.ncbi.nlm.nih.gov/articles/PMC12824648/
285. Maurer MJ, Prochazka VK, El-Galaly TC, Flowers CR, Villa D, Bachy E, Cahn EJ, Fournier M, Larson MC, Dietrich CE, Jakobsen LH, Ghesquières H, Kridel R, Gandhi MK, Cheah CY, Hawkes EA, Seymour JF, Freeman CL, Clausen MR, Wahlin BE, Friedberg JW, Casulo C, Habermann TM, Wang Y, Nastoupil LJ, de Nully Brown P, Belada D, Janíková A, Mocikova H, Fürst T, Feugier P, Tilly H, Haioun C, Davies AJ, Cartron G, Burack R, Chihara D, Martin P, Cohen JB, Lossos IS, Kahl BS, Sehn LH, Smedby KE, Salles G, Trneny M, Link BK, Morschhauser F, Cerhan JR. FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma. J Clin Oncol. 2026 Jan 10;44(2):117-128. doi: 10.1200/JCO-25-00892. Epub 2025 Dec 2. PMID: 41329901; PMCID: PMC12674000. https://pmc.ncbi.nlm.nih.gov/articles/PMC12674000/
286. Morschhauser F, Salles G, Sehn LH, Herrera AF, Friedberg JW, Trněný M, Lenz G, Sharman JP, Herbaux C, Burke JM, Matasar M, Collins GP, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Pinto A, Rai S, Izutsu K, Greil R, Mykhalska L, Bergua-Burgués JM, Cheung MC, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Jiang Y, McCall B, Chohan S, Sugidono M, Yan M, Lee Batlevi C, Tilly H, Flowers CR. Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2026 Jan;44(1):71. doi: 10.1200/JCO-25-02667. Epub 2025 Nov 20. Erratum for: J Clin Oncol. 2025 Dec 10;43(35):3698-3705. doi: 10.1200/JCO-25-00925. PMID: 41264903. https://ascopubs.org/doi/10.1200/JCO-25-02667?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
287. Erbella F, Bachy E, Cartron G, Gat E, Manson G, Morschhauser F, Gros FX, Roulin L, Tessoulin B, Bories P, Tournilhac O, Ricard L, Guidez S, Choquet S, Casasnovas RO, Brisou G, Campidelli A, Castilla-Llorente C, Jardin F, Gyan E, Guffroy B, Abraham J, Decroocq J, Chauchet A, Joris M, Claves F, Carras S, Guillerm G, Loschi M, Hermine O, Taguy-Schimidt A, Le Gouill S, Houot R, Di Blasi R. Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry. Blood Adv. 2026 Jan 27;10(2):392-401. doi: 10.1182/bloodadvances.2025016727. PMID: 41124667; PMCID: PMC12828827. https://pmc.ncbi.nlm.nih.gov/articles/PMC12828827/
288. Montagne A, Bertho G, Papastergiou T, Chartier L, Ricci R, Jardin F, Ghesquières H, Rossi C, Morschhauser F, Haioun C, Ribrag V, Feugier P, Brisou G, Oberic L, Gaulard P, Giraud N, Bennani Y, Thieblemont C, Baud V. Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis. Blood Adv. 2026 Jan 27;10(2):358-366. doi: 10.1182/bloodadvances.2025017248. PMID: 41056515; PMCID: PMC12828828. https://pmc.ncbi.nlm.nih.gov/articles/PMC12828828/
289. Pellat A, Manfredi S, Truant S, Roth G, Le Malicot K, Bouché O, Piessen G, Tougeron D, Coriat R, Jary M, Schwarz L, Benoist S, Amil M, Desgrippes R, Lecomte T, Muller M, Guillet M, Locher C, Genet C, Gallois C, Taieb J, Hautefeuille V. Ability of computed tomography and endoscopic ultrasound to predict pathological tumor node metastasis staging of resected ampullary carcinomas (AC): an analysis of the Fédération Française de Cancérologie Digestive AC prospective cohort study. Gastrointest Endosc. 2026 Feb 17:S0016-5107(26)00112-4. doi: 10.1016/j.gie.2026.02.012. Epub ahead of print. PMID: 41713519. https://www.sciencedirect.com/science/article/pii/S0016510726001124?via%3Dihub
290. Cinotti R, Bonnet E, Borie F, Christou N, Demay J, Dupont H, Fieuzal L, Gouel A, Karsenti D, Kobeiter H, Lermitte E, Monard C, Montravers P, Morel J, Moskowicz D, Ortega-Deballon P, Pastene B, Rondeau N, Sabbagh C, Schwarz L, Souche R, Veziant J, De Jong A, Weiss E. Guidelines: Antibiotic prophylaxis in digestive and bariatric surgery, digestive endoscopy and interventional radiology. Anaesth Crit Care Pain Med. 2026 Jan 31;45(6):101757. doi: 10.1016/j.accpm.2026.101757. Epub ahead of print. PMID: 41628819.
291. Droogh DHM, Planting I, Chouitar Y, Groen JV, de Boer MGJ, van Prehn J, D’Angelica MI, Besselink MG, Bonsing BA, Groot Koerkamp B, van Santvoort HC, Schwarz L, Vahrmeijer AL, Mieog JSD; Dutch Pancreatic Cancer Group. Global practices in antibiotic prophylaxis for pancreatoduodenectomy: insights from an international survey among HPB surgeons. HPB (Oxford). 2026 Mar 10:S1365-182X(26)00089-4. doi: 10.1016/j.hpb.2026.02.009. Epub ahead of print. PMID: 41881710. https://www.sciencedirect.com/science/article/pii/S1365182X26000894?via%3Dihub
292. Aguilera Munoz L, Laurent L, Salmeron S, Lorenzo D, Sauvanet A, Paye F, Svrcek M, Navez J, Michoud C, Saurin JC, Périnel J, Adham M, Branche J, Schwarz L, Chaigneau T, Dupont B, Tribillon E, de Ponthaud C, Gaujoux S, Napoléon B, d’Engremont C, Deregnaucourt T, Foubert F, Le Rhun M, Ronot M, Nicolle R, Ernst O, Cros J, Vullierme MP, Rebours V. Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approach. HPB (Oxford). 2026 Mar 14:S1365-182X(26)00091-2. doi: 10.1016/j.hpb.2026.03.001. Epub ahead of print. PMID: 41905867.
293. Giuliani T, Siriwardena AK, Vollmer CM, Hilal MA, Adham M, Barreto SG, Boggi U, Castillo CF, Del Chiaro M, Falconi M, Friess H, Frigerio I, Fusai GK, Gianotti L, Goh BKP, Halloran CM, Hartwig W, He J, Hogg ME, Jiang K, Katz MHG, Kleeff J, Labori KJ, Lillemoe KD, Pandanaboyana S, Rangelova E, Schwarz L, Serrablo A, Uzunoglu FG, Zerbi A, Dervenis C, Neoptolemos JP, Büchler MW, Besselink MG, Ferrone CR, Hackert T, Salvia R, Shrikhande SV, Strobel O, Werner J, Wolfgang CL, Marchegiani G; International Study Group for Pancreatic Surgery. The International Study Group for Pancreatic Surgery (ISGPS) Definition and Classification of Postpancreatectomy Mortality. Ann Surg. 2026 Jan 23. doi: 10.1097/SLA.0000000000007019. Epub ahead of print. PMID: 41572457.
294. Sesques P, Houot R, Al Tabaa Y, Le Bras F, Ysebaert L, Choquet S, Jardin F, Bay JO, Gros FX, Morschhauser F, Rossi C, Gastinne T, Thieblemont C, Joris M, Ricard L, Regny C, La Rochelle LD, Feugier P, Marcais A, Griolet S, Tarte K, Laurent C, Cartron G. Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse. Haematologica. 2026 May 21. doi: 10.3324/haematol.2026.300537. Epub ahead of print. PMID: 42163719. https://haematologica.org/article/view/14188